<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">ACS Omega</journal-id>
    <journal-id journal-id-type="iso-abbrev">ACS Omega</journal-id>
    <journal-id journal-id-type="publisher-id">ao</journal-id>
    <journal-id journal-id-type="coden">acsodf</journal-id>
    <journal-title-group>
      <journal-title>ACS Omega</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2470-1343</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9773354</article-id>
    <article-id pub-id-type="doi">10.1021/acsomega.2c03398</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Network Science
and Group Fusion Similarity-Based
Searching to Explore the Chemical Space of Antiparasitic Peptides</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9756-6745</contrib-id>
        <name>
          <surname>Ayala-Ruano</surname>
          <given-names>Sebastián</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath2">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2721-1142</contrib-id>
        <name>
          <surname>Marrero-Ponce</surname>
          <given-names>Yovani</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff3" ref-type="aff">§</xref>
        <xref rid="aff4" ref-type="aff">∥</xref>
        <xref rid="aff5" ref-type="aff">⊥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2421-0382</contrib-id>
        <name>
          <surname>Aguilera-Mendoza</surname>
          <given-names>Longendri</given-names>
        </name>
        <xref rid="aff5" ref-type="aff">⊥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <name>
          <surname>Pérez</surname>
          <given-names>Noel</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9908-2418</contrib-id>
        <name>
          <surname>Agüero-Chapin</surname>
          <given-names>Guillermin</given-names>
        </name>
        <xref rid="aff6" ref-type="aff">#</xref>
        <xref rid="aff7" ref-type="aff">∇</xref>
      </contrib>
      <contrib contrib-type="author" id="ath6">
        <name>
          <surname>Antunes</surname>
          <given-names>Agostinho</given-names>
        </name>
        <xref rid="aff6" ref-type="aff">#</xref>
        <xref rid="aff7" ref-type="aff">∇</xref>
      </contrib>
      <contrib contrib-type="author" id="ath7">
        <name>
          <surname>Aguilar</surname>
          <given-names>Ana Cristina</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Grupo
de Medicina Molecular y Traslacional (MeM&amp;T), Escuela de Medicina,
Colegio de Ciencias de la Salud (COCSA), <institution>Universidad San Francisco de Quito</institution>, Av. Interoceánica Km 12 1/2 y Av. Florencia, Quito 17-1200-841, <country>Ecuador</country></aff>
      <aff id="aff2"><label>‡</label>Colegio
de Ciencias e Ingenierías “El Politécnico”, <institution>Universidad San Francisco de Quito (USFQ)</institution>, Quito 170901, <country>Ecuador</country></aff>
      <aff id="aff3"><label>§</label><institution>Computer-Aided
Molecular “Biosilico” Discovery and Bioinformatics Research
International Network (CAMD-BIR IN)</institution>, Cumbayá, Quito 170901, <country>Ecuador</country></aff>
      <aff id="aff4"><label>∥</label>Universidad
San Francisco de Quito (USFQ), <institution>Instituto
de Simulación Computacional (ISC-USFQ)</institution>, Diego de Robles y vía Interoceánica, Quito 170157, Pichincha, <country>Ecuador</country></aff>
      <aff id="aff5"><label>⊥</label>Departamento
de Ciencias de la Computación, <institution>Centro
de Investigación Científica y de Educación Superior
de Ensenada (CICESE)</institution>, Baja California 22860, <country>Mexico</country></aff>
      <aff id="aff6"><label>#</label>CIIMAR/CIMAR,
Interdisciplinary Centre of Marine and Environmental Research, <institution>University of Porto</institution>, Terminal de Cruzeiros do Porto de Leixões, Av. General Norton
de Matos s/n, 4450-208 Porto, <country>Portugal</country></aff>
      <aff id="aff7"><label>∇</label>Department
of Biology, Faculty of Sciences, <institution>University
of Porto</institution>, Rua do Campo
Alegre, 4169-007 Porto, <country>Portugal</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>ymarrero@usfq.edu.ec</email> or <email>ymarrero77@yahoo.es</email>. Phone: <phone>+593-2-297-1700</phone> (ext. 4021). <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.uv.es/yoma/">http://www.uv.es/yoma/</uri> or <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://ymponce.googlepages.com/home">http://ymponce.googlepages.com/home</uri>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>06</day>
      <month>12</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>20</day>
      <month>12</month>
      <year>2022</year>
    </pub-date>
    <volume>7</volume>
    <issue>50</issue>
    <fpage>46012</fpage>
    <lpage>46036</lpage>
    <history>
      <date date-type="received">
        <day>31</day>
        <month>05</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>21</day>
        <month>11</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2022 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2022</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_0011" id="ab-tgr1"/>
      </p>
      <p>Antimicrobial peptides (AMPs) have appeared as promising
compounds
to treat a wide range of diseases. Their clinical potentialities reside
in the wide range of mechanisms they can use for both killing microbes
and modulating immune responses. However, the hugeness of the AMPs’
chemical space (AMPCS), represented by more than 10<sup>65</sup> unique
sequences, has represented a big challenge for the discovery of new
promising therapeutic peptides and for the identification of common
structural motifs. Here, we introduce network science and a similarity
searching approach to discover new promising AMPs, specifically antiparasitic
peptides (APPs). We exploited the network-based representation of
APPs’ chemical space (APPCS) to retrieve valuable information
by using three network types: chemical space (CSN), half-space proximal
(HSPN), and metadata (METN). Some centrality measures were applied
to identify in each network the most important and nonredundant peptides.
Then, these central peptides were considered as queries (Qs) in group
fusion similarity-based searches against a comprehensive collection
of known AMPs, stored in the graph database <italic>StarPepDB</italic>, to propose new potential APPs. The performance of the resulting
multiquery similarity-based search models (<italic>mQSSMs</italic>) was evaluated in five benchmarking data sets of APP/non-APPs. The
predictions performed by the best <italic>mQSSM</italic> showed a
strong-to-very-strong performance since their external Matthews correlation
coefficient (MCC) values ranged from 0.834 to 0.965. Outstanding MCC
values (&gt;0.85) were attained by the <italic>mQSSM</italic> with
219
Qs from both networks CSN and HSPN with 0.5 as similarity threshold
in external data sets. Then, the performance of our best <italic>mQSSM</italic> was compared with the APPs prediction servers <italic>AMPDiscover</italic> and <italic>AMPFun</italic>. The proposed model showed its relevance
by outperforming <italic>state-of-the-art</italic> machine learning
models to predict APPs. After applying the best <italic>mQSSM</italic> and additional filters on the non-APP space from <italic>StarPepDB</italic>, 95 AMPs were repurposed as potential APP hits. Due to the high
sequence diversity of these peptides, different computational approaches
were applied to identify relevant motifs for searching and designing
new APPs. Lastly, we identified 11 promising APP lead candidates by
using our best <italic>mQSSMs</italic> together with diversity-based
network analyses, and 24 web servers for activity/toxicity and drug-like
properties. These results support that network-based similarity searches
can be an effective and reliable strategy to identify APPs. The proposed
models and pipeline are freely available through the <italic>StarPep
toolbox</italic> software at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://mobiosd-hub.com/starpep">http://mobiosd-hub.com/starpep</uri>.</p>
    </abstract>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>FundaÃ§Ã£o para a CiÃªncia e a Tecnologia</institution>
            <institution-id institution-id-type="doi">10.13039/501100001871</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>UIDB/04423/2020</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Universidad San Francisco de Quito</institution>
            <institution-id institution-id-type="doi">10.13039/501100010654</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>16905</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Universidad San Francisco de Quito</institution>
            <institution-id institution-id-type="doi">10.13039/501100010654</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>16897</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>European Regional Development Fund</institution>
            <institution-id institution-id-type="doi">10.13039/501100008530</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>UIDP/04423/2020</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>European Regional Development Fund</institution>
            <institution-id institution-id-type="doi">10.13039/501100008530</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>UIDB/04423/2020</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Universitat de ValÃ¨ncia</institution>
            <institution-id institution-id-type="doi">10.13039/501100003508</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NA</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>FundaÃ§Ã£o para a CiÃªncia e a Tecnologia</institution>
            <institution-id institution-id-type="doi">10.13039/501100001871</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>UIDP/04423/2020</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ao2c03398</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ao2c03398</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <label>1</label>
    <title>Introduction</title>
    <p>In the last several decades,
antimicrobials have contributed to
preventing and treating infectious diseases caused by bacteria, viruses,
fungi, and parasites.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Nonetheless, several
causes have created conditions for the emergence of multidrug-resistant
(MDR) pathogens that are not treatable with the available drugs.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> According to the World Health Organization, antimicrobial
resistance (AMR) is one of the top ten global public health threats
facing humanity in this century, so this is a worrying issue with
potential consequences for human, animal, and environmental health.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup></p>
    <p>In this scenario, it is mandatory to search
for new antimicrobials
that are less susceptible to evolutionary resistance mechanisms and
that decrease damaging inflammation. Antimicrobial peptides (AMPs)
or cationic host defense peptides (CHDPs) have appeared as promising
compounds to control infectious diseases avoiding AMR, due to their
exceptional microbicidal properties and/or by immunomodulating host
responses.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> AMPs are small compounds, commonly
with fewer than 50 amino acids, amphipathic properties, and a net
positive charge between 2 and 9 at physiological pH.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> These molecules are part of the primary immune responses,
the first defense barrier against microbial pathogens of different
living organisms, including bacteria, plants, fungi, invertebrates,
amphibians, and mammals.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></p>
    <p>Some advantages
of AMPs over traditional antimicrobials are slower
emergence of resistance, antibiofilm activity, modes of action that
do not rely on specific targets, and capacity to modulate host immune
responses.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Therefore, the effectiveness
of CHDPs resides on the wide range of mechanisms they can use for
both killing microbes and modulating immune responses, which depend
on their concentration and dose, external stimuli, target cell or
tissue, administration mechanism, host microbiota, and so forth.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> AMPs can kill microbes affecting their extracellular
dynamics, mainly by the membrane perturbation of pathogens, using
different mechanisms. Moreover, these compounds can interrupt transcription,
replication, cell wall synthesis, and other important processes by
binding to intracellular molecular targets.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> Some of the CHDPs’ immunomodulatory actions are the recruitment
of leukocytes to the site of infection.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup></p>
    <p>It has also been proven that AMPs have potential uses to treat
a wide range of diseases, including infections caused by MDR bacteria,<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref9">9</xref></sup> chronic inflammatory diseases like asthma,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> arthritis,<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> and colitis,<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> and some types of cancers.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> Some CHDPs’ antimicrobial activities such as antiparasitic,
antiviral, and antifungal have been less explored but have a great
potential to combat infectious diseases caused by nonbacterial pathogens.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> Considering this prospect, in this report, we
have focused on the AMPs’ antiparasitic activity, which could
help to treat malaria and neglected tropical diseases such as Leishmaniases,
and Chagas disease, among others.<sup><xref ref-type="bibr" rid="ref15">15</xref></sup></p>
    <p>Parasitic organisms are the causative agents of some of the world’s
most devastating and prevalent infections.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> This group of pathogens includes members such as the protozoans <italic>Trypanosoma</italic>, <italic>Leishmania</italic>, <italic>Plasmodium</italic>, and helminths such as <italic>Schistosoma</italic>, <italic>Wuchereria</italic>, and <italic>Echinococcus</italic>. Parasitic diseases remain a
major public health problem worldwide. Among the billions of people
suffering from these diseases, more than a million die annually, and
one person in every four persons harbors parasitic worms. Therefore,
there is an urgent need to develop tools, as well as new drug candidates
and strategies, to overcome the upcoming burden of parasitic diseases.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Although poorly explored, antiparasitic peptides
(APPs) demonstrate high potential for future application in therapeutics
of infectious diseases, especially parasitic neglected ones.<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> That is, peptide drugs for neglected
diseases are still at early stages compared to other drugs developed
for chronic and noninfectious diseases. But even at a slow pace, studies
and research on APPs are being demonstrated to be a reality for the
treatment of parasitic neglected diseases.<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup></p>
    <p>There are multiple sources to retrieve AMPs, such as natural
peptides
produced as part of the immune system of different organisms,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> synthetic peptides derived from natural CHDPs,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> cryptic peptides obtained from proteomes or
microbiomes using bioinformatics,<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup> mass spectrometry-based
proteomics experiments with fragmentation techniques,<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> and so forth. Therefore, AMPs’ chemical space (AMPCS)
is huge; it is estimated that there are more than 10<sup>65</sup> unique
sequences of peptides with 50 residues or fewer,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> which represent a big challenge for the discovery of new
promising bioactive peptides and the identification of common features
(e.g., sequence and structural motifs determining their relevant biological
functions).<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> In this context, computational-aided
pipelines have been proposed as efficient alternatives to do high-throughput
screening (HTS) of CHDPs.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup></p>
    <p>Traditionally,
strategies applied for the discovery of AMPs have
relied on bioinformatics methods such as sequence and structure-based
alignment searches; pattern-matching approaches like profile Hidden
Markov Models and regular expressions; evolutionary algorithms; molecular
fingerprint comparisons; and quantitative structure–activity
relationship (QSAR) models.<sup><xref ref-type="bibr" rid="ref27">27</xref>−<xref ref-type="bibr" rid="ref29">29</xref></sup> More recently, machine learning
(ML) algorithms, sometimes in combination with the aforementioned
methods, have been extensively used to predict and discover new potential
AMPs.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> Most of the ML methods to predict
AMPs have focused on supervised strategies, requiring labeled data
sets to train these models. These supervised algorithms have shown
some issues regarding the size, quality, diversity, application domain,
and representativeness of data sets required to train the models,
which can produce inappropriate predictions and wrong results.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup></p>
    <p>Considering the limitations and drawbacks
of the available methods
to discover AMPs, we present a novel approach based on network science
tools and multiquery similarity searching models (<italic>mQSSMs</italic>) to discover new potential AMPs, specifically APPs. Network science
is a discipline that studies complex systems, large collections of
components that are characterized by having a lot of interactions,
emergence, self-organization, and adaptation, among other properties.<sup><xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref></sup> Similarity searching is a virtual screening strategy that compares
a molecular query, characterized by molecular features, against the
set of features of other molecules from a database, obtaining a ranked
list that possesses the most similar molecules to the query at the
top of the list. That is, similarity searching involves the use of
a similarity measure (coefficient) to score the degree of similarity
between a query structure (or several queries) and each target compound
in a database, and the <italic>similar property principle</italic> means that the highest-ranked query structures by a similarity measure
are likely to have similar properties to those of the template(s).<sup><xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref35">35</xref></sup></p>
    <p>We have taken advantage of network-based representation of
APPs’
chemical space (APPCS) to retrieve valuable information by using chemical
space networks (CSNs), half-space proximal networks (HSPNs), and metadata
networks (METNs). Some centrality measures were applied to identify
the most important nodes, and these APPs were taken as queries to
perform similarity-based searches by group fusion (MAX-SIM rule) models
against the graph database <italic>StarPepDB</italic>(<xref ref-type="bibr" rid="ref36">36</xref>) (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://mobiosd-hub.com/starpep">http://mobiosd-hub.com/starpep</uri>). These <italic>mQSSMs</italic> allowed us to repurpose new potential
APPs. It is worth mentioning that this is the first time we are exploring
the chemical space from <italic>StarPepDB</italic> to retrieve valuable
information on certain known AMPs. To validate the worth of this strategy,
we evaluated the <italic>mQSSMs</italic> performance in five benchmarking
data sets of APP/non-APPs (retrospective studies), and classification
results were contrasted with the performance metrics of ML APPs prediction
servers <italic>AMPDiscover</italic> (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://biocom-ampdiscover.cicese.mx">https://biocom-ampdiscover.cicese.mx</uri>)<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> and <italic>AMPFun</italic> (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://fdblab.csie.ncu.edu.tw/AMPfun/index.html">http://fdblab.csie.ncu.edu.tw/AMPfun/index.html</uri>).<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p>
  </sec>
  <sec id="sec2">
    <label>2</label>
    <title>Data Sets and Methods</title>
    <p>Our workflow
was divided into four stages: (i) network analysis,
(ii) multiquery similarity searching models, (iii) APPs prediction,
and (iv) discovery of sequence motifs. The first stage consisted of
data extraction, networks building, similarity cutoff analysis, the
study of global networks properties, calculation of centrality measures,
and retrieval of the most central APPs sets by each metric. The second
stage included the design of network-based similarity searching models,
selection of the best ones, and comparison of our models with ML approaches
to predict APPs. The third stage was the prediction of new potential
APPs by applying the best <italic>mQSSMs</italic> to screen the entire <italic>StarPepDB</italic> and subsequently some filters of toxicity and
hemolytic activities; the resulting APPs were confirmed with the annotation
of external Web servers. The last stage was the discovery of sequence
motifs shared by the potential antiparasitic leads, using multiple
sequence alignments, alignment-free methods, and the <italic>PROSITE</italic> server. The Abstract graphic summarizes all of these stages.</p>
    <sec id="sec2.1">
      <label>2.1</label>
      <title>Networks Analysis</title>
      <sec id="sec2.1.1">
        <label>2.1.1</label>
        <title>Data Collection</title>
        <p>The APPs were obtained
from <italic>StarPepDB</italic>, a graph database that contains 45 120
nodes representing AMPs and additional nodes for metadata, obtained
from about 40 data sources.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> As far as
we know, this is one of the largest integrated AMPs databases until
now. The <italic>StarPepDB</italic> is embedded in the <italic>StarPep
toolbox</italic>, a software designed to perform network analysis
of data contained in this resource.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Thus,
we filtered the database by metadata function using the “<italic>Antiparasitic</italic>” search term and retrieved 550 APPs
(see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI1-A</ext-link> in the Supporting Information,
a FASTA file).</p>
      </sec>
      <sec id="sec2.1.2">
        <label>2.1.2</label>
        <title>Creation of Networks</title>
        <p>The <italic>StarPep toolbox</italic> allowed us to create three types of networks:
CSNs, HSPNs, and METNs. CSNs and HSPNs are similarity or correlation
networks,<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> defined as <italic>G</italic> = (<italic>V</italic>, <italic>E</italic>) where <italic>V</italic> is a set of nodes and <italic>E</italic> is a set of edges. In these
networks, nodes in <italic>V</italic> represent AMPs, characterized
by multidimensional molecular descriptor (sequences-based features)
vectors, and edges linking nodes in <italic>E</italic> are pairwise
similarity relationships between sequence-based descriptors of the
peptides. Thus, nodes of CSNs and HSPNs are connected because they
are similar to each other, instead of the existence of physical interactions
among these compounds.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> In addition, METNs
are multilayer networks, defined as <italic>G</italic> = (<italic>V</italic>, <italic>E</italic>, <italic>L</italic>), where <italic>V</italic> and <italic>E</italic> are the sets of nodes and edges,
the same as in CSNs and HSPNs, and <italic>L</italic> is the set of
layers representing different edge types or labels.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> METNs have two layers: metadata and AMPs. Metadata consist
of additional information on AMPs such as origin, database, function,
target pathogen, crossref, <italic>N</italic>-terminus, <italic>C</italic>-terminus, and unusual amino acids. Note that CSNs and HSPNs are
networks where there is only one kind of node and relationship. However,
a more interconnected system has been considered for further analysis,
by connecting the nodes representing AMPs with their different types
of metadata such as origin, database, function, target pathogen, and
so on.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> Among these nodes, peptides, and
metadata, the edges depict multitype links and hierarchical connections
for a better organization and network navigation. Hierarchy relationships
between nodes are established by the edges in both layers of METNs.</p>
        <p>In CSNs and HSPNs, the set of molecular descriptors that codifies
an AMP can be derived from sequence-based descriptors by applying
statistical and aggregation operators on amino acid property vectors
(see SI1-2 in ref (<xref ref-type="bibr" rid="ref36">36</xref>)). The cross-out sequence’s descriptors were calculated using <italic>StarPep software</italic> by selecting all the available amino acid
properties (e.g., the heat of formation, side-chain mass, among others),
all groups of amino acid types (e.g., aliphatic, aromatic, unfolding,
and so forth), and traditional aggregation operators, but those based
on GOWAWA and the Choquet integral. The neighborhood (<italic>k</italic> neighbors up to 6) was included as one of the aggregation operators.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup></p>
        <p>The selection of suitable sequence descriptors
to map the chemical
space of AMPs is a key parameter to create CSNs and HSPNs, which was
widely explored in ref (<xref ref-type="bibr" rid="ref36">36</xref>). From the defined chemical space, the similarity relationships between
AMPs form a symmetric similarity matrix <italic>M</italic> of size <italic>|V|</italic> × <italic>|V|</italic>, with <italic>|V|</italic> being the number of AMPs. The symmetric property of <italic>M</italic> means that <italic>∀</italic><sub><italic>u,v</italic></sub><italic>M</italic><sub><italic>u,v</italic></sub> = <italic>M</italic><sub><italic>v,u</italic></sub>, where <italic>u</italic> and <italic>v</italic> are any two nodes from <italic>V</italic>. Each entry <italic>M</italic><sub><italic>u,v</italic></sub> corresponds to the similarity
score between nodes <italic>u</italic> and <italic>v</italic> in <italic>M</italic>. Then, a similarity threshold <italic>t</italic> is applied
on <italic>M</italic> to filter the most prominent similarity relations,
and if the similarity scores are greater than or equal to <italic>t</italic> they remain on <italic>M</italic>; otherwise, they are
assigned to zero.<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> The new matrix is known as threshold
matrix <italic>T</italic>, and both CSN and HSPN were constructed
from <italic>T</italic> (see eq 1 in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI2-A1</ext-link>).<sup><xref ref-type="bibr" rid="ref36">36</xref></sup></p>
        <p>Therefore, CSN and HSPN are
weighted and undirected networks, with
similarity values between AMPs as weights, and there exists an edge
between two nodes if this value is greater than or equal to a given
cutoff <italic>t</italic>.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> The criteria
applied to choose this similarity threshold are explained in the next
section.</p>
        <p>The main difference between CSNs and HSPNs is the way
they are
constructed. CSNs create a similarity matrix of all pairwise relationships
between nodes and establish an edge only if the pairwise similarity
value is equal to or greater than a given threshold.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> On the other hand, HSPNs do not consider all the possible
pairwise relationships between nodes; instead, these networks apply
the half-space proximal test over the set of nodes,<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> obtaining a connected network with a small fraction of
the maximum number of edges.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> HSPNs have
been applied to create a vector representation of residue contacts
in protein 3D structures,<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> but this is
the first time we are using them to represent the AMPCS.</p>
        <p>In
this report, we created CSN, HSPN, and METNs of the 550 APPs
available in <italic>StarPepDB</italic>. METNs of origin, database,
function, and target pathogen were constructed using the <italic>Metadata
Network option</italic> from the <italic>StarPep toolbox</italic>.
For CSN and HSPN, we first chose the default sequence identity value
to remove redundant APPs. Thus, 415 APPs sharing a maximum of 98%
of identity were used to generate the networks (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI1-A_I</ext-link>), applying the local alignment algorithm Smith-Waterman<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> and BLOSUM-62 substitution matrix. Second, an
optimized set of alignment-free sequence descriptors and methods were
used to represent them as recommended in ref (<xref ref-type="bibr" rid="ref36">36</xref>). Next, the Euclidean distance
metric with MIN–MAX normalization to establish the pairwise
similarity relationships among nodes was applied. The similarity threshold
of both networks was set up considering different parameters, as is
explained in the next section. Then, we retrieved CSN and HSPN giant
components (405 APPs comprised the giant component of both networks,
see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI1-A_II</ext-link>), defined as the largest connected
component of a network, using the <italic>Central Informative Nodes
in Network Analysis (CINNA)</italic> R package.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> The giant components of both networks were used onward
for all calculations. To visualize these networks in a meaningful
way, we examined a family of force-directed layout algorithms that
can be used to spatialize the network and rearrange nodes. These algorithms
change the position of nodes by considering that they repulse each
other, whereas similarity relationships may attract their attached
nodes like springs.<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> Particularly, the <italic>Fruchterman-Reingold</italic> algorithm<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> was the most suitable for drawing CSN and HSPN of APPs.</p>
        <p>In
addition, we created two null network models with the same number
of nodes and edges of CSN and HSPN giant components by applying the <italic>Gilbert</italic> method, a variation of the well-known <italic>Erdős-Rényi</italic> model. In this random network model, the edges are chosen uniformly
and randomly from the set of all possible edges of the network.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> We created these random networks using the <italic>sample_gnm</italic> function from the <italic>igraph</italic> R package,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> applying a random seed of 100 with the <italic>seed</italic> function. All network visualizations were customized
with <italic>Gephi</italic>(<xref ref-type="bibr" rid="ref53">53</xref>) and Inkscape.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p>
      </sec>
      <sec id="sec2.1.3">
        <label>2.1.3</label>
        <title>Networks Similarity Threshold Analysis</title>
        <p>We constructed CSNs and HSPNs of APPs according to specifications
explained in the previous section but by changing the similarity threshold
in the range of 0.05 and 0.90 with a step of 0.05 (36 networks in
total, 18 for each network type). As long as the cutoff increases,
some edges were removed from networks, becoming increasingly sparser
graphs. Then, we retrieved some metrics of these networks at different
similarity cutoffs using the <italic>StarPep toolbox</italic>. The
first metric was the network density, which is the actual number of
edges over the maximum number of edges in a network<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> (see eq 2 in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI2-A2</ext-link>).</p>
        <p>We also removed singletons, nodes without edges connected to it,
or the ones with zero-degree,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> filtering
the 550 APPs by <italic>Network measure</italic> with attribute <italic>Weighted Degree</italic> to be greater than zero.</p>
        <p>The modularity
of the networks was also analyzed at each similarity
cutoff. This is a network measure that compares the density in a community
with the expected density for the same group of nodes on a random
network.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> We calculated modularity and
the number of communities using the <italic>modularity optimization</italic> clustering algorithm (based on the Louvain method)<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> (see eq 3 in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI2-A3</ext-link>).</p>
        <p>According to a previous report, the average clustering coefficient
(ACC), a global measure of nodes neighborhood connectivity,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> is a good indicator to set up the proper similarity
threshold to create similarity networks,<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> so we calculated the ACC for all networks using the <italic>transitivity</italic> function from the <italic>igraph</italic> R package,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> which applies the definition of ACC for weighted
networks proposed in ref (<xref ref-type="bibr" rid="ref57">57</xref>). Therefore, we decided the best similarity threshold for
CSNs and HSPNs evaluating all the aforementioned network measures.
Plots of this parameter were created with the <italic>ggplot2</italic>(<xref ref-type="bibr" rid="ref58">58</xref>) R package.</p>
      </sec>
      <sec id="sec2.1.4">
        <label>2.1.4</label>
        <title>Study of Global Network Properties</title>
        <p>The global characterization of networks is useful for identifying
general topological and structural patterns, and, thus, understanding
the phenomena we are modeling, in this case the representation of
the APPCS. These calculations were applied only to CSN and HSPN with
the best similarity thresholds. In the last section, we obtained some
of these features such as density, number of communities, modularity,
singletons, and ACC for CSNs and HSPNs and their respective null network
models. These properties are related to the number of edges, connectivity,
and community structure of networks.</p>
        <p>Moreover, we measured some
properties associated with component structure and reachability of
networks, including the number of connected components, diameter,
and average shortest path (ASP). A connected component is a subnetwork
whose nodes can be reached from one another by traversing edges.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> Diameter is defined as the largest shortest
path of a network, and ASP corresponds to the expected length of the
shortest path between two nodes chosen at random (see eq 4 in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI2-A4</ext-link>).<sup><xref ref-type="bibr" rid="ref55">55</xref></sup></p>
        <p>We
also plotted the degree distributions of networks. All of these
metrics were calculated with the <italic>StarPep toolbox</italic> and <italic>igraph</italic> R package.</p>
      </sec>
      <sec id="sec2.1.5">
        <label>2.1.5</label>
        <title>Centrality Analysis</title>
        <p>Centrality
is a key concept in network science; it provides an intuition for
the importance of nodes in networks, which may play critical roles
in the system that is being modeled.<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> In
this study, the most influential nodes can provide useful information
from the APPCS, and also these peptides can be used to retrieve new
potential APPs by similarity searches. Therefore, we calculated the
four centrality measures available in the <italic>StarPep toolbox</italic> (weighted degree (WD), betweenness (BE), harmonic (HC), and hub-bridge
(HB)) for both CSN and HSPN, and all of these values were normalized
with the min–max method. Also, we explored possible correlations
between these measures with the Spearman coefficient, using the <italic>corrmorant</italic> R package.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> To corroborate
the correlation analysis, common APPs were identified within the top-50
most central nodes retrieved by different centrality measures, using <italic>in-house</italic> R scripts.</p>
        <p>To retrieve the most central and
unique APP sets by each metric, first, we decreased the redundancy
among them by applying the <italic>Scaffold extraction</italic> plugin
from the <italic>StarPep toolbox</italic>. These peptides were ranked
in decreasing order by each centrality measure, and redundant sequences
were removed at a given percentage of sequence identity. We chose
a sequence identity value of 50% to consider that a particular peptide
is related to an already selected central peptide and, as a consequence,
removed from the network. For these sequence comparisons, we applied
the Smith-Waterman local alignment algorithm<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> and BLOSUM-62 substitution matrix. Then, we retrieved APPs whose
centrality scores were at least 10% of the most central APP value
by each metric. We applied this process for both CSN and HSPN.</p>
      </sec>
    </sec>
    <sec id="sec2.2">
      <label>2.2</label>
      <title>Similarity Searching Models</title>
      <sec id="sec2.2.1">
        <label>2.2.1</label>
        <title>Description of Models</title>
        <p>Our models
consisted of multiquery searches against some databases, and the combination
of similarity scores by group fusion applying various similarity thresholds.
All the components of our models are explained below:<list list-type="bullet"><list-item><p><bold>Query data sets:</bold> The queries of our model
were the most central and nonredundant APP sets by the four centrality
measures considered in this study for CSN, HSPN, and the consensus
sets of both networks. In addition, we considered the set of 13 singletons
(see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI1-B</ext-link>, a FASTA file), which was the
same for both networks, and some combinations of the most promising
sets. Finally, we had twenty-one query data sets, seven for each network,
six for the combination of both networks, and the set of singletons.</p></list-item><list-item><p><bold>Target or calibration databases:</bold> We considered
five databases of APPs and non-APPs reported in ref (<xref ref-type="bibr" rid="ref37">37</xref>). There were different
balanced and unbalanced data sets stored in five FASTA files with
thousands of labeled APPs and non-APPs (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI1C-G</ext-link>).</p></list-item><list-item><p><bold>Similarity coefficient:</bold> The Smith-Waterman
local alignment algorithm,<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> implemented
in BioJava,<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> with BLOSUM-62 substitution
matrix allowed us to calculate the similarity scores, which were numbers
between 0 and 1.</p></list-item><list-item><p><bold>Group fusion:</bold> In this fusion model, the
reference peptide can be presented by any one of the extracted peptidic
scaffolds (reduced chemical space); however, the similarity measure
(defined below) was kept constant. Some studies have demonstrated
that fusion by similarity scores and the maximum fusion rule are the
best parameters for these models,<sup><xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref62">62</xref></sup> so we implemented
these standards in our pipeline. Therefore, given a reference peptide <italic>Q</italic> and a peptide <italic>D</italic> from the target database,
the algorithm of group fusion measures similarity scores <italic>S</italic>(<italic>Q</italic>, <italic>D</italic>) between <italic>Q</italic> and all the molecules of the database, and retrieves the single
fused score by the maximum fusion rule. Thus, the fused score is the
largest of all similarity scores.</p></list-item><list-item><p><bold>Similarity threshold:</bold> After applying the
group fusion model for all queries of a data set, we ranked the results
in decreasing order of the fused scores. Then, we tested seven similarity
thresholds in the range of 0.3 and 0.9 with a step of 0.1. Therefore,
all of the peptides with fused scores greater than or equal to the
specific cutoff were predicted as APPs.</p></list-item></list></p>
        <p>We performed these models with the <italic>StarPep toolbox</italic>, using the <italic>Multiple query sequences</italic> option of the <italic>Peptides search by</italic> menu. In this software, group fusion
by similarity scores and the maximum fusion rule are implemented by
default, and users can change the query set, target/calibration data
set, similarity coefficient, and similarity threshold. Thus, we imported
each of the five target databases to the <italic>StarPep toolbox</italic> in different workspaces, and we applied multiquery sequence searches
with each of the twenty-one queries sets against each of the target
databases. The query data sets were composed of central and singleton
peptides, previously selected by <italic>scaffold extraction</italic> protocol with the starPep toolbox. As we had twenty-one query data
sets and seven similarity thresholds, we evaluated 147 different <italic>mQSSMs</italic>. The best models were identified using several classification
performance measures, which are explained in the next section. We
presented a graphical summary of the pipeline used in our <italic>mQSSMs</italic> in <xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>A.</p>
        <fig id="sch1" position="float">
          <label>Scheme 1</label>
          <caption>
            <title>(A) Workflow Corresponding to the Similarity Searching
Modeling Process
(Retrospective Study) and (B) APPs Selection Process (Prospective
Virtual Screening Study)</title>
            <p id="sch1-fn1">This scheme was
created with <italic>Inkscape</italic>.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_0009" id="gr1" position="float"/>
        </fig>
      </sec>
      <sec id="sec2.2.2">
        <label>2.2.2</label>
        <title>Selection of the Best Models and Comparisons
with ML APPs Prediction Servers</title>
        <p>To assess the relative performance
of the <italic>mQSSMs</italic>, we used the five data sets of APPs
and non-APPs recently provided in ref (<xref ref-type="bibr" rid="ref37">37</xref>). These data sets were obtained from <italic>StarPepDB</italic>, whose description can be found in <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://biocom-ampdiscover.cicese.mx/dataset">https://biocom-ampdiscover.cicese.mx/dataset</uri>. Each set of queries and similarity thresholds was wrapped into
a calibration algorithm, comprising a modified virtual screening simulation
technique.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> In these models, we used just
the queries’ subset of APPs as the multiquery calibration group,
while the active and inactive subsets were the target data sets. The
prediction ensemble, composed of similarity scores of each peptide <italic>D</italic> in the target data set with each query <italic>Q</italic>, was ordered with the MAX-SIM multiclassifier.<sup><xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref64">64</xref></sup> The ordered list was scanned for every active and inactive APP-labeled
peptide of the target database, and these results were used to calculate
performance metrics, obtained from the confusion matrix<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>A). The performance metrics were used to evaluate the quality
of the early retrieval.</p>
        <p>In ref (<xref ref-type="bibr" rid="ref66">66</xref>) the authors reported a unified overview of methods
that are currently used for evaluating classification tasks, as well
as the advantages and downsides of each approach. Here, we used the
several performance metrics derived from the confusion matrix of the
actual versus predicted class (see eq 5 in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI2-A5</ext-link>): (i) sensitivity (SN, also called true positive rate, hit rate,
and recall), (ii) precision (PR), (iii) specificity (SP, also called
true negative rate), (iv) accuracy (<italic>Q</italic>%—global
good classification), (v) kappa, and (vi) Matthews correlation coefficient
(MCC).</p>
        <p>Finally, the performance metrics for the five calibration
data
sets were used to carry out comparisons among models by using the
statistics of Iman and Davenport.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> These
statistical tests showed that Friedman’s value was undesirably
conservative. Whenever significant differences were detected, the
post hoc tests<sup><xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref68">68</xref>,<xref ref-type="bibr" rid="ref69">69</xref></sup> were used to compare the Friedman best-ranked models or reference
measure with the remaining ones. This step-up procedure works in the
opposite direction to Holm’s test and allows the control of
the so-called familywise type I error arising from multiple pairwise
comparisons.<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> After applying these statistical
tests, we obtained the best <italic>mQSSM</italic>. A second comparison
was carried out to compare our best similarity searching models with
ML-based models reported in the literature for APP prediction<sup><xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref38">38</xref></sup> by using the same five calibration data sets.</p>
      </sec>
    </sec>
    <sec id="sec2.3">
      <label>2.3</label>
      <title>New APPs Predictions</title>
      <p>We used the <italic>StarPepDB</italic> as a space of search to discover new potential
APPs and the <italic>StarPep toolbox</italic> for exploring the APPCS.
First, we removed the toxic peptides and known APPs from <italic>StarPepDB</italic>, applying the not operator and filtering the database by metadata
Function with <italic>Antiparasitic</italic>, <italic>Toxic</italic>, and <italic>Toxic/Venom</italic> queries. Then, we reduced the
redundancy of these sequences with the <italic>nonredundant</italic> plugin, applying a similarity identity value of 0.95 with the local
alignment algorithm Smith-Waterman,<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> and
BLOSUM-62 substitution matrix. These nontoxic, non-APP, and nonredundant
peptides were the chemical space to search for new potential APPs.
Hence, we used the best <italic>mQSSM</italic>, obtained in the previous
section, as a prediction tool to detect new APPs in the previously
mentioned chemical space.</p>
      <p>We removed from the space of unknown
and nontoxic APPs those virtual hits with sequence length greater
than or equal to 30, sharing a similarity score of one, and that contain
nonstandard amino acids. To avoid toxic peptides in our list of APPs
candidates, we uploaded the FASTA file
of these sequences to the <italic>ToxinPred</italic> server (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://webs.iiitd.edu.in/raghava/toxinpred/">https://webs.iiitd.edu.in/raghava/toxinpred/</uri>),<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> applying the <italic>SVM (Swiss-Prot)
+ Motif based</italic> model with an SVM threshold of zero. The APPs
predicted as toxic by ToxinPred were discarded. We also used the <italic>HemoPI</italic> server (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://webs.iiitd.edu.in/raghava/hemopi/">https://webs.iiitd.edu.in/raghava/hemopi/</uri>)<sup><xref ref-type="bibr" rid="ref71">71</xref></sup> to remove potential hemolytic peptides,
applying <italic>SVM + Motif (HemoPI-1)</italic> and <italic>SVM +
Motif (HemoPI-2)</italic> models, and removing peptides with a PROB
score greater than or equal to 0.7 in both models. Then, the remaining
virtual hits were further reduced by developing mQSSM aimed at detecting
similarities with the most central toxic peptides available in <italic>StarPepDB.</italic> The centrality analysis was performed as explained
above.</p>
      <p>In addition, we used <italic>AMPDiscover</italic>(<xref ref-type="bibr" rid="ref37">37</xref>) and <italic>AMPFun</italic>(<xref ref-type="bibr" rid="ref38">38</xref>) servers to confirm our APP predictions. Therefore, Random
Forest
and Deep Learning models of <italic>AMPDiscover</italic> and <italic>AMPFun</italic> were evaluated on the virtual hits. Then, we created
a CSN and an HSPN with the remaining virtual hits and applied nonredundant
scaffold reduction based on harmonic centrality with a 0.7 identity
threshold on each network. Thus, we obtained the consensus set of
sequences between both networks. Ultimately, a CSN was constructed
with the remaining set of virtual hits. We selected the singletons
and communities with two nodes, applied the <italic>Modularity optimization</italic> clustering algorithm, and extracted the nonredundant set for each
community applying a similarity threshold of 0.5, the Harmonic centrality,
and the other parameters established by default. Therefore, singletons,
communities of two nodes, and representatives for each cluster were
the lead peptides proposed as potential APPs in this study. A graphical
summary of this section is depicted in <xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>.</p>
      <fig id="sch2" position="float">
        <label>Scheme 2</label>
        <caption>
          <title>Filtering Workflow to Obtain the New Potential
APPs</title>
          <p id="sch2-fn1">This scheme was
created with <italic>Inkscape</italic>.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_0010" id="gr2" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.4">
      <label>2.4</label>
      <title>Discovery of Sequence Motifs</title>
      <sec id="sec2.4.1">
        <label>2.4.1</label>
        <title>Multiple Sequence Alignments</title>
        <p>We
created a CSN with lead compounds and obtained its communities using
the <italic>Modularity optimization</italic> clustering algorithm.
Then, these resulting clusters were aligned independently by using
multiple sequence alignment (MSA), publicly available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ebi.ac.uk/Tools/msa/">https://www.ebi.ac.uk/Tools/msa/</uri>. To determine consensus motifs within each cluster, three different
MSA algorithms were applied with their default parameters: Multiple
Alignment using Fast Fourier Transform (<italic>MAFFT</italic>) v7
with the iterative refinement FFT-NS-i option,<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> Multiple Sequence Comparison by Log-Expectation (<italic>MUSCLE</italic>),<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> and Tree-based Consistency
Objective Function for Alignment Evaluation (<italic>T-Coffee</italic>).<sup><xref ref-type="bibr" rid="ref74">74</xref></sup></p>
        <p>The resulting MSAs were employed
to extract the consensus sequences by considering the frequency of
each residue at every column of the alignment. The residues with a
higher score than a certain threshold estimated for each column will
conform to the positions (putative motifs) in the consensus. Both
the <italic>Jalview</italic> software v2.11.1.4<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> and the <italic>EMBOSS Cons</italic> web server<sup><xref ref-type="bibr" rid="ref76">76</xref></sup> (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ebi.ac.uk/Tools/msa/emboss_cons/">https://www.ebi.ac.uk/Tools/msa/emboss_cons/</uri>) were used for this aim.</p>
      </sec>
      <sec id="sec2.4.2">
        <label>2.4.2</label>
        <title>Alignment-Free Method</title>
        <p>Lead compounds
were analyzed with the Sensitive, Thorough, Rapid, Enriched Motif
Elicitation (<italic>STREME</italic>) software<sup><xref ref-type="bibr" rid="ref77">77</xref></sup> to discover fixed-length patterns (ungapped motifs) that
were enriched in each cluster. The predictions were performed via
its web server (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://meme-suite.org/meme/tools/streme">https://meme-suite.org/meme/tools/streme</uri>), fully integrated
within the widely used <italic>MEME</italic> Suite of sequence analysis
tools (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://meme-suite.org/meme/">https://meme-suite.org/meme/</uri>).<sup><xref ref-type="bibr" rid="ref78">78</xref></sup> Control sets were generated by shuffling
input peptides. The motif width was set between 3 and 5 amino acids
in length. <italic>STREME</italic> evaluated motifs using a statistical
test of the enrichment of matches for the target motif in the query
set of sequences compared to a set of control sequences.<sup><xref ref-type="bibr" rid="ref77">77</xref></sup></p>
      </sec>
      <sec id="sec2.4.3">
        <label>2.4.3</label>
        <title>Motif Search in PROSITE</title>
        <p>Potential
APPs were queried by the Motif Search tool (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.genome.jp/tools/motif/">https://www.genome.jp/tools/motif/</uri>), integrated into the <italic>GenomeNet Suite</italic> (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.genome.jp/">https://www.genome.jp/</uri>).<sup><xref ref-type="bibr" rid="ref79">79</xref></sup><italic>PROSITE</italic> Pattern and <italic>PROSITE</italic> Profile libraries<sup><xref ref-type="bibr" rid="ref80">80</xref></sup> were
only considered for the motif search within each cluster.</p>
      </sec>
    </sec>
  </sec>
  <sec id="sec3">
    <label>3</label>
    <title>Results and Discussion</title>
    <sec id="sec3.1">
      <label>3.1</label>
      <title>Navigating and Mining the APPCS</title>
      <sec id="sec3.1.1">
        <label>3.1.1</label>
        <title>Networks of APPs</title>
        <p>Before creating
CSN and HSPN, we conducted some analyses to decide the proper similarity
threshold for both networks. The similarity cutoff to define edges
is a mandatory parameter to create CSNs, and it is optional for HSPNs.
The selection of this threshold is not trivial because it modifies
network topology and some properties like density, modularity, among
others.<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> There is a lack of predefined
standard values for this task because it depends on the input data,
similarity relationships between nodes, and other aspects. Therefore,
it is recommended to define this threshold case by case,<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> so we studied what would be the best cutoff
values for both networks taking into account some network metrics.</p>
        <p>Some previous articles have found similarity networks have an inversely
proportional relationship between their similarity threshold and density
values,<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref42">42</xref></sup> which means that networks with high cutoffs
have fewer edges and are sparser. Both CSNs and HSPNs showed the mentioned
behavior between similarity thresholds and density (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Tables SI2-1 and SI2-2</ext-link>). HSPN density values were much lower than
the corresponding values of CSN, as we expected because of the differences
between methods building these networks, as explained in the <xref rid="sec2" ref-type="other">Data Sets and Methods</xref> section. In addition, density
values were the same on HSPNs with a cutoff between 0.05 and 0.45
because the number of edges almost did not change (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Table SI2-2</ext-link>). If the density is too high, it would be complicated
to interpret network topological features, while at low values it
is likely to lose information, so an equilibrium between both extremes
is a must.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup></p>
        <fig id="fig1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Network measures to determine
the proper similarity threshold for
CSN and HSPN. (A) Density, (B) average clustering coefficient (ACC),
(C) modularity, (D) communities, and (E) singletons. This figure was
created with ggplot2 R package<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> and edited
with Inkscape.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_0001" id="gr3" position="float"/>
        </fig>
        <p>The ACC had a particular behavior, it increased
at low and high
similarity thresholds in the CSNs, and the HSPNs with high cutoffs
even had larger ACC than networks with lower values (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Tables SI2-1 and SI2-2</ext-link>). These results were counterintuitive because
the logic output would be that dense networks increase their connectedness,
while the sparser ones decrease this parameter. Nonetheless, adding
edges to some nodes does not guarantee that their neighbors are connected,
which is measured by ACC; instead, the opposite could occur,<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> as is shown in the HSPN results (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Table SI2-2</ext-link>).</p>
        <p>In ref (<xref ref-type="bibr" rid="ref42">42</xref>), the
authors studied the relationship between ACC and similarity threshold
in networks of small molecules, obtained from the World of Molecular
Bioactivity database and the PubChem Molecular Libraries Small Molecule
Repository. They found that the ACC versus similarity threshold function
of networks reconstructed from different data sets had a local maximum
in a cutoff value associated with the best clustering outcome, and
it would be the best option to choose.<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> Our results showed that the local maximum similarity thresholds
for CSN and HSPN were 0.90 and 0.65, respectively (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Tables SI2-1 and SI2-2</ext-link>). Moreover, additional parameters were analyzed
to confirm if these values were the best cutoffs, as explained below.</p>
        <p>The modularity of both types of networks did not change too much
at initial similarity cutoffs, but then these values increased until
a global maximum of 0.94 and 0.96 for CSNs and HSPNs respectively
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Tables SI2-1 and SI2-2</ext-link>). Higher values of this
network measure indicate if a community structure exists,<sup><xref ref-type="bibr" rid="ref81">81</xref></sup> and it is associated with the number of communities
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>D). An excessive
number of communities is not desirable because it is likely that some
of these clusters would be artifacts.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> In both CSN and HSPN, the number of communities at high similarity
thresholds increased too much compared to their low counterparts (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>D, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Tables SI2-1 and SI2-2</ext-link>), so these aspects were considered
to choose the similarity cutoff for both types of networks.</p>
        <p>The last parameter was the number of singletons (also well-known
as <italic>outliers</italic> or <italic>atypical</italic> sequences),
unique APPs not similar to other nodes from our networks. These peptides
are worth exploring because they could have new properties that enhance
their antiparasitic activity. This network measure had a behavior
as modularity, with no change at initial similarity thresholds, but
increasing their values at higher cutoffs (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>E, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Tables SI2-1 and SI2-2</ext-link>), and it is not desirable to have an excessive number of singletons
nor very few.</p>
        <p>Considering all metrics from the 36 networks with
different similarity
cutoffs (18 cutoff values for both CSNs and HSPNs), the best similarity
threshold for both types of networks was 0.65. The HSPN with this
similarity cutoff was the local maximum point of ACC, and it presented
intermediate values of density, modularity, communities, and singletons.
Although CSN with a similarity threshold of 0.65 was not the local
maximum of ACC, the other parameters were the most appropriate (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Tables SI2-1 and SI2-2</ext-link>).</p>
        <p>Therefore, we created CSN and
HSPN applying the 0.65 similarity
threshold. We obtained the giant components of both networks, and
we constructed null models with the same number of nodes and edges
of the giant components. <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> shows visualizations of both CSN and HSPN giant components
and their null models, with nodes colored by their community and sized
by their weighted degree or strength, calculated by summing up edge
weights of the adjacent edges for each node.<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> The graphml files of all networks are available as <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI3</ext-link>.</p>
        <fig id="fig2" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Network of APPs. (A) CSN and (B) HSPN giant components.
(C) CSN
and (D) HSPN random models with the same number of nodes and edges
as panels A and B. In all networks, nodes are colored by their community
and sized by their weighted degree. All the visualizations were created
with <italic>Gephi,</italic>(<xref ref-type="bibr" rid="ref53">53</xref>) applying
the <italic>Fruchterman-Reingold</italic> layout algorithm,<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> and edited with <italic>Inkscape</italic>.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_0002" id="gr4" position="float"/>
        </fig>
        <p>The size of all nodes from null networks was the
same (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>C,D)
because we created
these graphs using a random model that did not have APPs as nodes,
so there were no weights to calculate strength. Another noticeable
feature from <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> was that the real networks had an apparent community structure,
absent in the random models.</p>
        <p>We calculated some networks metrics
to measure in a formal way
the differences between CSN and HSPN, as well as between real and
random networks, in terms of their community structures and other
aspects. The number of vertices, singletons, and connected components
of CSN and HSPN were the same, which was shown in complete networks,
giant components, and random models (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Indeed, the singletons of both networks
were the same 13 APPs (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI1-B</ext-link>), so we
had only one set of these unique nodes for further analysis.</p>
        <table-wrap id="tbl1" position="float">
          <label>Table 1</label>
          <caption>
            <title>Global Networks Properties of the
Complete Graphs, Giant Components, and Random Models</title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">Network<xref rid="t1fn1" ref-type="table-fn">a</xref></th>
                <th style="border:none;" align="center">CSN</th>
                <th style="border:none;" align="center">HSPN</th>
                <th style="border:none;" align="center">CSN GC</th>
                <th style="border:none;" align="center">HSPN GC</th>
                <th style="border:none;" align="center">CSN RM</th>
                <th style="border:none;" align="center">HSPN RM</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">Vertices</td>
                <td style="border:none;" align="left">415</td>
                <td style="border:none;" align="left">415</td>
                <td style="border:none;" align="left">405</td>
                <td style="border:none;" align="left">405</td>
                <td style="border:none;" align="left">405</td>
                <td style="border:none;" align="left">405</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Edges</td>
                <td style="border:none;" align="left">19,302</td>
                <td style="border:none;" align="left">1,564</td>
                <td style="border:none;" align="left">19,294</td>
                <td style="border:none;" align="left">1,557</td>
                <td style="border:none;" align="left">19,294</td>
                <td style="border:none;" align="left">1,557</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Connected components</td>
                <td style="border:none;" align="left">5</td>
                <td style="border:none;" align="left">5</td>
                <td style="border:none;" align="left">1</td>
                <td style="border:none;" align="left">1</td>
                <td style="border:none;" align="left">1</td>
                <td style="border:none;" align="left">1</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Density</td>
                <td style="border:none;" align="left">0.2247</td>
                <td style="border:none;" align="left">0.0182</td>
                <td style="border:none;" align="left">0.2358</td>
                <td style="border:none;" align="left">0.0190</td>
                <td style="border:none;" align="left">0.2358</td>
                <td style="border:none;" align="left">0.0190</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">ACC</td>
                <td style="border:none;" align="left">0.6988</td>
                <td style="border:none;" align="left">0.0551</td>
                <td style="border:none;" align="left">0.6943</td>
                <td style="border:none;" align="left">0.0480</td>
                <td style="border:none;" align="left">0.2361</td>
                <td style="border:none;" align="left">0.0226</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Modularity</td>
                <td style="border:none;" align="left">0.234</td>
                <td style="border:none;" align="left">0.455</td>
                <td style="border:none;" align="left">0.233</td>
                <td style="border:none;" align="left">0.452</td>
                <td style="border:none;" align="left">0.071</td>
                <td style="border:none;" align="left">0.335</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Communities</td>
                <td style="border:none;" align="left">11</td>
                <td style="border:none;" align="left">15</td>
                <td style="border:none;" align="left">7</td>
                <td style="border:none;" align="left">9</td>
                <td style="border:none;" align="left">10</td>
                <td style="border:none;" align="left">12</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Singletons</td>
                <td style="border:none;" align="left">13</td>
                <td style="border:none;" align="left">13</td>
                <td style="border:none;" align="left">0</td>
                <td style="border:none;" align="left">0</td>
                <td style="border:none;" align="left">0</td>
                <td style="border:none;" align="left">0</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Diameter</td>
                <td style="border:none;" align="left">∞</td>
                <td style="border:none;" align="left">∞</td>
                <td style="border:none;" align="left">9</td>
                <td style="border:none;" align="left">12</td>
                <td style="border:none;" align="left">2</td>
                <td style="border:none;" align="left">6</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">ASP</td>
                <td style="border:none;" align="left">∞</td>
                <td style="border:none;" align="left">∞</td>
                <td style="border:none;" align="left">2.254</td>
                <td style="border:none;" align="left">3.732</td>
                <td style="border:none;" align="left">1.764</td>
                <td style="border:none;" align="left">3.166</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="t1fn1">
              <label>a</label>
              <p>All the measures were calculated
with igraph.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> GC: giant component, RM:
random model, ACC: average cluster coefficient, ASP: average shortest
path.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Density and ACC of HSPN tended to have lower values
than CSN, while
the opposite occurred with modularity, communities, diameter, and
ASP. This behavior is related to the way each network model is constructed
and the number of edges obtained by each process, as we explained
in <xref rid="sec2" ref-type="other">Data Sets and Methods</xref>. If a network has
many links, as is the case of CSNs, the network’s fraction
of the possible number of edges and its connectivity would increase,
which are the aspects measured by density and ACC, respectively.</p>
        <p>On the other hand, community detection in dense networks would
be difficult due to their interconnectedness between nodes, so assigning
a node to a specific cluster would be fuzzy.<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> This fact was observed in the lower modularity and number of communities
values in CSNs compared to HSPNs. The same pattern appeared in the
two measures related to reachability, diameter, and ASP (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>), a logical result
because dense networks like CSN have more possible paths to reach
a node from another one, so the diameter and ASP from CSN were lower
than the corresponding values in HSPN. The diameter and ASP for both
complete networks were assigned to be infinite because these models
had more than one component, so it is not possible to link some of
their nodes, and for convenience these values are infinite.</p>
        <p>Comparing the giant components with their random model counterparts,
the numbers of vertices, edges, connected components, density, and
singletons were the same. However, modularity, number of communities,
and ACC values of giant components were greater than the random models
(<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Hence, the
real networks showed a better community structure and neighbor connectivity,
as is shown visually in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>. In CSN and HSPN, communities could be APP families that
share certain chemical and structural properties. The diameter and
ASP values were also greater in real networks, so the reachability
of these graphs was lower compared to the null models.</p>
        <p>In addition,
we plotted the degree distributions of giant components
and random models from CSN and HSPN to explore some properties and
if these networks behave as general models.<sup><xref ref-type="bibr" rid="ref55">55</xref></sup></p>
        <p>The degree of the HSPN giant component and their random models
are distributed normally, as is shown with their bell-shaped distribution
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A), revealing
the random behavior of HSPN. The randomness in HSPN was expected due
to the way this network is constructed, following the half-space proximal
test, as was explained in <xref rid="sec2" ref-type="other">Data Sets and Methods</xref>. By contrast, the CSN giant component pattern distribution was not
as evident as the other networks in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A, so we visualized its degree distribution
with the complementary cumulative distribution function (CCDF) because
it reflects these patterns in a better way.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> The cumulative degree distribution showed that in CSN the probabilities
for finding a node with degree <italic>x</italic> or higher were similar
across different degree values (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B), so there was no power-law behavior due to the lack
of scale invariance between degree and CCDF.<sup><xref ref-type="bibr" rid="ref82">82</xref></sup> Therefore, the CSN was more related to a random model, as well as
HSPN.</p>
        <fig id="fig3" position="float">
          <label>Figure 3</label>
          <caption>
            <p>(A) Degree distributions in a log–log scale of the giant
components and random models from both CSN and HSPN. The horizontal
axis is vertex degree <italic>k</italic>, and the vertical axis is
the probability of a node to have a degree of <italic>k</italic>.
(B) Complementary cumulative distribution function of the CSN giant
component degree. The horizontal axis is vertex degree <italic>x</italic>, and the vertical axis is the probability for finding a node of
degree <italic>k</italic> greater than or equal to <italic>x</italic>. This figure was created with <italic>ggplot2</italic> R package<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> and edited with <italic>Inkscape</italic>.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_0003" id="gr5" position="float"/>
        </fig>
        <p>Moreover, the METNs showed valuable information
about the APPCS.
We observed that most of the APPs come from synthetic constructs,
which are observed as the largest node or hub in the network, and
a few of them are derived from parasites, bacteria, and animals (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A). As we expected,
the most prevalent functions were antiparasitic and antimicrobial,
but some of the APPs have been associated with antibacterial (Gram-positive
and Gram-negative), antifungal, and anticancer properties, among other
activities (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>B). The most predominant pathogen targets were some bacteria such
as <italic>Escherichia coli</italic> and <italic>Staphylococcus aureus</italic>, although we also found parasites such as <italic>Plasmodium</italic>, <italic>Leishmania</italic>, and <italic>Trypanosoma</italic> (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>C). The results of
pathogen targets can be biased because there are many more antimicrobial
essays made in bacteria than in parasites.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> Regarding databases, most of the APPs come from DBAASP,<sup><xref ref-type="bibr" rid="ref83">83</xref></sup> SATPdb,<sup><xref ref-type="bibr" rid="ref84">84</xref></sup> ParaPep,<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> and APD<sup><xref ref-type="bibr" rid="ref85">85</xref></sup> (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>D). ParaPep is one
of the biggest databases of validated APPs,<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> so including its information in starPepDB helped us to map the known
APPCS.</p>
        <fig id="fig4" position="float">
          <label>Figure 4</label>
          <caption>
            <p>METNs with metadata of (A) origin, (B) function, (C) target pathogen,
and (D) database. In all networks, red nodes are APPs, and the blue
ones are metadata, and all of them are sized by their degree. All
the visualizations were created with <italic>Gephi</italic>,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> applying the <italic>Fruchterman-Reingold</italic> layout algorithm,<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> and edited with <italic>Inkscape</italic>.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_0004" id="gr6" position="float"/>
        </fig>
      </sec>
      <sec id="sec3.1.2">
        <label>3.1.2</label>
        <title>Centrality Analysis and Influential but
Nonredundant APPs</title>
        <p>The results of normalized centrality measures
for all nodes from both CSN and HSPN can be found as <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI4-A and SI4-B</ext-link>, respectively. These centrality measures consider
different network properties to identify influential nodes, but some
metrics might have similar results. Hence, we studied possible correlations
between these variables with the Spearman coefficient. We applied
this correlation measure because the distributions of some of these
metrics were skewed (see main diagonal at <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>A,B), so the assumption of normality was
not satisfied, and other correlation coefficients like Pearson would
not be a good choice.<sup><xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref87">87</xref></sup></p>
        <fig id="fig5" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Spearman correlation analysis of centrality
measures from (A) CSN
and (B) HSPN. In panels A and B, the distribution of each variable,
the pairwise scatter plots with a fitted line, and the values of the
Spearman correlation are shown in the main diagonal, bottom diagonal,
and upper diagonal, respectively. On the right side of each correlogram,
the legend color shows the scale of the correlation coefficients.
This figure was created with <italic>corrmorant</italic> R package<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> and edited with <italic>Inkscape</italic>.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_0005" id="gr7" position="float"/>
        </fig>
        <p>In both kinds of networks, the centrality measures
of harmonic,
hub-bridge, and weighted degree had a high positive correlation between
them, greater than 0.80 in all cases, which is also shown graphically
in the pairwise scatter plots between these variables (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>). These results showed that
the notion of the importance of these three centrality measures is
highly related. Betweenness centrality had intermediate correlations
values with the rest of the metrics, so it was also associated with
the other measures, but at a lower level compared to the relationships
among the others. Correlation analysis was supported by the common
APPs in the top 50 most central nodes retrieved by different centrality
measures, showing similar associations between the centrality measures
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Tables SI2-3 and SI2-4</ext-link>). Considering these
outcomes, the centrality sets from correlated measures were merged
and tested together as queries against the validated data sets, as
is explained in the next section.</p>
        <p>An important aspect to consider
with the obtention of central nodes
was their representativeness by different communities, which was achieved
with the chosen criteria, as is shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Table SI2-5</ext-link>. Thus, our central nodes for each network and centrality
measure belonged to different communities, which in these networks
could be APPs families. In this way, the central nodes represented
the APPCS and most of its potential APPs families. However, these
influential nodes could be redundant in their communities because
they would be highly similar to one another.</p>
        <p>As a proof of concept
for the redundancy of peptides inside communities
of our networks, we extracted the APPs from CSN’s community
3 and obtained subcommunities of this cluster using the <italic>modularity
optimization</italic> algorithm, as is shown in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>.</p>
        <fig id="fig6" position="float">
          <label>Figure 6</label>
          <caption>
            <p>(A) APPs CSN and (B) subnetwork of 57 APPs from
CSN’s community
3 and its subcommunities. In both networks, nodes are colored by their
community and sized by their weighted degree. All the visualizations
were created with Gephi,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> applying the <italic>Fruchterman-Reingold</italic> layout algorithm,<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> and edited with <italic>Inkscape</italic>.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_0006" id="gr8" position="float"/>
        </fig>
        <p>Then, we obtained the sequences and other physicochemical
properties
of some representative APPs from each subcommunity (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). We observed that several
from CSN’s community 3 had the same sequence length of 29,
10, 5, and 16 amino acids in 1, 2, 3, and 5 subcommunities, respectively.
In addition, the same (or rather similar) amino acid residues composed
those peptides, and their physicochemical properties had similar values
(<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). Hence, in
general, it is expected that inside the most central nodes we could
obtain highly similar APPs, so it may be better to extract some nonredundant
sequences from the networks instead of just selecting the highest-ranked
ones by each centrality measure. To remove this potential redundancy
in APPs, and obtain central but nonredundant peptides, we applied
the <italic>Scaffold extraction</italic> plugin from the <italic>starPep
toolbox</italic>, as was explained in the centrality analysis section
of <xref rid="sec2" ref-type="other">Data Sets and Methods</xref>. Thus, we obtained
the most central and nonredundant APPs by each centrality measure
and network, and we exported them as FASTA files, which are available
as <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI5</ext-link>. These sets of influential and unique
APPs were used in the next section to retrieve new potential APPs
by similarity searching.</p>
        <table-wrap id="tbl2" position="float">
          <label>Table 2</label>
          <caption>
            <title>Sequences and Some Physicochemical
Properties of Representative APPs from Subcommunities of CSN’s
Community 3</title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="center"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">Community</th>
                <th style="border:none;" align="center">Name<xref rid="t2fn1" ref-type="table-fn">a</xref></th>
                <th style="border:none;" align="center">Sequence</th>
                <th style="border:none;" align="center">Length</th>
                <th style="border:none;" align="center">Charge<xref rid="t2fn2" ref-type="table-fn">b</xref></th>
                <th style="border:none;" align="center">Mol wt<xref rid="t2fn2" ref-type="table-fn">b</xref></th>
                <th style="border:none;" align="center">Hydrophobicity<xref rid="t2fn2" ref-type="table-fn">b</xref></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="center">
                  <bold>1</bold>
                </td>
                <td style="border:none;" align="left">starPep_09852</td>
                <td style="border:none;" align="left">GKGLXXGKXXGLXXGKXXGLXXGKXXGKR</td>
                <td style="border:none;" align="left">29</td>
                <td style="border:none;" align="left">6</td>
                <td style="border:none;" align="left">1611.25</td>
                <td style="border:none;" align="left">–0.26</td>
              </tr>
              <tr>
                <td style="border:none;" align="center"> </td>
                <td style="border:none;" align="left">starPep_09855</td>
                <td style="border:none;" align="left">GKGLXXGRXXGFXXGRXXGFXXGRXXGKR</td>
                <td style="border:none;" align="left">29</td>
                <td style="border:none;" align="left">6</td>
                <td style="border:none;" align="left">1763.30</td>
                <td style="border:none;" align="left">–0.37</td>
              </tr>
              <tr>
                <td style="border:none;" align="center">
                  <bold>2</bold>
                </td>
                <td style="border:none;" align="left">starPep_20193</td>
                <td style="border:none;" align="left">FPFFNQYVKL</td>
                <td style="border:none;" align="left">10</td>
                <td style="border:none;" align="left">1</td>
                <td style="border:none;" align="left">1302.68</td>
                <td style="border:none;" align="left">0.04</td>
              </tr>
              <tr>
                <td style="border:none;" align="center"> </td>
                <td style="border:none;" align="left">starPep_20234</td>
                <td style="border:none;" align="left">FPWFNQYVKL</td>
                <td style="border:none;" align="left">10</td>
                <td style="border:none;" align="left">1</td>
                <td style="border:none;" align="left">1341.72</td>
                <td style="border:none;" align="left">0.02</td>
              </tr>
              <tr>
                <td style="border:none;" align="center">
                  <bold>3</bold>
                </td>
                <td style="border:none;" align="left">starPep_09474</td>
                <td style="border:none;" align="left">FHPHE</td>
                <td style="border:none;" align="left">5</td>
                <td style="border:none;" align="left">0</td>
                <td style="border:none;" align="left">665.77</td>
                <td style="border:none;" align="left">–0.18</td>
              </tr>
              <tr>
                <td style="border:none;" align="center"> </td>
                <td style="border:none;" align="left">starPep_11159</td>
                <td style="border:none;" align="left">LHPHE</td>
                <td style="border:none;" align="left">5</td>
                <td style="border:none;" align="left">0</td>
                <td style="border:none;" align="left">631.76</td>
                <td style="border:none;" align="left">–0.19</td>
              </tr>
              <tr>
                <td style="border:none;" align="center">
                  <bold>4</bold>
                </td>
                <td style="border:none;" align="left">starPep_04155</td>
                <td style="border:none;" align="left">IASASCTTCICTCSCSS</td>
                <td style="border:none;" align="left">17</td>
                <td style="border:none;" align="left">0</td>
                <td style="border:none;" align="left">1641.10</td>
                <td style="border:none;" align="left">0.02</td>
              </tr>
              <tr>
                <td style="border:none;" align="center"> </td>
                <td style="border:none;" align="left">starPep_02009</td>
                <td style="border:none;" align="left">SCTTCVCTCSCCTT</td>
                <td style="border:none;" align="left">14</td>
                <td style="border:none;" align="left">0</td>
                <td style="border:none;" align="left">1415.83</td>
                <td style="border:none;" align="left">–0.05</td>
              </tr>
              <tr>
                <td style="border:none;" align="center">5</td>
                <td style="border:none;" align="left">starPep_13642</td>
                <td style="border:none;" align="left">WIQXITXLXXQXXXPF</td>
                <td style="border:none;" align="left">16</td>
                <td style="border:none;" align="left">0</td>
                <td style="border:none;" align="left">1145.51</td>
                <td style="border:none;" align="left">0.15</td>
              </tr>
              <tr>
                <td style="border:none;" align="center"> </td>
                <td style="border:none;" align="left">starPep_13916</td>
                <td style="border:none;" align="left">YIQXITXLXXQXXXPF</td>
                <td style="border:none;" align="left">16</td>
                <td style="border:none;" align="left">0</td>
                <td style="border:none;" align="left">1122.47</td>
                <td style="border:none;" align="left">0.11</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="t2fn1">
              <label>a</label>
              <p>ID of the peptides in starPepDB.</p>
            </fn>
            <fn id="t2fn2">
              <label>b</label>
              <p>The physicochemical properties
of
APPs were calculated with ToxinPred server.<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> Mol wt: molecular weight.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>The numbers of central nodes obtained from CSN with
hub-bridge,
weighted degree, and betweenness centrality measures were lower compared
to the values derived from HSPN, while for harmonic centrality these
values were almost the same for CSN and HSPN (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Table SI2-5</ext-link>). Moreover, the numbers of central APPs from both
CSN and HSPN with harmonic, hub-bridge, and weighted degree centrality
measures were greater than one hundred APPs, which was not the case
for betweenness centrality (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Table SI2-5</ext-link>).</p>
      </sec>
    </sec>
    <sec id="sec3.2">
      <label>3.2</label>
      <title>Multiquery Similarity Searching Models for
APPs</title>
      <sec id="sec3.2.1">
        <label>3.2.1</label>
        <title>Performance of the Best <italic>mQSSMs</italic></title>
        <p>In our <italic>mQSSMs</italic>, the constant parameters
were the similarity coefficient and group fusion model, while we varied
the query set, target database, and similarity threshold (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>A). Five target databases
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI1C-G</ext-link>, five FASTA files) were provided
in ref (<xref ref-type="bibr" rid="ref37">37</xref>), namely
D1–D5, and were used to calibrate and evaluate the novel <italic>mQSSMs</italic>. These databases included balanced data sets (D1,
D2, D4) with a similar proportion of positive and negative classes,
and unbalanced data sets (D3, D5), which have much more negative instances
than positive ones (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>). D1–D3 databases contain sequences of lengths between
5 and 100 amino acids, while sequences from D4–D5 have lengths
between 5 and 30 amino acids.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> The D1–D3
data sets were recently used as training, test, and external validation
data sets, respectively, to generate ML models by using genetic algorithm
metaheuristics and random forest (RF), where the default configurations
in the Weka tool v3.8 were applied.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> On
the other hand, D4–D5 databases were previously used as external
validation data sets to carry out a comparative study of the best
RF-based classification models obtained for APPs discrimination. Here,
we used these five benchmarking data sets of APP/non-APPs (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>) to compare the performance
between our <italic>mQSSMs</italic> and the algorithms reported in
the literature for predicting APPs.</p>
        <table-wrap id="tbl3" position="float">
          <label>Table 3</label>
          <caption>
            <title>Antiparasitic Data Sets to Calibrate/Evaluate
and Compare the <italic>mQSSMs</italic> Proposed in This Report with
Several Methods Reported in the Literature<xref rid="t3fn1" ref-type="table-fn">a</xref></title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">ID/Fasta
file</th>
                <th style="border:none;" align="center">Name</th>
                <th style="border:none;" align="center">Number of
sequences</th>
                <th style="border:none;" align="center">Positive
(APPs)</th>
                <th style="border:none;" align="center">Negative
(non-APPs)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">D1/SI1-C</td>
                <td style="border:none;" align="left">TR_starPep_AP</td>
                <td style="border:none;" align="left">198</td>
                <td style="border:none;" align="left">99</td>
                <td style="border:none;" align="left">99</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">D2/SI1-D</td>
                <td style="border:none;" align="left">TS_starPep_AP</td>
                <td style="border:none;" align="left">62</td>
                <td style="border:none;" align="left">31</td>
                <td style="border:none;" align="left">31</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">D3/SI1-F</td>
                <td style="border:none;" align="left">EX_starPep_AP</td>
                <td style="border:none;" align="left">11,182</td>
                <td style="border:none;" align="left">411</td>
                <td style="border:none;" align="left">10,771</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">D4/SI1-F</td>
                <td style="border:none;" align="left">B-TS_starPep_AP</td>
                <td style="border:none;" align="left">57</td>
                <td style="border:none;" align="left">26</td>
                <td style="border:none;" align="left">31</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">D5/SI1-G</td>
                <td style="border:none;" align="left">B-EX_starPep_AP</td>
                <td style="border:none;" align="left">11,080</td>
                <td style="border:none;" align="left">309</td>
                <td style="border:none;" align="left">10,771</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="t3fn1">
              <label>a</label>
              <p>This table was adapted from Table
1 of ref (<xref ref-type="bibr" rid="ref37">37</xref>). SI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Supporting Information</ext-link>, TR: training, TS: test,
EX: external, B_TS: benchmarking test, B_EX: benchmarking external.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>As we had twenty-one query sets, and seven similarity
thresholds
(0.3 to 0.9 with 0.1 step), we generated 147 different <italic>mQSSMs</italic>, which were evaluated with the five target databases (D1–D5),
and their results were summarized in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI6</ext-link> as four excel files containing output predictions (active or inactive
for APPs and non-APPs, respectively) for all models. We had ninety-eight <italic>mQSSMs</italic> for CSN (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI6-A</ext-link>) and HSPN
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI6-B</ext-link>), forty-nine for each network, forty-two
models for the combination of both networks (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI6-C</ext-link>), and seven <italic>mQSSMs</italic> for the set of singletons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI6-D</ext-link>). The query sets and number of queries
for all the models are presented in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">Table SI2-6</ext-link>.</p>
        <p><xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref> shows
the
performance metrics of the best nine models to predict APPs, evaluated
with the D1–D5 validation data sets, whereas <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI7-A</ext-link> contains the corresponding statistical parameters for
all 147 <italic>mQSSMs</italic>. As can be noted, the number of Qs
included in the best 3 models for each network ranged from 165 to
219 sequences. It can also be observed that all these best <italic>mQSSMs</italic> had good results according to their performance metrics,
showing values of average recall, average precision, kappa statistic,
and accuracy greater than 0.8.</p>
        <table-wrap id="tbl4" position="float">
          <label>Table 4</label>
          <caption>
            <title>Performance of the Best Nine <italic>mQSSMs</italic> to Identify APPs, Evaluated on the Benchmarking D1–D5
Databases</title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">Performance
metrics (target database)<xref rid="t4fn1" ref-type="table-fn">a</xref></th>
                <th style="border:none;" align="center" char=".">186Q_0.5
(HB-HC-Singletons)</th>
                <th style="border:none;" align="center" char=".">178Q_0.5
(HC-Singletons)</th>
                <th style="border:none;" align="center" char=".">165Q_0.5
HC</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td colspan="4" style="border:none;" align="center">Best 3 <italic>mQSSMs</italic> from CSN</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D1)</td>
                <td style="border:none;" align="char" char=".">0.934</td>
                <td style="border:none;" align="char" char=".">0.914</td>
                <td style="border:none;" align="char" char=".">0.894</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D1)</td>
                <td style="border:none;" align="char" char=".">0.869</td>
                <td style="border:none;" align="char" char=".">0.828</td>
                <td style="border:none;" align="char" char=".">0.788</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D1)</td>
                <td style="border:none;" align="char" char=".">0.934</td>
                <td style="border:none;" align="char" char=".">0.914</td>
                <td style="border:none;" align="char" char=".">0.894</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D1)</td>
                <td style="border:none;" align="char" char=".">0.94</td>
                <td style="border:none;" align="char" char=".">0.924</td>
                <td style="border:none;" align="char" char=".">0.913</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D2)</td>
                <td style="border:none;" align="char" char=".">0.952</td>
                <td style="border:none;" align="char" char=".">0.952</td>
                <td style="border:none;" align="char" char=".">0.935</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D2)</td>
                <td style="border:none;" align="char" char=".">0.903</td>
                <td style="border:none;" align="char" char=".">0.903</td>
                <td style="border:none;" align="char" char=".">0.871</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D2)</td>
                <td style="border:none;" align="char" char=".">0.952</td>
                <td style="border:none;" align="char" char=".">0.952</td>
                <td style="border:none;" align="char" char=".">0.935</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D2)</td>
                <td style="border:none;" align="char" char=".">0.952</td>
                <td style="border:none;" align="char" char=".">0.952</td>
                <td style="border:none;" align="char" char=".">0.937</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D3)</td>
                <td style="border:none;" align="char" char=".">0.991</td>
                <td style="border:none;" align="char" char=".">0.991</td>
                <td style="border:none;" align="char" char=".">0.991</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D3)</td>
                <td style="border:none;" align="char" char=".">0.86</td>
                <td style="border:none;" align="char" char=".">0.86</td>
                <td style="border:none;" align="char" char=".">0.863</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D3)</td>
                <td style="border:none;" align="char" char=".">0.904</td>
                <td style="border:none;" align="char" char=".">0.904</td>
                <td style="border:none;" align="char" char=".">0.898</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D3)</td>
                <td style="border:none;" align="char" char=".">0.96</td>
                <td style="border:none;" align="char" char=".">0.96</td>
                <td style="border:none;" align="char" char=".">0.972</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D4)</td>
                <td style="border:none;" align="char" char=".">0.947</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.965</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D4)</td>
                <td style="border:none;" align="char" char=".">0.894</td>
                <td style="border:none;" align="char" char=".">0.929</td>
                <td style="border:none;" align="char" char=".">0.929</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D4)</td>
                <td style="border:none;" align="char" char=".">0.945</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.965</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D4)</td>
                <td style="border:none;" align="char" char=".">0.949</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.965</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D5)</td>
                <td style="border:none;" align="char" char=".">0.991</td>
                <td style="border:none;" align="char" char=".">0.991</td>
                <td style="border:none;" align="char" char=".">0.992</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D5)</td>
                <td style="border:none;" align="char" char=".">0.832</td>
                <td style="border:none;" align="char" char=".">0.832</td>
                <td style="border:none;" align="char" char=".">0.842</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D5)</td>
                <td style="border:none;" align="char" char=".">0.89</td>
                <td style="border:none;" align="char" char=".">0.89</td>
                <td style="border:none;" align="char" char=".">0.886</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D5)</td>
                <td style="border:none;" align="char" char=".">0.945</td>
                <td style="border:none;" align="char" char=".">0.945</td>
                <td style="border:none;" align="char" char=".">0.964</td>
              </tr>
            </tbody>
          </table>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">Performance
metrics (target database)<xref rid="t4fn1" ref-type="table-fn">a</xref></th>
                <th style="border:none;" align="center" char=".">200Q_0.5
HB-HC-Singletons</th>
                <th style="border:none;" align="center" char=".">187Q_0.5
HB-HC</th>
                <th style="border:none;" align="center" char=".">173Q_0.5
HC-Singletons</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td colspan="4" style="border:none;" align="center">Best 3 <italic>mQSSMs</italic> from HSPN</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D1)</td>
                <td style="border:none;" align="char" char=".">0.939</td>
                <td style="border:none;" align="char" char=".">0.904</td>
                <td style="border:none;" align="char" char=".">0.929</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D1)</td>
                <td style="border:none;" align="char" char=".">0.879</td>
                <td style="border:none;" align="char" char=".">0.808</td>
                <td style="border:none;" align="char" char=".">0.859</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D1)</td>
                <td style="border:none;" align="char" char=".">0.939</td>
                <td style="border:none;" align="char" char=".">0.904</td>
                <td style="border:none;" align="char" char=".">0.929</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D1)</td>
                <td style="border:none;" align="char" char=".">0.946</td>
                <td style="border:none;" align="char" char=".">0.919</td>
                <td style="border:none;" align="char" char=".">0.936</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D2)</td>
                <td style="border:none;" align="char" char=".">0.968</td>
                <td style="border:none;" align="char" char=".">0.935</td>
                <td style="border:none;" align="char" char=".">0.935</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D2)</td>
                <td style="border:none;" align="char" char=".">0.935</td>
                <td style="border:none;" align="char" char=".">0.871</td>
                <td style="border:none;" align="char" char=".">0.871</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D2)</td>
                <td style="border:none;" align="char" char=".">0.968</td>
                <td style="border:none;" align="char" char=".">0.935</td>
                <td style="border:none;" align="char" char=".">0.935</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D2)</td>
                <td style="border:none;" align="char" char=".">0.968</td>
                <td style="border:none;" align="char" char=".">0.937</td>
                <td style="border:none;" align="char" char=".">0.937</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D3)</td>
                <td style="border:none;" align="char" char=".">0.991</td>
                <td style="border:none;" align="char" char=".">0.992</td>
                <td style="border:none;" align="char" char=".">0.99</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D3)</td>
                <td style="border:none;" align="char" char=".">0.874</td>
                <td style="border:none;" align="char" char=".">0.881</td>
                <td style="border:none;" align="char" char=".">0.85</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D3)</td>
                <td style="border:none;" align="char" char=".">0.921</td>
                <td style="border:none;" align="char" char=".">0.915</td>
                <td style="border:none;" align="char" char=".">0.898</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D3)</td>
                <td style="border:none;" align="char" char=".">0.955</td>
                <td style="border:none;" align="char" char=".">0.969</td>
                <td style="border:none;" align="char" char=".">0.957</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">y (D4)</td>
                <td style="border:none;" align="char" char=".">0.982</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.965</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D4)</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.929</td>
                <td style="border:none;" align="char" char=".">0.929</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D4)</td>
                <td style="border:none;" align="char" char=".">0.984</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.965</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D4)</td>
                <td style="border:none;" align="char" char=".">0.981</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.965</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D5)</td>
                <td style="border:none;" align="char" char=".">0.992</td>
                <td style="border:none;" align="char" char=".">0.993</td>
                <td style="border:none;" align="char" char=".">0.991</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D5)</td>
                <td style="border:none;" align="char" char=".">0.838</td>
                <td style="border:none;" align="char" char=".">0.854</td>
                <td style="border:none;" align="char" char=".">0.817</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D5)</td>
                <td style="border:none;" align="char" char=".">0.904</td>
                <td style="border:none;" align="char" char=".">0.9</td>
                <td style="border:none;" align="char" char=".">0.882</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D5)</td>
                <td style="border:none;" align="char" char=".">0.935</td>
                <td style="border:none;" align="char" char=".">0.958</td>
                <td style="border:none;" align="char" char=".">0.939</td>
              </tr>
            </tbody>
          </table>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="char" char="."/>
              <col align="char" char="."/>
              <col align="char" char="."/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">Performance
metrics (target database)<xref rid="t4fn1" ref-type="table-fn">a</xref></th>
                <th style="border:none;" align="center" char=".">178Q_0.5
HC</th>
                <th style="border:none;" align="center" char=".">206Q_0.5
HB-HC</th>
                <th style="border:none;" align="center" char=".">219Q_0.5
HB-HC-Singletons</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td colspan="4" style="border:none;" align="center">Best 3 <italic>mQSSMs</italic> from Both HSPN-CSN</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D1)</td>
                <td style="border:none;" align="char" char=".">0.919</td>
                <td style="border:none;" align="char" char=".">0.909</td>
                <td style="border:none;" align="char" char=".">0.944</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D1)</td>
                <td style="border:none;" align="char" char=".">0.838</td>
                <td style="border:none;" align="char" char=".">0.818</td>
                <td style="border:none;" align="char" char=".">0.889</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D1)</td>
                <td style="border:none;" align="char" char=".">0.919</td>
                <td style="border:none;" align="char" char=".">0.909</td>
                <td style="border:none;" align="char" char=".">0.944</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D1)</td>
                <td style="border:none;" align="char" char=".">0.93</td>
                <td style="border:none;" align="char" char=".">0.923</td>
                <td style="border:none;" align="char" char=".">0.95</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D2)</td>
                <td style="border:none;" align="char" char=".">0.935</td>
                <td style="border:none;" align="char" char=".">0.952</td>
                <td style="border:none;" align="char" char=".">0.984</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D2)</td>
                <td style="border:none;" align="char" char=".">0.871</td>
                <td style="border:none;" align="char" char=".">0.903</td>
                <td style="border:none;" align="char" char=".">0.968</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D2)</td>
                <td style="border:none;" align="char" char=".">0.935</td>
                <td style="border:none;" align="char" char=".">0.952</td>
                <td style="border:none;" align="char" char=".">0.984</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D2)</td>
                <td style="border:none;" align="char" char=".">0.937</td>
                <td style="border:none;" align="char" char=".">0.952</td>
                <td style="border:none;" align="char" char=".">0.984</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D3)</td>
                <td style="border:none;" align="char" char=".">0.991</td>
                <td style="border:none;" align="char" char=".">0.993</td>
                <td style="border:none;" align="char" char=".">0.992</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D3)</td>
                <td style="border:none;" align="char" char=".">0.868</td>
                <td style="border:none;" align="char" char=".">0.89</td>
                <td style="border:none;" align="char" char=".">0.885</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D3)</td>
                <td style="border:none;" align="char" char=".">0.904</td>
                <td style="border:none;" align="char" char=".">0.922</td>
                <td style="border:none;" align="char" char=".">0.928</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D3)</td>
                <td style="border:none;" align="char" char=".">0.969</td>
                <td style="border:none;" align="char" char=".">0.97</td>
                <td style="border:none;" align="char" char=".">0.958</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D4)</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.982</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D4)</td>
                <td style="border:none;" align="char" char=".">0.929</td>
                <td style="border:none;" align="char" char=".">0.929</td>
                <td style="border:none;" align="char" char=".">0.965</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D4)</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.984</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D4)</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.965</td>
                <td style="border:none;" align="char" char=".">0.981</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Accuracy (D5)</td>
                <td style="border:none;" align="char" char=".">0.992</td>
                <td style="border:none;" align="char" char=".">0.993</td>
                <td style="border:none;" align="char" char=".">0.992</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">KappaStatistic (D5)</td>
                <td style="border:none;" align="char" char=".">0.845</td>
                <td style="border:none;" align="char" char=".">0.866</td>
                <td style="border:none;" align="char" char=".">0.856</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AverageRecall (D5)</td>
                <td style="border:none;" align="char" char=".">0.891</td>
                <td style="border:none;" align="char" char=".">0.91</td>
                <td style="border:none;" align="char" char=".">0.914</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">AveragePrecision (D5)</td>
                <td style="border:none;" align="char" char=".">0.961</td>
                <td style="border:none;" align="char" char=".">0.959</td>
                <td style="border:none;" align="char" char=".">0.942</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="t4fn1">
              <label>a</label>
              <p>Models performance on five D1–D5
benchmarking data sets of APP/non-APPs, which are described in <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>. Q: query, CSN: Chemical
space network, HSPN: half-space proximal network, HB: hub-bridge centrality,
HC: harmonic centrality, mQSSMs: multiquery similarity searching models.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>We observed that the best similarity threshold was
0.5 in all <italic>mQSSMs</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI7-A</ext-link>). The best reference
query sets were HC &gt; WD &gt; HB ≫ BE &gt; singletons in
both networks
(see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI7-A and SI7-C</ext-link> for more details).
However, the combination of query sets obtained with different centrality
measures (in the same network and from both networks) was always better
than any query set derived from a single centrality measure. Combinations
of query data sets such as HB-HC-singletons in CSN, HSPN, and mixing
both networks at the same time (CSN-HSPN) were the best <italic>mQSSMs</italic> (<xref rid="tbl4" ref-type="other">Tables <xref rid="tbl4" ref-type="other">4</xref></xref> and <xref rid="tbl5" ref-type="other">5</xref>). Similarly, the fusion of the 13 singletons to
any central query data sets enhanced the recovery of models, which
is a logical result due to atypical nodes, and central query sets
represent the complete space of known APPs.</p>
        <table-wrap id="tbl5" position="float">
          <label>Table 5</label>
          <caption>
            <title>Comparison between the Best <italic>mQSSMs</italic> to Predict APPs Proposed in This Study and Those
Reported in the Literature on the Antiparasitic Benchmarking Test
and External Data Sets<xref rid="t5fn1" ref-type="table-fn">a</xref></title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">Parameters</th>
                <th style="border:none;" align="center">ProtDCal-AP_RF</th>
                <th style="border:none;" align="center">ProtDCal-AP_RF_Hierarchical</th>
                <th style="border:none;" align="center">AMPfun</th>
                <th style="border:none;" align="center">178Q_0.5
(HC-Singletons) CSN</th>
                <th style="border:none;" align="center">200Q_0.5
HB-HC-Singletons HSPN</th>
                <th style="border:none;" align="center">219Q_0.5
HB-HC-Singletons HSPN-CSN</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td colspan="7" style="border:none;" align="center">D4 Data Set</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">SN<sub>B-TS</sub></td>
                <td style="border:none;" align="center">0.885</td>
                <td style="border:none;" align="center">0.769</td>
                <td style="border:none;" align="center">0.538</td>
                <td style="border:none;" align="center">0.962</td>
                <td style="border:none;" align="center">0.963</td>
                <td style="border:none;" align="center">0.963</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">SP<sub>B-TS</sub></td>
                <td style="border:none;" align="center">0.903</td>
                <td style="border:none;" align="center">0.936</td>
                <td style="border:none;" align="center">0.71</td>
                <td style="border:none;" align="center">0.962</td>
                <td style="border:none;" align="center">1</td>
                <td style="border:none;" align="center">1</td>
              </tr>
              <tr>
                <td style="border:none;" align="left"><italic>Q</italic>%<sub>B-TS</sub></td>
                <td style="border:none;" align="center">0.895</td>
                <td style="border:none;" align="center">0.86</td>
                <td style="border:none;" align="center">0.632</td>
                <td style="border:none;" align="center">0.965</td>
                <td style="border:none;" align="center">0.983</td>
                <td style="border:none;" align="center">0.983</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">MCC<sub>B-TS</sub></td>
                <td style="border:none;" align="center">0.788</td>
                <td style="border:none;" align="center">0.721</td>
                <td style="border:none;" align="center">0.252</td>
                <td style="border:none;" align="center">0.929</td>
                <td style="border:none;" align="center">0.965</td>
                <td style="border:none;" align="center">
                  <bold>0.965</bold>
                </td>
              </tr>
              <tr>
                <td colspan="7" style="border:none;" align="center">D5
Data Set</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">SN<sub>B-EX</sub></td>
                <td style="border:none;" align="center">0.799</td>
                <td style="border:none;" align="center">0.783</td>
                <td style="border:none;" align="center">0.45</td>
                <td style="border:none;" align="center">0.896</td>
                <td style="border:none;" align="center">0.875</td>
                <td style="border:none;" align="center">0.8893</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">SP<sub>B-EX</sub></td>
                <td style="border:none;" align="center">0.867</td>
                <td style="border:none;" align="center">0.944</td>
                <td style="border:none;" align="center">0.883</td>
                <td style="border:none;" align="center">0.783</td>
                <td style="border:none;" align="center">0.8123</td>
                <td style="border:none;" align="center">0.832</td>
              </tr>
              <tr>
                <td style="border:none;" align="left"><italic>Q</italic>%<sub>B-EX</sub></td>
                <td style="border:none;" align="center">0.865</td>
                <td style="border:none;" align="center">0.939</td>
                <td style="border:none;" align="center">0.871</td>
                <td style="border:none;" align="center">0.9914</td>
                <td style="border:none;" align="center">0.992</td>
                <td style="border:none;" align="center">0.993</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">MCC<sub>B-EX</sub></td>
                <td style="border:none;" align="center">0.306</td>
                <td style="border:none;" align="center">0.45</td>
                <td style="border:none;" align="center">0.165</td>
                <td style="border:none;" align="center">0.834</td>
                <td style="border:none;" align="center">0.839</td>
                <td style="border:none;" align="center">0.856</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="t5fn1">
              <label>a</label>
              <p>AP: antiparasitic, RF: random forest,
Q: query, CSN: chemical space network, HSPN: half-space proximal network,
HB: hub-bridge centrality, HC: harmonic centrality, <italic>mQSSMs</italic>: multiquery similarity searching models, SN: sensitivity, SP: specificity, <italic>Q</italic>%: accuracy, MCC: Matthew’s correlation coefficient,
B-TS: benchmarking test, B-EX: benchmarking external.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>All the best 21 <italic>mQSSMs</italic> had successful
predictive
ability according to the average recall, average precision, kappa
statistic, and accuracy performance metrics (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI7-A and SI7-C</ext-link> for more details). Outstanding outcomes were
attained by the <italic>mQSSM</italic> with 219 Qs from both networks
(HB-HC-Singletons CSN-HSPN) and by using 0.5 as similarity threshold,
with the previous performance metrics being greater than or approximately
equal to 0.83 in D4–D5 external validation data sets (<xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI7-B, and SI7-C</ext-link>). Moreover, it can be stated that the predictions
performed by the best <italic>mQSSMs</italic> were not random (MCC
≫ 0). It is important to remark that these antiparasitic <italic>mQSSMs</italic> had a strong-to-very-strong predictive agreement
since their test/external MCC values ranged from 0.834 to 0.965.</p>
        <p>The best <italic>mQSSMs</italic> developed in this report for each
network were used to perform a comparative study with <italic>state-of-the-art</italic> ML-based methods reported in the literature for predicting APPs:
the <italic>AMPfun</italic> server,<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> and
alignment-free quantitative sequence–activity models (AF-QSAMs)
implemented in <italic>AMP-Discover</italic>.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup></p>
        <p>Regarding the outcomes achieved in the antiparasitic classification,
the superiority of the three proposed models was remarkable, since
the <italic>AMPfun</italic> model<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> and <italic>AMP-Discover</italic> AF-QSAMs<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> presented
a weak predictive ability y (MCC &lt; 0.26 and MCC &lt; 0.45, respectively)
on both benchmarking data sets (<xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>).</p>
      </sec>
      <sec id="sec3.2.2">
        <label>3.2.2</label>
        <title>Statistical Comparison</title>
        <p>A sole accepted
and established test does not exist for multiple comparison tests
(MCT, for more detail, see <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://sci2s.ugr.es/sicidm">http://sci2s.ugr.es/sicidm</uri>). In fact, model comparison and
the selection of the best one is a staple among scientific investigations.<sup><xref ref-type="bibr" rid="ref88">88</xref></sup> We selected the best <italic>mQSSMs</italic> by evaluating our models with various criteria (<italic>Q</italic>%, SE, SP, and MCC) on the five target databases, and applied a paired-parametric
post hoc test (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI7-C and SI7-D</ext-link> for
more details). We determined the differences between our models by
using several nonparametric statistical tests.<sup><xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref68">68</xref>,<xref ref-type="bibr" rid="ref69">69</xref></sup> In the first place, we applied an Iman–Davenport
test<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> to check whether all the results
obtained by the algorithms present any inequality, and in the case
of finding some, then we can know, by using a Holm test,<sup><xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref68">68</xref>,<xref ref-type="bibr" rid="ref69">69</xref></sup> what algorithm partners’
average results are dissimilar, that is to say, a Friedman’s
test, which rejected the null hypothesis that all predictors performed
comparably on average. The same can be concluded from the results
of an Iman and Davenport’s test.</p>
        <p>The MCTs showed according
to the rankings’ method that <bold>219Q_0.5 HB-HC-Singletons
HSPN-CSN</bold> was the best algorithm, while <bold>200Q_0.5 HB-HC-Singletons
HSPN</bold> and <bold>178Q_0.5 HC-Singletons CSN</bold> had the second
and third best average value of ranking in the five validation data
sets, in concordance with the results depicted by <xref rid="tbl4" ref-type="other">Tables <xref rid="tbl4" ref-type="other">4</xref></xref> and <xref rid="tbl5" ref-type="other">5</xref> (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI7-C and SI7-D</ext-link> for more details).</p>
        <p>Besides, a second Iman–Davenport test<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> was carried out to detect if significant differences existed
between our models and <italic>state-of-the-art</italic> algorithms
to predict APPs (<xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>). In this sense, the null hypothesis (no-differences) was rejected
for the case where the test values were higher than the critical value.
Then, we performed the Holm test,<sup><xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref68">68</xref>,<xref ref-type="bibr" rid="ref69">69</xref></sup> and for the case of the benchmark data sets, we found
statistically significant differences between our <italic>mQSSMs</italic> and literature methods, but no significant differences were found
between our best <italic>mQSSM</italic> and the second and third best <italic>mQSSMs</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI7-D</ext-link>). Namely, in these
five validation databases significant differences were observed by
our best <italic>mQSSMs</italic>, at α = 0.05. <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref> is a graphical representation
of the average ranks (ranking scores) obtained by the best <italic>mQSSMs</italic> and literature methods in the <italic>Friedman Test</italic>, showing the relative position in the ranking of each of the six
models and their differences with the best-ranked one (<bold>219Q_0.5
HB-HC-Singletons HSPN-CSN</bold>, see also <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI7-D</ext-link> for more details). For example, <bold>200Q_0.5 HB-HC-Singletons
HSPN</bold> performed similarly to the first ranked method, and slightly
better than <bold>178Q_0.5 HC-Singletons CSN</bold>. Somewhat larger
differences were detected between our <italic>mQSSMs</italic> and
the literature models, including <italic>ProtDCal-AP_RF_Hierarchical</italic>, <italic>ProtDCal-AP_RF</italic>,<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> and <italic>AMPfun</italic>.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p>
        <fig id="fig7" position="float">
          <label>Figure 7</label>
          <caption>
            <p>Average ranks obtained
by each method in the Friedman Test. Friedman
statistic (distributed according to chi-square with 5 degrees of freedom):
21.571. <italic>P</italic>-value computed by Friedman Test: 0.000631.
Iman and Davenport statistic (distributed according to F-distribution
with 5 and 35 degrees of freedom): 8.194. P-value computed by Iman
and Davenport Test: 0.00003336.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_0007" id="gr9" position="float"/>
        </fig>
      </sec>
    </sec>
    <sec id="sec3.3">
      <label>3.3</label>
      <title>Virtual Screening for Discovery of Putative
APPs</title>
      <p>Our starting search space was the entire <italic>StarPepDB</italic>, which contains about 45 120 peptides. After applying a series
of filters with the <italic>StarPep toolbox</italic> and some external
web servers, as well as the best <italic>mQSSM</italic>, we retrieved
ninety-five leads that have never been associated with the antiparasitic
activity, available in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI8-1</ext-link> as a FASTA
file. <xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref> summarizes
the filtering process applied to retrieve the set of new potential
APPs. In addition, <xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>B depicts the prospective virtual screening process to reduce
most of the peptides from the initial search space, applying our best <italic>mQSSM.</italic><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>A shows the CSN of the 95 potential APPs with its communities, which
exhibit the diversity that these peptides still have (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI3-11</ext-link> has the graphml file of this network).</p>
      <fig id="fig8" position="float">
        <label>Figure 8</label>
        <caption>
          <p>(A) CSN
of 95 potential AMPs, in which nodes are colored by their
community and sized by harmonic centrality. METNs with metadata of
(B) origin, (C) function, (D) target pathogen, and (E) database. In
all METNs, red nodes are APPs, and the blue ones are metadata, and
all of them are sized by their degree. All the visualizations were
created with <italic>Gephi</italic>,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> applying
the <italic>Fruchterman-Reingold</italic> layout algorithm,<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> and edited with <italic>Inkscape</italic>.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_0008" id="gr10" position="float"/>
      </fig>
      <p>The chemical space of the 45 120 peptides
in <italic>StarPepDB</italic> was reduced to the 47.62% (21 488 peptides)
when the nontoxic and
nonantiparasitic active peptides as well as sequence redundance (lower
than 90% sequence similarity) were filtered in <italic>StarPep</italic> software. Next, the <italic>mQSSMs</italic> were used for discrimination
of APP/non-APPs, and only 2854 hits were selected (see second step
in <xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>). From
these putative peptides, 1939 sequences were prioritized, all with
less than 30 classic amino acids. When toxic and hemolytic end points
were filtered by the ToxinPred2<sup><xref ref-type="bibr" rid="ref89">89</xref></sup> and the
HemoPI<sup><xref ref-type="bibr" rid="ref90">90</xref></sup> servers, respectively, 1823 nontoxic
and nonhemolytic putative APPs were kept in the pipeline. In the next
step, 1782 sequences were recovered after removal of peptides like
the toxic peptides set in <italic>StarPep</italic> software. Next,
the <italic>AMPDiscover</italic>(<xref ref-type="bibr" rid="ref37">37</xref>) and <italic>AMPFun</italic>(<xref ref-type="bibr" rid="ref38">38</xref>) servers were used to
confirm our APP predictions, obtaining a total of 1525 hits. Lastly,
the removal of sequence redundancy by <italic>scaffold extraction</italic> in <italic>StarPep</italic> software was another critical filter,
where the number of sequences was reduced to 95 APP hits.</p>
      <p>To
measure such similarity among the 95 leads, we calculated pairwise
sequence identity among all of them. We found that most of the sequences
share pairwise identity values below 30%, represented by the blue
points in the heatmap depicted in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI2-7A</ext-link>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI2-7B</ext-link> also shows the structural singularity
of lead peptides because most pairwise identity values belong to 0–0.1,
0.1–0.2, and 0.2–0.3 bins of the histogram.</p>
      <p>In
addition, METNs of these peptides revealed some common characteristics
shared by them. The origin of the leads was mainly from synthetic
constructs (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>B), as the METN showed for the APPs (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A). Regarding their annotated function, most
of these peptides have antimicrobial and antibacterial (Gram-positive
and Gram-negative) activities (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>C), so their main pathogen targets are also bacteria
such as <italic>Escherichia coli</italic> and <italic>Staphylococcus
aureus</italic> (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>D). Moreover, these potential APPs were mainly obtained from DRAMP,<sup><xref ref-type="bibr" rid="ref91">91</xref></sup> DBAASP,<sup><xref ref-type="bibr" rid="ref83">83</xref></sup> and SATPdb,<sup><xref ref-type="bibr" rid="ref84">84</xref></sup> among other databases (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>E).</p>
      <p>As far as we know, none of the
lead 95 compounds reported in this
study have been associated with the antiparasitic activity. However,
some of them have been reported to have other activities. For instance,
starPep_00322 or caerin 1.19 is a peptide derived from the skin secretion
of the frog <italic>Litoria gracilenta</italic>, identified as a wide-spectrum
antibiotic,<sup><xref ref-type="bibr" rid="ref92">92</xref></sup> and as antiviral agent against
HIV.<sup><xref ref-type="bibr" rid="ref93">93</xref></sup> There are other peptides associated
with general antimicrobial activity such as starPep_15171 or N-Mag-C,<sup><xref ref-type="bibr" rid="ref94">94</xref></sup> while others have antiviral activity like starPep_09816
or MG2d, antifungal activity such as starPep_17290 or Cap-LFampH-K,<sup><xref ref-type="bibr" rid="ref95">95</xref></sup> and antibacterial activity like starPep_01732
or Phylloseptin-2.1TR.<sup><xref ref-type="bibr" rid="ref96">96</xref></sup> Consequently,
our method can be considered as a drug repurposing strategy addressed
to detect the antiparasitic activity on peptides with other previously
reported activities.</p>
    </sec>
    <sec id="sec3.4">
      <label>3.4</label>
      <title>Discovery of APPs Sequence Motifs</title>
      <p>To perform a wide exploration of motifs that could be determining
a repurposed antiparasitic activity in peptides not labeled as APPs,
the resulting ninety-five lead peptides identified after applying
the above-mentioned filtering steps (<xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>) were clustered by mapping them onto the
CSN space (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>A). Thus, we identified five clusters; four out of the five contained
members share some network regularities/properties, but the fifth
cluster was selected to store singletons (peptides identified as atypical
in the CSN). The five clusters were made up of twenty-six, nine, thirty-five,
eighteen, and seven members, respectively (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI8-2–6</ext-link> are FASTA files with sequences of the five clusters). The sequence
diversity within each cluster was evaluated against all global alignments,
reaching an overall identity lower than 30% in all clusters, which
means that is very unlikely to find homologous sequences within each
cluster.<sup><xref ref-type="bibr" rid="ref97">97</xref></sup> This analysis confirmed the
structural singularity of the ninety-five APPs considered as new sequence
scaffolds.</p>
      <p>In this sense, the five clusters were screened for
discovering sequence patterns/motifs among these peptides that have
been identified as potential APPs. As they represent new structural
and singular scaffolds, new motifs accounting for the antiparasitic
activity should be found. The motif search was performed by using
different motif identification algorithms, including MSA, STREME,<sup><xref ref-type="bibr" rid="ref77">77</xref></sup> and PROSITE.<sup><xref ref-type="bibr" rid="ref80">80</xref></sup> We
applied MSA algorithms developed after the classical ClustalW,<sup><xref ref-type="bibr" rid="ref98">98</xref></sup> so that they can deal with the sequence diversity
shown in each cluster and, thus, detect more accurately any conserved
signature or motif.</p>
      <p>In this sense, MAFFT,<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> MUSCLE,<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> and T-Coffee<sup><xref ref-type="bibr" rid="ref74">74</xref></sup> were
applied to carry out MSAs in each cluster. The philosophy behind each
MSA algorithm is different to improve alignment quality. MAFFT uses
a Fourier transform (FFT) to optimize protein alignments based on
the amino acid sequence properties and have included iterative steps
to refine the alignments,<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> while MUSCLE
combines alignment-free (k-<italic>mers</italic> counting) and alignment-based
(Kimura) distances to perform the progressive alignment, which is
controlled by a log-expectation score function, and also includes
iterative refinement alignment steps.<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> On the other hand, T-Coffee constructs progressive MSA by combining
information derived from global and local alignment.<sup><xref ref-type="bibr" rid="ref74">74</xref></sup></p>
      <p>Each MSA algorithm provided a consensus sequence
that was estimated
by the Jalview<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> and the EMBOSS Cons.<sup><xref ref-type="bibr" rid="ref76">76</xref></sup> As EMBOSS Cons gives a more legible output,
only displaying high scored amino acids/positions (capital letters),
less scored but positive residues (lower-case letters), and nonconsensus
positions (X) that are under the threshold score, we identified the
motifs using this software. Nonconsensus positions were complemented
by the visual inspection of the corresponding positions in the Jalview
software and the Seq2Logo (available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.cbs.dtu.dk/biotools/Seq2Logo">http://www.cbs.dtu.dk/biotools/Seq2Logo</uri>)<sup><xref ref-type="bibr" rid="ref99">99</xref></sup> by using default parameters. <xref rid="tbl6" ref-type="other">Table <xref rid="tbl6" ref-type="other">6</xref></xref> depicts the consensus
motifs, unraveled by each MSA algorithm, as well as the frequency
of these motifs in the 550 APPs from <italic>StarPepDB</italic> and
the 95 lead compounds reported in this study. In general, most of
the motifs had a low frequency of occurrence on both 550 APPs and
95 lead compounds, being the most frequent motif <italic>KxxG</italic> (<italic>x</italic> being any amino acid) with 120 occurrences in
the 550 APPs and 20 in the 95 lead chemicals (<xref rid="tbl6" ref-type="other">Table <xref rid="tbl6" ref-type="other">6</xref></xref>). The low frequency from most of the motifs
obtained by MSA could suggest they are novel signatures for characterizing
APPs, so these motifs can be considered as scaffolds to search for
new APPs.</p>
      <table-wrap id="tbl6" position="float">
        <label>Table 6</label>
        <caption>
          <title>Discovered Motifs by Multiple Sequence
Alignment</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="center"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">No.</th>
              <th style="border:none;" align="center">Motif</th>
              <th style="border:none;" align="center">Frequency
of occurrence 550 APPs/95 potential APPs</th>
              <th style="border:none;" align="center">EMBOSS Consensus</th>
              <th style="border:none;" align="center">Frequency
of occurrence 550 APPs/95 potential APPs</th>
              <th style="border:none;" align="center">Cluster</th>
              <th style="border:none;" align="center">Cluster size</th>
              <th style="border:none;" align="center">MSA Method</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">1</td>
              <td style="border:none;" align="left">K[fl]GK</td>
              <td style="border:none;" align="left">22/4</td>
              <td style="border:none;" align="left">KxGk</td>
              <td style="border:none;" align="left">31/6</td>
              <td style="border:none;" align="center">1</td>
              <td style="border:none;" align="left">26</td>
              <td style="border:none;" align="left">MAFFT</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">2</td>
              <td style="border:none;" align="left">kK[fl][ga]K</td>
              <td style="border:none;" align="left">15/3</td>
              <td style="border:none;" align="left">kKxxK</td>
              <td style="border:none;" align="left">57/14</td>
              <td style="border:none;" align="center"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">MUSCLE</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">3</td>
              <td style="border:none;" align="left">K[fy][fl]G</td>
              <td style="border:none;" align="left">0/2</td>
              <td style="border:none;" align="left">KxxG</td>
              <td style="border:none;" align="left">117/20</td>
              <td style="border:none;" align="center"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">T-Coffee</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">4</td>
              <td style="border:none;" align="left">RK[vi]AL</td>
              <td style="border:none;" align="left">0/0</td>
              <td style="border:none;" align="left">RKxAL</td>
              <td style="border:none;" align="left">0/0</td>
              <td style="border:none;" align="center">2</td>
              <td style="border:none;" align="left">9<xref rid="t6fn1" ref-type="table-fn">a</xref></td>
              <td style="border:none;" align="left">MAFFT</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">5</td>
              <td style="border:none;" align="left">aLLAL</td>
              <td style="border:none;" align="left">0/0</td>
              <td style="border:none;" align="left">axLAL</td>
              <td style="border:none;" align="left">8/3</td>
              <td style="border:none;" align="center"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">MUSCLE</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">6</td>
              <td style="border:none;" align="left">K[l]K[pa]RPa</td>
              <td style="border:none;" align="left">0/0</td>
              <td style="border:none;" align="left">KKxRPa</td>
              <td style="border:none;" align="left">0/0</td>
              <td style="border:none;" align="center"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">T-Coffee/MUSCLE</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">7</td>
              <td style="border:none;" align="left">L[kl]I[la]RK</td>
              <td style="border:none;" align="left">0/0</td>
              <td style="border:none;" align="left">LxIxRK</td>
              <td style="border:none;" align="left">0/0</td>
              <td style="border:none;" align="center">3</td>
              <td style="border:none;" align="left">35<xref rid="t6fn1" ref-type="table-fn">a</xref></td>
              <td style="border:none;" align="left">MAFFT</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">8</td>
              <td style="border:none;" align="left">IL[kr]K</td>
              <td style="border:none;" align="left">2/1</td>
              <td style="border:none;" align="left">ILxK</td>
              <td style="border:none;" align="left">6/2</td>
              <td style="border:none;" align="center"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">MUSCLE</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">9</td>
              <td style="border:none;" align="left">r[ilv]I[il]K</td>
              <td style="border:none;" align="left">0/0</td>
              <td style="border:none;" align="left">rxIxK</td>
              <td style="border:none;" align="left">6/2</td>
              <td style="border:none;" align="center"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">T-Coffee</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">10</td>
              <td style="border:none;" align="left">RWR[rw]r[mrs]RR</td>
              <td style="border:none;" align="left">0/0</td>
              <td style="border:none;" align="left">RWRxrxRR</td>
              <td style="border:none;" align="left">0/0</td>
              <td style="border:none;" align="center">4</td>
              <td style="border:none;" align="left">18</td>
              <td style="border:none;" align="left">MAFFT</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="center"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">MUSCLE</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="center"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">T-Coffee</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">11</td>
              <td style="border:none;" align="left">L[ap]L[lp]L</td>
              <td style="border:none;" align="left">0/0</td>
              <td style="border:none;" align="left">LxLxL</td>
              <td style="border:none;" align="left">14/5</td>
              <td style="border:none;" align="center">5 (singletons)</td>
              <td style="border:none;" align="left">7</td>
              <td style="border:none;" align="left">MUSCLE</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t6fn1">
            <label>a</label>
            <p>The MSA quality of clusters 2 and
3 was improved by removing noised peptides, so we removed starPep_36552
from cluster 2, and starPep_16010-starPep_16459 from cluster 3.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Moreover, alignments and sequence logos by each of
the clusters
are available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI9</ext-link>. To perform a wide
motif search, unaligned patterns in the peptides should be also discovered.
In this sense, the alignment-free approach STREME was used to find
enriched patterns ranging from three to five amino acids length within
the peptide clusters. STREME has been reported as the most accurate
and sensitive algorithm among its competing state-of-art partners<sup><xref ref-type="bibr" rid="ref77">77</xref></sup> (e.g., DREME,<sup><xref ref-type="bibr" rid="ref100">100</xref></sup> HOMER,<sup><xref ref-type="bibr" rid="ref101">101</xref></sup> MEME<sup><xref ref-type="bibr" rid="ref78">78</xref></sup>). Unlike
previously algorithms, STREME efficiently counts position matches
by using a position weight matrix (PWM) representing the motif candidate
and also creates a Markov Model of a user-specified order from the
control sequences. Both elements are considered when counting motif
matches, keeping the search away from those that are mere artifacts
of lower-order statistics of the input sequences.<sup><xref ref-type="bibr" rid="ref77">77</xref></sup><xref rid="tbl7" ref-type="other">Table <xref rid="tbl7" ref-type="other">7</xref></xref> displays
enriched motifs found within each cluster with respect to the control
sequences. Motifs appearing in more than 30% of the query sequences
were listed according to their statistical significance or score.
We observed that motifs obtained with STREME also had a low frequency
of occurrence in the 550 APPs and the 95 lead compounds, so these
motifs can be new patterns to search novel APPs (<xref rid="tbl7" ref-type="other">Table <xref rid="tbl7" ref-type="other">7</xref></xref>).</p>
      <table-wrap id="tbl7" position="float">
        <label>Table 7</label>
        <caption>
          <title>Discovered Motifs by STREME<xref rid="t7fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">No.</th>
              <th style="border:none;" align="center">Motif</th>
              <th style="border:none;" align="center">Cluster</th>
              <th style="border:none;" align="center">Cluster size</th>
              <th style="border:none;" align="center">Matches in
positive sequences</th>
              <th style="border:none;" align="center">Matches in
control sequences</th>
              <th style="border:none;" align="center">Score</th>
              <th style="border:none;" align="center">Frequency
of occurrence 550 APPs/95 potential APPs</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">1</td>
              <td style="border:none;" align="left">GAI</td>
              <td style="border:none;" align="left">1</td>
              <td style="border:none;" align="left">26</td>
              <td style="border:none;" align="left">15</td>
              <td style="border:none;" align="left">1</td>
              <td style="border:none;" align="left">2.0 × 10<sup>–5</sup></td>
              <td style="border:none;" align="left">6/2</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">2</td>
              <td style="border:none;" align="left">LHS</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">11</td>
              <td style="border:none;" align="left">0</td>
              <td style="border:none;" align="left">1.3 × 10<sup>–4</sup></td>
              <td style="border:none;" align="left">7/5</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">3</td>
              <td style="border:none;" align="left">GKF</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">12</td>
              <td style="border:none;" align="left">2</td>
              <td style="border:none;" align="left">1.9 × 10<sup>–3</sup></td>
              <td style="border:none;" align="left">7/5</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">4</td>
              <td style="border:none;" align="left">PRPY</td>
              <td style="border:none;" align="left">2</td>
              <td style="border:none;" align="left">9</td>
              <td style="border:none;" align="left">4</td>
              <td style="border:none;" align="left">0</td>
              <td style="border:none;" align="left">4.1 × 10<sup>–2</sup></td>
              <td style="border:none;" align="left">0/1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">5</td>
              <td style="border:none;" align="left">ALKKA</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">3</td>
              <td style="border:none;" align="left">0</td>
              <td style="border:none;" align="left">1.0 × 10<sup>–1</sup></td>
              <td style="border:none;" align="left">2/2</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">6</td>
              <td style="border:none;" align="left">KKALL</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">3</td>
              <td style="border:none;" align="left">0</td>
              <td style="border:none;" align="left">1.0 × 10<sup>–1</sup></td>
              <td style="border:none;" align="left">4/2</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">7</td>
              <td style="border:none;" align="left">RLGI</td>
              <td style="border:none;" align="left">3</td>
              <td style="border:none;" align="left">35</td>
              <td style="border:none;" align="left">8</td>
              <td style="border:none;" align="left">0</td>
              <td style="border:none;" align="left">2.5 × 10<sup>–3</sup></td>
              <td style="border:none;" align="left">0/1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">8</td>
              <td style="border:none;" align="left">L[IA]KKF</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">7</td>
              <td style="border:none;" align="left">0</td>
              <td style="border:none;" align="left">5.6 × 10<sup>–3</sup></td>
              <td style="border:none;" align="left">0/0</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">9</td>
              <td style="border:none;" align="left">GLL</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">9</td>
              <td style="border:none;" align="left">1</td>
              <td style="border:none;" align="left">6.7 × 10<sup>–3</sup></td>
              <td style="border:none;" align="left">15/1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">10</td>
              <td style="border:none;" align="left">WQWR</td>
              <td style="border:none;" align="left">4</td>
              <td style="border:none;" align="left">18</td>
              <td style="border:none;" align="left">8</td>
              <td style="border:none;" align="left">0</td>
              <td style="border:none;" align="left">1.4 × 10<sup>–3</sup></td>
              <td style="border:none;" align="left">8/2</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">11</td>
              <td style="border:none;" align="left">MRR</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">7</td>
              <td style="border:none;" align="left">1</td>
              <td style="border:none;" align="left">2.0 × 10<sup>–2</sup></td>
              <td style="border:none;" align="left">3/4</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">12</td>
              <td style="border:none;" align="left">RRF</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">5</td>
              <td style="border:none;" align="left">0</td>
              <td style="border:none;" align="left">2.3 × 10<sup>–2</sup></td>
              <td style="border:none;" align="left">2/2</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">13</td>
              <td style="border:none;" align="left">LLLRL</td>
              <td style="border:none;" align="left">5</td>
              <td style="border:none;" align="left">7</td>
              <td style="border:none;" align="left">2</td>
              <td style="border:none;" align="left">0</td>
              <td style="border:none;" align="left">2.3 × 10<sup>–1</sup></td>
              <td style="border:none;" align="left">0/0</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t7fn1">
            <label>a</label>
            <p>APPs: antiparasitic peptides.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Lastly, we also queried the peptide clusters against
PROSITE Pattern
and PROSITE Profile databases<sup><xref ref-type="bibr" rid="ref80">80</xref></sup> by using
the search engine Motif Search of the GenomeNet suite.<sup><xref ref-type="bibr" rid="ref79">79</xref></sup> Significant hits were only found among a few
members of clusters one and four (<xref rid="tbl8" ref-type="other">Table <xref rid="tbl8" ref-type="other">8</xref></xref>). Matching patterns and profiles can be
straightforwardly associated with AMP-related signatures such as the
histone 2A, cyclotides, mammalian defensins, and myotoxins. Although
transferrin-like domains are found in many proteins with diverse functions,
some of them like the mammalian blood serotransferrin may have an
antibacterial effect by removing toxic free iron from the blood, as
well as the lactoferrin, found in the mammalian milk, which showed
antimicrobial activity.<sup><xref ref-type="bibr" rid="ref95">95</xref></sup></p>
      <table-wrap id="tbl8" position="float">
        <label>Table 8</label>
        <caption>
          <title>Discovered Motifs Found in PROSITE<xref rid="t8fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">No.</th>
              <th style="border:none;" align="center">Motif</th>
              <th style="border:none;" align="center">Cluster</th>
              <th style="border:none;" align="center">Hit Peptide</th>
              <th style="border:none;" align="center">PROSITE Database</th>
              <th style="border:none;" align="center">Match with</th>
              <th style="border:none;" align="center">Signature</th>
              <th style="border:none;" align="center">Frequency
of occurrence 550 APPs/95 potential APPs</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">1</td>
              <td style="border:none;" align="left">AGLQFPV</td>
              <td style="border:none;" align="left">1</td>
              <td style="border:none;" align="left">starPep_36218</td>
              <td style="border:none;" align="left">Pattern</td>
              <td style="border:none;" align="left">[AC]GLxFPV</td>
              <td style="border:none;" align="left">Histone H2A</td>
              <td style="border:none;" align="left">0/1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">2</td>
              <td style="border:none;" align="left">CGETCVLGTC</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">starPep_10020</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">C[GA]E[ST]C[FTV][GLTI]G[TSK]C</td>
              <td style="border:none;" align="left">Cyclotides Moebius</td>
              <td style="border:none;" align="left">0/1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">3</td>
              <td style="border:none;" align="left">CYCRIPACLAGERRYGTCFYRRRVWAFCC</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">starPep_01640</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">CxCx(3,5)Cx(7)GxCx(9)CC</td>
              <td style="border:none;" align="left">Mammalian defensins</td>
              <td style="border:none;" align="left">0/1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">4</td>
              <td style="border:none;" align="left">DAIWNLLRQAQEKFG</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">starPep_17290</td>
              <td style="border:none;" align="left">Profile</td>
              <td style="border:none;" align="left">ECIWHLLQRMQQLFGHGGKDP</td>
              <td style="border:none;" align="left">Transferrin-like domain</td>
              <td style="border:none;" align="left">0/1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">5</td>
              <td style="border:none;" align="left">GSAFCGETCVLGTCYTPDCSCTALVCLKN</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">starPep_10020</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GLPVCGETCVWGPCNTPGCTCKWPVCYRN</td>
              <td style="border:none;" align="left">Cyclotides</td>
              <td style="border:none;" align="left">0/1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">6</td>
              <td style="border:none;" align="left">KMDSRWRWKSCKK</td>
              <td style="border:none;" align="left">4</td>
              <td style="border:none;" align="left">starPep_27296</td>
              <td style="border:none;" align="left">Profile</td>
              <td style="border:none;" align="left">KMDCRWRWKCCKK</td>
              <td style="border:none;" align="left">Myotoxins_2</td>
              <td style="border:none;" align="left">0/1</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t8fn1">
            <label>a</label>
            <p>APPs: antiparasitic peptides.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>As we mentioned before, motifs listed in <xref rid="tbl6" ref-type="other">Tables <xref rid="tbl6" ref-type="other">6</xref></xref> and <xref rid="tbl7" ref-type="other">7</xref> were searched
against the APPs registered in <italic>StarPepDB</italic> and the
95 lead candidates to discriminate the possible new signatures from
the existing ones. We need to consider that new motifs should not
appear in any of the registered APPs or should be at a very low frequency,
which was the case for most of the motifs obtained by MSA and STREME
methods.</p>
    </sec>
    <sec id="sec3.5">
      <label>3.5</label>
      <title>From 95 APP Hits to 11 Drug-like Lead Candidates</title>
      <p>The 95 peptides from the prospective virtual screening show antiparasitic
activity and sequence singularity, but only a few computational tools
have been used so far for their other properties/toxicity characterization.
Therefore, the set of 95 APP virtual hits was further screened by
several activity prediction tools listed in <xref rid="tbl9" ref-type="other">Table <xref rid="tbl9" ref-type="other">9</xref></xref>, relevant for enhancing their plausible
therapeutic utility.</p>
      <table-wrap id="tbl9" position="float">
        <label>Table 9</label>
        <caption>
          <title>List of Tool Used to Predict Several
End Points of the Promising APP Leads</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">no.</th>
              <th style="border:none;" align="center">Web server</th>
              <th style="border:none;" align="center">Predicted
End point</th>
              <th style="border:none;" align="center">Link</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td colspan="4" style="border:none;" align="center">Activity</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">1</td>
              <td style="border:none;" align="left">AMPfun</td>
              <td style="border:none;" align="left">Various
(anticancer, antiparasitic,
etc.)</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://fdblab.csie.ncu.edu.tw/AMPfun/">http://fdblab.csie.ncu.edu.tw/AMPfun/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">2</td>
              <td style="border:none;" align="left">AMPDiscovery</td>
              <td style="border:none;" align="left">Various (anticancer, antiparasitic,
etc.)</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://biocom-ampdiscover.cicese.mx">https://biocom-ampdiscover.cicese.mx</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">3</td>
              <td style="border:none;" align="left">AMAP</td>
              <td style="border:none;" align="left">Various (anticancer, antiparasitic,
etc.)</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://amap.pythonanywhere.com/home">http://amap.pythonanywhere.com/home</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">4</td>
              <td style="border:none;" align="left">AxPEP</td>
              <td style="border:none;" align="left">Antimicrobial</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://app.cbbio.online/ampep/method">https://app.cbbio.online/ampep/method</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">5</td>
              <td style="border:none;" align="left">dPABBs</td>
              <td style="border:none;" align="left">Biofilm</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ab-openlab.csir.res.in/abp/antibiofilm">https://ab-openlab.csir.res.in/abp/antibiofilm</uri>
              </td>
            </tr>
            <tr>
              <td colspan="4" style="border:none;" align="center">Toxicity</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">6</td>
              <td style="border:none;" align="left">ToxinPred</td>
              <td style="border:none;" align="left">Toxic</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://webs.iiitd.edu.in/raghava/toxinpred">https://webs.iiitd.edu.in/raghava/toxinpred</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">7</td>
              <td style="border:none;" align="left">HemoPI</td>
              <td style="border:none;" align="left">Hemolytic</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://webs.iiitd.edu.in/raghava/hemopi">https://webs.iiitd.edu.in/raghava/hemopi</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">8</td>
              <td style="border:none;" align="left">HemoPred</td>
              <td style="border:none;" align="left">Hemolytic</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://codes.bio/hemopred/">http://codes.bio/hemopred/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">9</td>
              <td style="border:none;" align="left">Happenn</td>
              <td style="border:none;" align="left">Hemolytic</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://research.timmons.eu/happenn">https://research.timmons.eu/happenn</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">10</td>
              <td style="border:none;" align="left">Macrel</td>
              <td style="border:none;" align="left">Antimicrobial and hemolytic</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.big-data-biology.org/software/macrel/">https://www.big-data-biology.org/software/macrel/</uri>
              </td>
            </tr>
            <tr>
              <td colspan="4" style="border:none;" align="center">Properties
and Pharmacokinetics</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">11</td>
              <td style="border:none;" align="left">SolupHred</td>
              <td style="border:none;" align="left">pH-dependent
Solubility</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ppmclab.pythonanywhere.com/SolupHred">https://ppmclab.pythonanywhere.com/SolupHred</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">12</td>
              <td style="border:none;" align="left">GRAVY</td>
              <td style="border:none;" align="left">Solubility related feature</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.gravy-calculator.de/index.php">http://www.gravy-calculator.de/index.php</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">13</td>
              <td style="border:none;" align="left">CellPPD</td>
              <td style="border:none;" align="left">Cell penetrating</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://webs.iiitd.edu.in/raghava/cellppd/multi_pep.php">https://webs.iiitd.edu.in/raghava/cellppd/multi_pep.php</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">14</td>
              <td style="border:none;" align="left">C2Pred</td>
              <td style="border:none;" align="left">Cell penetrating</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://lin-group.cn/server/C2Pred">http://lin-group.cn/server/C2Pred</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">15</td>
              <td style="border:none;" align="left">MLCPP</td>
              <td style="border:none;" align="left">Cell penetrating</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.thegleelab.org/cgi-bin/MLCPP/MLCPP.py">http://www.thegleelab.org/cgi-bin/MLCPP/MLCPP.py</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">16</td>
              <td style="border:none;" align="left">PlifePred</td>
              <td style="border:none;" align="left">Half-life in blood</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://webs.iiitd.edu.in/raghava/plifepred">https://webs.iiitd.edu.in/raghava/plifepred</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">17</td>
              <td style="border:none;" align="left">HLP</td>
              <td style="border:none;" align="left">Half-life in intestine like
environment</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://webs.iiitd.edu.in/cgibin/hlp">https://webs.iiitd.edu.in/cgibin/hlp</uri>
              </td>
            </tr>
            <tr>
              <td colspan="4" style="border:none;" align="center">Immunological
Actions</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">18</td>
              <td style="border:none;" align="left">AlgPred2</td>
              <td style="border:none;" align="left">Allergens</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://webs.iiitd.edu.in/raghava/algpred2">https://webs.iiitd.edu.in/raghava/algpred2</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">19</td>
              <td style="border:none;" align="left">MILAMP</td>
              <td style="border:none;" align="left">Amyloid</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://milamp.pythonanywhere.com/home">http://milamp.pythonanywhere.com/home</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">20</td>
              <td style="border:none;" align="left">MetAmyl</td>
              <td style="border:none;" align="left">Amylogenicity</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://metamyl.genouest.org/e107_plugins/metamyl_aggregation/db_prediction_meta.php">http://metamyl.genouest.org/e107_plugins/metamyl_aggregation/db_prediction_meta.php</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">21</td>
              <td style="border:none;" align="left">ANuPP</td>
              <td style="border:none;" align="left">Aggregation Nucleation Prediction</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://web.iitm.ac.in/bioinfo2/ANuPP">https://web.iitm.ac.in/bioinfo2/ANuPP</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">22</td>
              <td style="border:none;" align="left">ProInflam</td>
              <td style="border:none;" align="left">Inflammatory</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://metagenomics.iiserb.ac.in/proinflam">http://metagenomics.iiserb.ac.in/proinflam</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">23</td>
              <td style="border:none;" align="left">VaxinPAD</td>
              <td style="border:none;" align="left">Immunomodulatory</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://webs.iiitd.edu.in/raghava/vaxinpad/">https://webs.iiitd.edu.in/raghava/vaxinpad/</uri>
              </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">24</td>
              <td style="border:none;" align="left">PRRpred</td>
              <td style="border:none;" align="left">Pattern recognition receptor</td>
              <td style="border:none;" align="left">
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://webs.iiitd.edu.in/raghava/prrpred/aac.predict.php">https://webs.iiitd.edu.in/raghava/prrpred/aac.predict.php</uri>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Thus, the 95 potential virtual APPs (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI8-1 and SI8-7</ext-link>) were evaluated by 24 <italic>in silico</italic> tools
(see <xref rid="tbl9" ref-type="other">Table <xref rid="tbl9" ref-type="other">9</xref></xref>) to select
the best drug-like peptides. We jointly analyze several antiparasitic
activity predictions according to <italic>AMPDiscover</italic>,<sup><xref ref-type="bibr" rid="ref37">37</xref></sup><italic>AMPFun</italic>,<sup><xref ref-type="bibr" rid="ref38">38</xref></sup><italic>AMAP</italic>,<sup><xref ref-type="bibr" rid="ref102">102</xref></sup> and <italic>AxPEP</italic>(<xref ref-type="bibr" rid="ref103">103</xref>) web servers, toxic/hemolytic
effects by all ML models in ToxinPred2<sup><xref ref-type="bibr" rid="ref89">89</xref></sup> and by <italic>HemoPI</italic>,<sup><xref ref-type="bibr" rid="ref90">90</xref></sup><italic>HemoPred</italic>,<sup><xref ref-type="bibr" rid="ref104">104</xref></sup> Happenn,<sup><xref ref-type="bibr" rid="ref105">105</xref></sup> and <italic>Macrel</italic>,<sup><xref ref-type="bibr" rid="ref106">106</xref></sup> respectively. Other relevant end points such as cell permeability
and half-life were screened by (<italic>CellPPD</italic>,<sup><xref ref-type="bibr" rid="ref107">107</xref></sup><italic>C2Pred</italic><sup><xref ref-type="bibr" rid="ref108">108</xref></sup> and <italic>MLCPP</italic>(<xref ref-type="bibr" rid="ref109">109</xref>)) and (<italic>pLifePred</italic><sup><xref ref-type="bibr" rid="ref110">110</xref></sup> and <italic>HLP</italic>(<xref ref-type="bibr" rid="ref111">111</xref>)), respectively, while
the most popular immune-toxicity end points (see <xref rid="tbl9" ref-type="other">Table <xref rid="tbl9" ref-type="other">9</xref></xref>), like allergenic reactions
and aggregation/amylogenicity, were predicted by <italic>AlgPred2</italic>,<sup><xref ref-type="bibr" rid="ref112">112</xref></sup><italic>MILAMP</italic>,<sup><xref ref-type="bibr" rid="ref113">113</xref></sup><italic>MetAmyl</italic>,<sup><xref ref-type="bibr" rid="ref114">114</xref></sup> and others, see <xref rid="tbl9" ref-type="other">Table <xref rid="tbl9" ref-type="other">9</xref></xref>. <xref rid="tbl10" ref-type="other">Table <xref rid="tbl10" ref-type="other">10</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">SI8-7</ext-link> summarize the physicochemical
properties of the 11 best APP lead candidates as well as end point
predictions for all 95 virtual hits.</p>
      <table-wrap id="tbl10" position="float">
        <label>Table 10</label>
        <caption>
          <title>Physico-chemical Properties of 11
Best APP Lead Candidates</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">Peptide ID</th>
              <th style="border:none;" align="center">Length</th>
              <th style="border:none;" align="center">Peptide Sequence</th>
              <th style="border:none;" align="center" char=".">Hydrophobicity</th>
              <th style="border:none;" align="center" char=".">Steric hindrance</th>
              <th style="border:none;" align="center" char=".">Hydropathicity
(GRAVY)</th>
              <th style="border:none;" align="center" char=".">Amphipathicity</th>
              <th style="border:none;" align="center" char=".">Net Hydrogen</th>
              <th style="border:none;" align="center" char=".">Charge</th>
              <th style="border:none;" align="center" char=".">Solubility
pH7<xref rid="t10fn1" ref-type="table-fn">a</xref></th>
              <th style="border:none;" align="center" char=".">pI pH7<xref rid="t10fn1" ref-type="table-fn">a</xref></th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">starPep_43351</td>
              <td style="border:none;" align="left">9</td>
              <td style="border:none;" align="left">WQWKVRIWR</td>
              <td style="border:none;" align="char" char=".">–0.33</td>
              <td style="border:none;" align="char" char=".">0.62</td>
              <td style="border:none;" align="char" char=".">–1.16</td>
              <td style="border:none;" align="char" char=".">1.09</td>
              <td style="border:none;" align="char" char=".">1.67</td>
              <td style="border:none;" align="char" char=".">3.00</td>
              <td style="border:none;" align="char" char=".">1.56</td>
              <td style="border:none;" align="char" char=".">14.5</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">starPep_38012</td>
              <td style="border:none;" align="left">9</td>
              <td style="border:none;" align="left">RRRKIAHKM</td>
              <td style="border:none;" align="char" char=".">–0.74</td>
              <td style="border:none;" align="char" char=".">0.60</td>
              <td style="border:none;" align="char" char=".">–1.81</td>
              <td style="border:none;" align="char" char=".">1.79</td>
              <td style="border:none;" align="char" char=".">1.89</td>
              <td style="border:none;" align="char" char=".">5.50</td>
              <td style="border:none;" align="char" char=".">195.0</td>
              <td style="border:none;" align="char" char=".">13.9</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">starPep_37962</td>
              <td style="border:none;" align="left">9</td>
              <td style="border:none;" align="left">RRMKKLRRK</td>
              <td style="border:none;" align="char" char=".">–1.06</td>
              <td style="border:none;" align="char" char=".">0.67</td>
              <td style="border:none;" align="char" char=".">–2.67</td>
              <td style="border:none;" align="char" char=".">2.31</td>
              <td style="border:none;" align="char" char=".">2.44</td>
              <td style="border:none;" align="char" char=".">7.00</td>
              <td style="border:none;" align="char" char=".">244.19</td>
              <td style="border:none;" align="char" char=".">13.9</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">starPep_26368</td>
              <td style="border:none;" align="left">9</td>
              <td style="border:none;" align="left">SRFWRRWRK</td>
              <td style="border:none;" align="char" char=".">–0.78</td>
              <td style="border:none;" align="char" char=".">0.63</td>
              <td style="border:none;" align="char" char=".">–2.41</td>
              <td style="border:none;" align="char" char=".">1.50</td>
              <td style="border:none;" align="char" char=".">2.33</td>
              <td style="border:none;" align="char" char=".">5.00</td>
              <td style="border:none;" align="char" char=".">111.58</td>
              <td style="border:none;" align="char" char=".">14.5</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">starPep_25927</td>
              <td style="border:none;" align="left">10</td>
              <td style="border:none;" align="left">ISKRILTGKK</td>
              <td style="border:none;" align="char" char=".">–0.34</td>
              <td style="border:none;" align="char" char=".">0.64</td>
              <td style="border:none;" align="char" char=".">–0.53</td>
              <td style="border:none;" align="char" char=".">1.35</td>
              <td style="border:none;" align="char" char=".">1.20</td>
              <td style="border:none;" align="char" char=".">4.00</td>
              <td style="border:none;" align="char" char=".">93.36</td>
              <td style="border:none;" align="char" char=".">13.8</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">starPep_20524</td>
              <td style="border:none;" align="left">10</td>
              <td style="border:none;" align="left">FWQRRIRKWR</td>
              <td style="border:none;" align="char" char=".">–0.67</td>
              <td style="border:none;" align="char" char=".">0.65</td>
              <td style="border:none;" align="char" char=".">–1.99</td>
              <td style="border:none;" align="char" char=".">1.47</td>
              <td style="border:none;" align="char" char=".">2.20</td>
              <td style="border:none;" align="char" char=".">5.00</td>
              <td style="border:none;" align="char" char=".">108.56</td>
              <td style="border:none;" align="char" char=".">14.5</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">starPep_27296</td>
              <td style="border:none;" align="left">13</td>
              <td style="border:none;" align="left">KMDSRWRWKSCKK</td>
              <td style="border:none;" align="char" char=".">–0.62</td>
              <td style="border:none;" align="char" char=".">0.64</td>
              <td style="border:none;" align="char" char=".">–2.08</td>
              <td style="border:none;" align="char" char=".">1.51</td>
              <td style="border:none;" align="char" char=".">1.62</td>
              <td style="border:none;" align="char" char=".">5.00</td>
              <td style="border:none;" align="char" char=".">127.3</td>
              <td style="border:none;" align="char" char=".">11.4</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">starPep_38063</td>
              <td style="border:none;" align="left">15</td>
              <td style="border:none;" align="left">RRRRRRRVSRRFMRR</td>
              <td style="border:none;" align="char" char=".">–1.21</td>
              <td style="border:none;" align="char" char=".">0.68</td>
              <td style="border:none;" align="char" char=".">–2.76</td>
              <td style="border:none;" align="char" char=".">1.80</td>
              <td style="border:none;" align="char" char=".">3.00</td>
              <td style="border:none;" align="char" char=".">11.00</td>
              <td style="border:none;" align="char" char=".">278.52</td>
              <td style="border:none;" align="char" char=".">14.5</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">starPep_26368</td>
              <td style="border:none;" align="left">17</td>
              <td style="border:none;" align="left">KEFKRIVKRIKKFLRKL</td>
              <td style="border:none;" align="char" char=".">–0.48</td>
              <td style="border:none;" align="char" char=".">0.67</td>
              <td style="border:none;" align="char" char=".">–0.82</td>
              <td style="border:none;" align="char" char=".">1.80</td>
              <td style="border:none;" align="char" char=".">1.47</td>
              <td style="border:none;" align="char" char=".">8.00</td>
              <td style="border:none;" align="char" char=".">101.37</td>
              <td style="border:none;" align="char" char=".">12.7</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">starPep_15029</td>
              <td style="border:none;" align="left">18</td>
              <td style="border:none;" align="left">ALYKKIIKKLLESAKKLG</td>
              <td style="border:none;" align="char" char=".">–0.18</td>
              <td style="border:none;" align="char" char=".">0.62</td>
              <td style="border:none;" align="char" char=".">–0.09</td>
              <td style="border:none;" align="char" char=".">1.29</td>
              <td style="border:none;" align="char" char=".">0.83</td>
              <td style="border:none;" align="char" char=".">5.00</td>
              <td style="border:none;" align="char" char=".">60.81</td>
              <td style="border:none;" align="char" char=".">10.4</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">starPep_27030</td>
              <td style="border:none;" align="left">19</td>
              <td style="border:none;" align="left">KKWKMRRGAGRRRRRRRRR</td>
              <td style="border:none;" align="char" char=".">–1.13</td>
              <td style="border:none;" align="char" char=".">0.67</td>
              <td style="border:none;" align="char" char=".">–3.12</td>
              <td style="border:none;" align="char" char=".">2.00</td>
              <td style="border:none;" align="char" char=".">2.68</td>
              <td style="border:none;" align="char" char=".">14.00</td>
              <td style="border:none;" align="char" char=".">270.71</td>
              <td style="border:none;" align="char" char=".">14.5</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t10fn1">
            <label>a</label>
            <p>Properties were calculated with <italic>SolupHred</italic> server (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ppmclab.pythonanywhere.com/SolupHred">https://ppmclab.pythonanywhere.com/SolupHred</uri>). The rest of physico-chemical properties were calculated with <italic>ToxinPrep</italic> (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://webs.iiitd.edu.in/raghava/toxinpred">https://webs.iiitd.edu.in/raghava/toxinpred</uri>).</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Finally, a set of 11 positively charged potential
APP lead candidates
was retained. Ten of them range between 9 and 19 <italic>aa</italic> in length. In general, their physicochemical properties show low
scores for hydropathicity meaning that they are more hydrophilic,
positively influencing solubility. They all were positively predicted
as APPs by all <italic>in silico</italic> methods used. Additionally,
they are nontoxic and nonhemolytic, and showed high solubility and
low immunogenicity according to all tools listed in <xref rid="tbl9" ref-type="other">Table <xref rid="tbl9" ref-type="other">9</xref></xref>.</p>
    </sec>
  </sec>
  <sec id="sec4">
    <label>4</label>
    <title>Conclusions</title>
    <p>A novel approach based
on network science methods and similarity
searches was introduced to explore the APPCS. We explored the chemical
space of <italic>StarPepDB</italic> with three types of networks (CSNs,
HSPNs, METNs) and <italic>mQSSMs</italic> to retrieve valuable information
from this database. We demonstrated that the pipeline developed in
this research outperformed <italic>state-of-the-art</italic> ML models
available for APP prediction by far statistically significant differences.
The novel <italic>mQSSMs</italic> were comparatively tested with the
largest experimentally validated nonredundant peptide set reported
to date and largely outperformed several methods from the literature.
Thus, we have arrived at a novel computational strategy regardless
of ML algorithms that recognizes APPs at high effectivity and reliability.
This promising strategy may support research aimed at repurposing
bioactive peptides as potential (virtual) hits. In fact, as a result
of our method and other filters, we initially proposed 95 repurposed
hits as potential APPs that have not been associated with this activity
until now. Moreover, we explored sequence similarities and motifs
shared by these leads and discovered some promising common motifs
that can serve as templates for searching novel APPs. Finally, a multiobjective
selection was applied to select 11 potential peptides with antiparasitic
activity and several end points’ abilities using 24 freely
available web servers. It represents an easy and reliable methodology to discover putative therapeutic
APPs for posterior experimental validation.</p>
  </sec>
</body>
<back>
  <notes notes-type="data-availability" id="notes-2">
    <title>Data Availability Statement</title>
    <p>The starPep
toolbox software and the respective user manual, as well as <italic>mQSSMs</italic>, are freely available online at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://mobiosd-hub.com/starpep">http://mobiosd-hub.com/starpep</uri>. The Supporting Information is also available at Zenodo: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.5281/zenodo.5650160">10.5281/zenodo.5650160</uri>.</p>
  </notes>
  <notes id="notes-1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting
Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acsomega.2c03398?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsomega.2c03398</ext-link>.<list id="silist" list-type="simple"><list-item><p>Fasta files, tables of parameters, graphml files of
the networks created here, Excel files with normalized centrality
measures and multiquery similarity searching models, additional results,
PDFs showing comparison with the literatature, and a Powerpoint file
with information about 95 lead comounds (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c03398/suppl_file/ao2c03398_si_001.zip">ZIP</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c03398_si_001.zip">
        <caption>
          <p>ao2c03398_si_001.zip</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="COI-statement" id="notes-3">
    <p>The authors
declare no competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>Y.M-P.
thanks to the program <italic>Profesor coinvitado</italic> for a post<bold>-</bold>doctoral fellowship to work at Valencia
University in 2020. Y.M.-P. and N.P. acknowledge the support from
Collaboration Grant 2019-2020 (Project ID16897) and Med Grant 2019-2020
(Project ID16905). G.A.-C. and A.A were supported by the Strategic
Funding UIDB/04423/2020 and UIDP/04423/2020 through national funds
provided by FCT and European Regional Development Fund (ERDF), in
the framework of the program PT2020.</p>
  </ack>
  <glossary id="dl1">
    <def-list>
      <title>Abbreviations</title>
      <def-item>
        <term>AMPs</term>
        <def>
          <p>antimicrobial
peptides</p>
        </def>
      </def-item>
      <def-item>
        <term>AMPCS</term>
        <def>
          <p>AMPs’
chemical
space</p>
        </def>
      </def-item>
      <def-item>
        <term>APPs</term>
        <def>
          <p>antiparasitic
peptides</p>
        </def>
      </def-item>
      <def-item>
        <term>APPCS</term>
        <def>
          <p>APPs’
chemical space</p>
        </def>
      </def-item>
      <def-item>
        <term>CSN</term>
        <def>
          <p>chemical space network</p>
        </def>
      </def-item>
      <def-item>
        <term>HSPN</term>
        <def>
          <p>half-space proximal network</p>
        </def>
      </def-item>
      <def-item>
        <term>METN</term>
        <def>
          <p>metadata network</p>
        </def>
      </def-item>
      <def-item>
        <term>
          <italic>mQSSM</italic>
        </term>
        <def>
          <p>the multiquery similarity
searching model</p>
        </def>
      </def-item>
      <def-item>
        <term>MCC</term>
        <def>
          <p>Matthews correlation coefficient</p>
        </def>
      </def-item>
      <def-item>
        <term>MDR</term>
        <def>
          <p>multidrug-resistant</p>
        </def>
      </def-item>
      <def-item>
        <term>AMR</term>
        <def>
          <p>antimicrobial resistance</p>
        </def>
      </def-item>
      <def-item>
        <term>CHDPs</term>
        <def>
          <p>host defense peptides</p>
        </def>
      </def-item>
      <def-item>
        <term>ML</term>
        <def>
          <p>machine learning</p>
        </def>
      </def-item>
      <def-item>
        <term>ACC</term>
        <def>
          <p>average clustering coefficient</p>
        </def>
      </def-item>
      <def-item>
        <term>ASP</term>
        <def>
          <p>average shortest
path</p>
        </def>
      </def-item>
      <def-item>
        <term>WD</term>
        <def>
          <p>weighted
degree</p>
        </def>
      </def-item>
      <def-item>
        <term>BE</term>
        <def>
          <p>betweenness</p>
        </def>
      </def-item>
      <def-item>
        <term>HC</term>
        <def>
          <p>harmonic</p>
        </def>
      </def-item>
      <def-item>
        <term>HB</term>
        <def>
          <p>hub-bridge</p>
        </def>
      </def-item>
      <def-item>
        <term>Qs</term>
        <def>
          <p>queries</p>
        </def>
      </def-item>
      <def-item>
        <term>ref</term>
        <def>
          <p>reference</p>
        </def>
      </def-item>
      <def-item>
        <term>SN</term>
        <def>
          <p>sensitivity</p>
        </def>
      </def-item>
      <def-item>
        <term>PR</term>
        <def>
          <p>precision</p>
        </def>
      </def-item>
      <def-item>
        <term>SP</term>
        <def>
          <p>specificity</p>
        </def>
      </def-item>
      <def-item>
        <term><italic>Q</italic>%</term>
        <def>
          <p>accuracy</p>
        </def>
      </def-item>
      <def-item>
        <term>MSA</term>
        <def>
          <p>multiple sequence alignment</p>
        </def>
      </def-item>
      <def-item>
        <term>MAFFT</term>
        <def>
          <p>Multiple Alignment
using Fast Fourier Transform</p>
        </def>
      </def-item>
      <def-item>
        <term>MUSCLE</term>
        <def>
          <p>Multiple Sequence Comparison by Log-Expectation</p>
        </def>
      </def-item>
      <def-item>
        <term>T-Coffee</term>
        <def>
          <p>Tree-based Consistency
Objective Function for Alignment Evaluation</p>
        </def>
      </def-item>
      <def-item>
        <term>STREME</term>
        <def>
          <p>Sensitive, Thorough, Rapid, Enriched
Motif Elicitation</p>
        </def>
      </def-item>
      <def-item>
        <term>CCDF</term>
        <def>
          <p>complementary cumulative distribution function</p>
        </def>
      </def-item>
      <def-item>
        <term>RF</term>
        <def>
          <p>random forest</p>
        </def>
      </def-item>
      <def-item>
        <term>AF-QSAMs</term>
        <def>
          <p>alignment-free quantitative
sequence-activity models</p>
        </def>
      </def-item>
      <def-item>
        <term>MCT</term>
        <def>
          <p>multiple comparison tests</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Jones</surname><given-names>K. E.</given-names></name>; <name><surname>Patel</surname><given-names>N. G.</given-names></name>; <name><surname>Levy</surname><given-names>M. A.</given-names></name>; <name><surname>Storeygard</surname><given-names>A.</given-names></name>; <name><surname>Balk</surname><given-names>D.</given-names></name>; <name><surname>Gittleman</surname><given-names>J. L.</given-names></name>; <name><surname>Daszak</surname><given-names>P.</given-names></name><article-title>Global Trends in Emerging
Infectious Diseases</article-title>. <source>Nature</source><year>2008</year>, <volume>451</volume> (<issue>7181</issue>), <fpage>990</fpage>–<lpage>993</lpage>. <pub-id pub-id-type="doi">10.1038/nature06536</pub-id>.<pub-id pub-id-type="pmid">18288193</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Andersson</surname><given-names>D. I.</given-names></name>; <name><surname>Balaban</surname><given-names>N. Q.</given-names></name>; <name><surname>Baquero</surname><given-names>F.</given-names></name>; <name><surname>Courvalin</surname><given-names>P.</given-names></name>; <name><surname>Glaser</surname><given-names>P.</given-names></name>; <name><surname>Gophna</surname><given-names>U.</given-names></name>; <name><surname>Kishony</surname><given-names>R.</given-names></name>; <name><surname>Molin</surname><given-names>S.</given-names></name>; <name><surname>Tønjum</surname><given-names>T.</given-names></name><article-title>Antibiotic Resistance: Turning Evolutionary
Principles
into Clinical Reality</article-title>. <source>FEMS Microbiol. Rev.</source><year>2020</year>, <volume>44</volume> (<issue>2</issue>), <fpage>171</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1093/femsre/fuaa001</pub-id>.<pub-id pub-id-type="pmid">31981358</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="book" id="cit3"><person-group><collab>WHO</collab></person-group>. <source>Antimicrobial Resistance</source>; <publisher-name>World Health Organization</publisher-name>, <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance">https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance</uri> (accessed 2021-05-07).</mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Mookherjee</surname><given-names>N.</given-names></name>; <name><surname>Anderson</surname><given-names>M. A.</given-names></name>; <name><surname>Haagsman</surname><given-names>H. P.</given-names></name>; <name><surname>Davidson</surname><given-names>D. J.</given-names></name><article-title>Antimicrobial Host
Defence Peptides: Functions and Clinical Potential</article-title>. <source>Nat. Rev. Drug Discovery</source><year>2020</year>, <volume>19</volume> (<issue>5</issue>), <fpage>311</fpage>–<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1038/s41573-019-0058-8</pub-id>.<pub-id pub-id-type="pmid">32107480</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Mahlapuu</surname><given-names>M.</given-names></name>; <name><surname>Björn</surname><given-names>C.</given-names></name>; <name><surname>Ekblom</surname><given-names>J.</given-names></name><article-title>Antimicrobial Peptides as Therapeutic
Agents: Opportunities and Challenges</article-title>. <source>Crit.
Rev. Biotechnol.</source><year>2020</year>, <volume>40</volume> (<issue>7</issue>), <fpage>978</fpage>–<lpage>992</lpage>. <pub-id pub-id-type="doi">10.1080/07388551.2020.1796576</pub-id>.<pub-id pub-id-type="pmid">32781848</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Lazzaro</surname><given-names>B. P.</given-names></name>; <name><surname>Zasloff</surname><given-names>M.</given-names></name>; <name><surname>Rolff</surname><given-names>J.</given-names></name><article-title>Antimicrobial Peptides:
Application
Informed by Evolution</article-title>. <source>Science</source><year>2020</year>, <volume>368</volume> (<issue>6490</issue>), <fpage>aau5480</fpage><pub-id pub-id-type="doi">10.1126/science.aau5480</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Magana</surname><given-names>M.</given-names></name>; <name><surname>Pushpanathan</surname><given-names>M.</given-names></name>; <name><surname>Santos</surname><given-names>A. L.</given-names></name>; <name><surname>Leanse</surname><given-names>L.</given-names></name>; <name><surname>Fernandez</surname><given-names>M.</given-names></name>; <name><surname>Ioannidis</surname><given-names>A.</given-names></name>; <name><surname>Giulianotti</surname><given-names>M. A.</given-names></name>; <name><surname>Apidianakis</surname><given-names>Y.</given-names></name>; <name><surname>Bradfute</surname><given-names>S.</given-names></name>; <name><surname>Ferguson</surname><given-names>A. L.</given-names></name>; <name><surname>Cherkasov</surname><given-names>A.</given-names></name>; <name><surname>Seleem</surname><given-names>M. N.</given-names></name>; <name><surname>Pinilla</surname><given-names>C.</given-names></name>; <name><surname>de la Fuente-Nunez</surname><given-names>C.</given-names></name>; <name><surname>Lazaridis</surname><given-names>T.</given-names></name>; <name><surname>Dai</surname><given-names>T.</given-names></name>; <name><surname>Houghten</surname><given-names>R. A.</given-names></name>; <name><surname>Hancock</surname><given-names>R. E. W.</given-names></name>; <name><surname>Tegos</surname><given-names>G. P.</given-names></name><article-title>The Value of Antimicrobial Peptides in the Age of Resistance</article-title>. <source>Lancet Infect. Dis.</source><year>2020</year>, <volume>20</volume> (<issue>9</issue>), <fpage>e216</fpage>–<lpage>e230</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30327-3</pub-id>.<pub-id pub-id-type="pmid">32653070</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="book" id="cit8"><person-group person-group-type="allauthors"><name><surname>van der Does</surname><given-names>A. M.</given-names></name>; <name><surname>Hiemstra</surname><given-names>P. S.</given-names></name>; <name><surname>Mookherjee</surname><given-names>N.</given-names></name></person-group><article-title>Antimicrobial
Host Defence Peptides: Immunomodulatory Functions and Translational
Prospects</article-title>. In <source>Antimicrobial Peptides: Basics
for Clinical Application</source>; <person-group person-group-type="editor"><name><surname>Matsuzaki</surname><given-names>K.</given-names></name></person-group>, Ed.; <series>Advances in Experimental
Medicine and Biology</series>; <publisher-name>Springer</publisher-name>: <publisher-loc>Singapore</publisher-loc>, <year>2019</year>; pp <fpage>149</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-13-3588-4_10</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Browne</surname><given-names>K.</given-names></name>; <name><surname>Chakraborty</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>R.</given-names></name>; <name><surname>Willcox</surname><given-names>M. D.</given-names></name>; <name><surname>Black</surname><given-names>D. S.</given-names></name>; <name><surname>Walsh</surname><given-names>W. R.</given-names></name>; <name><surname>Kumar</surname><given-names>N.</given-names></name><article-title>A New Era of Antibiotics: The Clinical
Potential of Antimicrobial Peptides</article-title>. <source>Int. J.
Mol. Sci.</source><year>2020</year>, <volume>21</volume> (<issue>19</issue>), <fpage>7047</fpage><pub-id pub-id-type="doi">10.3390/ijms21197047</pub-id>.<pub-id pub-id-type="pmid">32987946</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Piyadasa</surname><given-names>H.</given-names></name>; <name><surname>Hemshekhar</surname><given-names>M.</given-names></name>; <name><surname>Altieri</surname><given-names>A.</given-names></name>; <name><surname>Basu</surname><given-names>S.</given-names></name>; <name><surname>van der
Does</surname><given-names>A. M</given-names></name>; <name><surname>Halayko</surname><given-names>A. J</given-names></name>; <name><surname>Hiemstra</surname><given-names>P. S</given-names></name>; <name><surname>Mookherjee</surname><given-names>N.</given-names></name><article-title>Immunomodulatory
Innate Defence Regulator (IDR) Peptide Alleviates Airway Inflammation
and Hyper-Responsiveness</article-title>. <source>Thorax</source><year>2018</year>, <volume>73</volume> (<issue>10</issue>), <fpage>908</fpage>–<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1136/thoraxjnl-2017-210739</pub-id>.<pub-id pub-id-type="pmid">29853649</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Chow</surname><given-names>L. N.Y.</given-names></name>; <name><surname>Choi</surname><given-names>K.-Y.</given-names></name>; <name><surname>Piyadasa</surname><given-names>H.</given-names></name>; <name><surname>Bossert</surname><given-names>M.</given-names></name>; <name><surname>Uzonna</surname><given-names>J.</given-names></name>; <name><surname>Klonisch</surname><given-names>T.</given-names></name>; <name><surname>Mookherjee</surname><given-names>N.</given-names></name><article-title>Human Cathelicidin LL-37-Derived
Peptide IG-19 Confers Protection in a Murine Model of Collagen-Induced
Arthritis</article-title>. <source>Mol. Immunol.</source><year>2014</year>, <volume>57</volume> (<issue>2</issue>), <fpage>86</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2013.08.011</pub-id>.<pub-id pub-id-type="pmid">24091294</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Ho</surname><given-names>S.</given-names></name>; <name><surname>Pothoulakis</surname><given-names>C.</given-names></name>; <name><surname>Wai Koon</surname><given-names>H.</given-names></name><article-title>Antimicrobial Peptides and Colitis</article-title>. <source>Curr. Pharm. Des.</source><year>2012</year>, <volume>19</volume> (<issue>1</issue>), <fpage>40</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.2174/1381612811306010040</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><person-group person-group-type="allauthors"><name><surname>Roudi</surname><given-names>R.</given-names></name>; <name><surname>Syn</surname><given-names>N.
L.</given-names></name>; <name><surname>Roudbary</surname><given-names>M.</given-names></name></person-group><article-title>Antimicrobial
Peptides As Biologic and Immunotherapeutic Agents against Cancer:
A Comprehensive Overview</article-title>. <source>Front. Immunol.</source><year>2017</year>, <volume>8</volume>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01320</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><person-group person-group-type="allauthors"><name><surname>Haney</surname><given-names>E. F.</given-names></name>; <name><surname>Straus</surname><given-names>S. K.</given-names></name>; <name><surname>Hancock</surname><given-names>R. E. W.</given-names></name></person-group><article-title>Reassessing
the Host Defense Peptide Landscape</article-title>. <source>Front.
Chem.</source><year>2019</year>, <volume>7</volume>. <pub-id pub-id-type="doi">10.3389/fchem.2019.00043</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Torrent</surname><given-names>M.</given-names></name>; <name><surname>Pulido</surname><given-names>D.</given-names></name>; <name><surname>Rivas</surname><given-names>L.</given-names></name>; <name><surname>Andreu</surname><given-names>D.</given-names></name><article-title>Antimicrobial Peptide
Action on Parasites</article-title>. <source>Curr. Drug Targets</source><year>2012</year>, <volume>13</volume> (<issue>9</issue>), <fpage>1138</fpage>–<lpage>1147</lpage>. <pub-id pub-id-type="doi">10.2174/138945012802002393</pub-id>.<pub-id pub-id-type="pmid">22664071</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Davis</surname><given-names>A. J.</given-names></name>; <name><surname>Kedzierski</surname><given-names>L.</given-names></name><article-title>Recent Advances in Antileishmanial Drug Development</article-title>. <source>Curr. Opin. Investig. Drugs</source><year>2005</year>, <volume>6</volume> (<issue>2</issue>), <fpage>163</fpage>–<lpage>169</lpage>.</mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Mehta</surname><given-names>D.</given-names></name>; <name><surname>Anand</surname><given-names>P.</given-names></name>; <name><surname>Kumar</surname><given-names>V.</given-names></name>; <name><surname>Joshi</surname><given-names>A.</given-names></name>; <name><surname>Mathur</surname><given-names>D.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Tuknait</surname><given-names>A.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Gautam</surname><given-names>S. K.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Varshney</surname><given-names>G. C.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><article-title>ParaPep:
A Web Resource for Experimentally Validated Antiparasitic Peptide
Sequences and Their Structures</article-title>. <source>Database</source><year>2014</year>, <volume>2014</volume>, <fpage>bau051</fpage><pub-id pub-id-type="doi">10.1093/database/bau051</pub-id>.<pub-id pub-id-type="pmid">24923818</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Vale</surname><given-names>N.</given-names></name>; <name><surname>Aguiar</surname><given-names>L.</given-names></name>; <name><surname>Gomes</surname><given-names>P.</given-names></name><article-title>Antimicrobial
Peptides: A New Class
of Antimalarial Drugs?</article-title>. <source>Front. Pharmacol.</source><year>2014</year>, <volume>5</volume>, <fpage>275</fpage><pub-id pub-id-type="doi">10.3389/fphar.2014.00275</pub-id>.<pub-id pub-id-type="pmid">25566072</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Cobb</surname><given-names>S. L.</given-names></name>; <name><surname>Denny</surname><given-names>P. W.</given-names></name><article-title>Antimicrobial Peptides
for Leishmaniasis</article-title>. <source>Curr. Opin. Investig. Drugs</source><year>2010</year>, <volume>11</volume> (<issue>8</issue>), <fpage>868</fpage>–<lpage>875</lpage>.</mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Jenssen</surname><given-names>H.</given-names></name>; <name><surname>Hamill</surname><given-names>P.</given-names></name>; <name><surname>Hancock</surname><given-names>R. E. W.</given-names></name><article-title>Peptide
Antimicrobial Agents</article-title>. <source>Clin. Microbiol. Rev.</source><year>2006</year>, <volume>19</volume> (<issue>3</issue>), <fpage>491</fpage>–<lpage>511</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00056-05</pub-id>.<pub-id pub-id-type="pmid">16847082</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Lax</surname><given-names>R.</given-names></name><article-title>The Future
of Peptide Development in the Pharmaceutical Industry</article-title>. <source>PharManufacturing: The International Peptide Review</source><year>2010</year>, <volume>6</volume>, <fpage>10</fpage>.</mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Vagner</surname><given-names>J.</given-names></name>; <name><surname>Qu</surname><given-names>H.</given-names></name>; <name><surname>Hruby</surname><given-names>V. J.</given-names></name><article-title>Peptidomimetics, a Synthetic Tool of Drug Discovery</article-title>. <source>Curr. Opin. Chem. Biol.</source><year>2008</year>, <volume>12</volume> (<issue>3</issue>), <fpage>292</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2008.03.009</pub-id>.<pub-id pub-id-type="pmid">18423417</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Pane</surname><given-names>K.</given-names></name>; <name><surname>Durante</surname><given-names>L.</given-names></name>; <name><surname>Crescenzi</surname><given-names>O.</given-names></name>; <name><surname>Cafaro</surname><given-names>V.</given-names></name>; <name><surname>Pizzo</surname><given-names>E.</given-names></name>; <name><surname>Varcamonti</surname><given-names>M.</given-names></name>; <name><surname>Zanfardino</surname><given-names>A.</given-names></name>; <name><surname>Izzo</surname><given-names>V.</given-names></name>; <name><surname>Di Donato</surname><given-names>A.</given-names></name>; <name><surname>Notomista</surname><given-names>E.</given-names></name><article-title>Antimicrobial Potency of Cationic Antimicrobial Peptides
Can Be Predicted from Their Amino Acid Composition: Application to
the Detection of “Cryptic” Antimicrobial Peptides</article-title>. <source>J. Theor. Biol.</source><year>2017</year>, <volume>419</volume>, <fpage>254</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtbi.2017.02.012</pub-id>.<pub-id pub-id-type="pmid">28216428</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Walsh</surname><given-names>C. J.</given-names></name>; <name><surname>Guinane</surname><given-names>C. M.</given-names></name>; <name><surname>O’Toole</surname><given-names>P. W.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name><article-title>A Profile Hidden
Markov Model to Investigate the Distribution and Frequency of LanB-Encoding
Lantibiotic Modification Genes in the Human Oral and Gut Microbiome</article-title>. <source>Peer J.</source><year>2017</year>, <volume>5</volume>, <fpage>e3254</fpage><pub-id pub-id-type="doi">10.7717/peerj.3254</pub-id>.<pub-id pub-id-type="pmid">28462050</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Azkargorta</surname><given-names>M.</given-names></name>; <name><surname>Soria</surname><given-names>J.</given-names></name>; <name><surname>Ojeda</surname><given-names>C.</given-names></name>; <name><surname>Guzmán</surname><given-names>F.</given-names></name>; <name><surname>Acera</surname><given-names>A.</given-names></name>; <name><surname>Iloro</surname><given-names>I.</given-names></name>; <name><surname>Suárez</surname><given-names>T.</given-names></name>; <name><surname>Elortza</surname><given-names>F.</given-names></name><article-title>Human Basal Tear Peptidome Characterization by CID,
HCD, and ETD Followed by in Silico and in Vitro Analyses for Antimicrobial
Peptide Identification</article-title>. <source>J. Proteome Res.</source><year>2015</year>, <volume>14</volume> (<issue>6</issue>), <fpage>2649</fpage>–<lpage>2658</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.5b00179</pub-id>.<pub-id pub-id-type="pmid">25946035</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Fuente-Nunez</surname><given-names>C. de la.</given-names></name><article-title>Toward
Autonomous Antibiotic Discovery</article-title>. <source>mSystems</source><year>2019</year>, <volume>4</volume> (<issue>3</issue>), <fpage>e00151-19</fpage><pub-id pub-id-type="doi">10.1128/mSystems.00151-19</pub-id>.<pub-id pub-id-type="pmid">31186311</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Porto</surname><given-names>W. F.</given-names></name>; <name><surname>Pires</surname><given-names>A. S.</given-names></name>; <name><surname>Franco</surname><given-names>O. L.</given-names></name><article-title>Computational
Tools for Exploring
Sequence Databases as a Resource for Antimicrobial Peptides</article-title>. <source>Biotechnol. Adv.</source><year>2017</year>, <volume>35</volume> (<issue>3</issue>), <fpage>337</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2017.02.001</pub-id>.<pub-id pub-id-type="pmid">28216008</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Capecchi</surname><given-names>A.</given-names></name>; <name><surname>Reymond</surname><given-names>J.-L.</given-names></name><article-title>Peptides in Chemical
Space</article-title>. <source>Med.
Drug Discovery</source><year>2021</year>, <volume>9</volume>, <fpage>100081</fpage><pub-id pub-id-type="doi">10.1016/j.medidd.2021.100081</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Agüero-Chapin</surname><given-names>G.</given-names></name>; <name><surname>Pérez-Machado</surname><given-names>G.</given-names></name>; <name><surname>Molina-Ruiz</surname><given-names>R.</given-names></name>; <name><surname>Pérez-Castillo</surname><given-names>Y.</given-names></name>; <name><surname>Morales-Helguera</surname><given-names>A.</given-names></name>; <name><surname>Vasconcelos</surname><given-names>V.</given-names></name>; <name><surname>Antunes</surname><given-names>A.</given-names></name><article-title>TI2BioP: Topological
Indices to BioPolymers. Its Practical Use to Unravel Cryptic Bacteriocin-like
Domains</article-title>. <source>Amino Acids</source><year>2011</year>, <volume>40</volume> (<issue>2</issue>), <fpage>431</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-010-0653-9</pub-id>.<pub-id pub-id-type="pmid">20563611</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Xu</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>F.</given-names></name>; <name><surname>Leier</surname><given-names>A.</given-names></name>; <name><surname>Xiang</surname><given-names>D.</given-names></name>; <name><surname>Shen</surname><given-names>H.-H.</given-names></name>; <name><surname>Marquez
Lago</surname><given-names>T. T.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Yu</surname><given-names>D.-J.</given-names></name>; <name><surname>Song</surname><given-names>J.</given-names></name><article-title>Comprehensive
Assessment of Machine Learning-Based Methods for Predicting Antimicrobial
Peptides</article-title>. <source>Brief. Bioinform.</source><year>2021</year>, <volume>22</volume> (<issue>5</issue>), <fpage>bbab083</fpage><pub-id pub-id-type="doi">10.1093/bib/bbab083</pub-id>.<pub-id pub-id-type="pmid">33774670</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><person-group person-group-type="allauthors"><name><surname>Cardoso</surname><given-names>M. H.</given-names></name>; <name><surname>Orozco</surname><given-names>R. Q.</given-names></name>; <name><surname>Rezende</surname><given-names>S. B.</given-names></name>; <name><surname>Rodrigues</surname><given-names>G.</given-names></name>; <name><surname>Oshiro</surname><given-names>K. G. N.</given-names></name>; <name><surname>Cândido</surname><given-names>E. S.</given-names></name>; <name><surname>Franco</surname><given-names>O. L.</given-names></name></person-group><article-title>Computer-Aided Design of Antimicrobial Peptides:
Are We Generating
Effective Drug Candidates</article-title>? <source>Front. Microbiol.</source><year>2020</year>, <volume>10</volume>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.03097</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="book" id="cit32"><person-group person-group-type="allauthors"><name><surname>Mitchell</surname><given-names>M.</given-names></name></person-group><source>Complexity: A Guided
Tour</source>; <publisher-name>Oxford University Press</publisher-name>, <year>2009</year>.</mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="book" id="cit33"><person-group person-group-type="allauthors"><name><surname>Barabási</surname><given-names>A.-L.</given-names></name></person-group><source>Network
Science</source>; <publisher-name>Cambridge University Press</publisher-name>, <year>2016</year>.</mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Willett</surname><given-names>P.</given-names></name>; <name><surname>Barnard</surname><given-names>J. M.</given-names></name>; <name><surname>Downs</surname><given-names>G. M.</given-names></name><article-title>Chemical
Similarity Searching</article-title>. <source>J. Chem. Inf. Comput.
Sci.</source><year>1998</year>, <volume>38</volume> (<issue>6</issue>), <fpage>983</fpage>–<lpage>996</lpage>. <pub-id pub-id-type="doi">10.1021/ci9800211</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Willett</surname><given-names>P.</given-names></name><article-title>Similarity-Based
Virtual Screening Using 2D Fingerprints</article-title>. <source>Drug
Discovery Today</source><year>2006</year>, <volume>11</volume> (<issue>23</issue>), <fpage>1046</fpage>–<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2006.10.005</pub-id>.<pub-id pub-id-type="pmid">17129822</pub-id></mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><name><surname>Aguilera-Mendoza</surname><given-names>L.</given-names></name>; <name><surname>Marrero-Ponce</surname><given-names>Y.</given-names></name>; <name><surname>García-Jacas</surname><given-names>C.
R.</given-names></name>; <name><surname>Chavez</surname><given-names>E.</given-names></name>; <name><surname>Beltran</surname><given-names>J. A.</given-names></name>; <name><surname>Guillen-Ramirez</surname><given-names>H. A.</given-names></name>; <name><surname>Brizuela</surname><given-names>C. A.</given-names></name><article-title>Automatic Construction
of Molecular Similarity Networks for Visual Graph Mining in Chemical
Space of Bioactive Peptides: An Unsupervised Learning Approach</article-title>. <source>Sci. Rep.</source><year>2020</year>, <volume>10</volume> (<issue>1</issue>), <fpage>18074</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-75029-1</pub-id>.<pub-id pub-id-type="pmid">33093586</pub-id></mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>Pinacho-Castellanos</surname><given-names>S. A.</given-names></name>; <name><surname>García-Jacas</surname><given-names>C. R.</given-names></name>; <name><surname>Gilson</surname><given-names>M. K.</given-names></name>; <name><surname>Brizuela</surname><given-names>C. A.</given-names></name><article-title>Alignment-Free
Antimicrobial Peptide Predictors: Improving Performance by a Thorough
Analysis of the Largest Available Data Set</article-title>. <source>J. Chem. Inf. Model.</source><year>2021</year>, <volume>61</volume> (<issue>6</issue>), <fpage>3141</fpage>–<lpage>3157</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.1c00251</pub-id>.<pub-id pub-id-type="pmid">34081438</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Chung</surname><given-names>C.-R.</given-names></name>; <name><surname>Kuo</surname><given-names>T.-R.</given-names></name>; <name><surname>Wu</surname><given-names>L.-C.</given-names></name>; <name><surname>Lee</surname><given-names>T.-Y.</given-names></name>; <name><surname>Horng</surname><given-names>J.-T.</given-names></name><article-title>Characterization
and Identification of Antimicrobial Peptides with Different Functional
Activities</article-title>. <source>Brief. Bioinform.</source><year>2020</year>, <volume>21</volume> (<issue>3</issue>), <fpage>1098</fpage>–<lpage>1114</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbz043</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>Aguilera-Mendoza</surname><given-names>L.</given-names></name>; <name><surname>Marrero-Ponce</surname><given-names>Y.</given-names></name>; <name><surname>Beltran</surname><given-names>J. A.</given-names></name>; <name><surname>Tellez Ibarra</surname><given-names>R.</given-names></name>; <name><surname>Guillen-Ramirez</surname><given-names>H. A.</given-names></name>; <name><surname>Brizuela</surname><given-names>C. A.</given-names></name><article-title>Graph-Based Data Integration from
Bioactive Peptide Databases of Pharmaceutical Interest: Toward an
Organized Collection Enabling Visual Network Analysis</article-title>. <source>Bioinformatics</source><year>2019</year>, <volume>35</volume> (<issue>22</issue>), <fpage>4739</fpage>–<lpage>4747</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btz260</pub-id>.<pub-id pub-id-type="pmid">30994884</pub-id></mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="undeclared" id="cit40"><person-group person-group-type="allauthors"><name><surname>Coscia</surname><given-names>M.</given-names></name></person-group><article-title>The Atlas for
the Aspiring Network Scientist</article-title>; arXiv [Preprint], <year>2021</year>.</mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Aguilera-Mendoza</surname><given-names>L.</given-names></name>; <name><surname>Marrero-Ponce</surname><given-names>Y.</given-names></name>; <name><surname>Beltran</surname><given-names>J. A.</given-names></name>; <name><surname>Tellez Ibarra</surname><given-names>R.</given-names></name>; <name><surname>Guillen-Ramirez</surname><given-names>H. A.</given-names></name>; <name><surname>Brizuela</surname><given-names>C. A.</given-names></name><article-title>Graph-Based Data Integration from
Bioactive Peptide Databases of Pharmaceutical Interest: Toward an
Organized Collection Enabling Visual Network Analysis</article-title>. <source>Bioinformatics</source><year>2019</year>, <volume>35</volume> (<issue>22</issue>), <fpage>4739</fpage>–<lpage>4747</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btz260</pub-id>.<pub-id pub-id-type="pmid">30994884</pub-id></mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Zahoránszky-Kőhalmi</surname><given-names>G.</given-names></name>; <name><surname>Bologa</surname><given-names>C. G.</given-names></name>; <name><surname>Oprea</surname><given-names>T. I.</given-names></name><article-title>Impact of Similarity Threshold on
the Topology of Molecular Similarity Networks and Clustering Outcomes</article-title>. <source>J. Cheminformatics</source><year>2016</year>, <volume>8</volume> (<issue>1</issue>), <fpage>16</fpage><pub-id pub-id-type="doi">10.1186/s13321-016-0127-5</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Maldonado</surname><given-names>A. G.</given-names></name>; <name><surname>Doucet</surname><given-names>J. P.</given-names></name>; <name><surname>Petitjean</surname><given-names>M.</given-names></name>; <name><surname>Fan</surname><given-names>B.-T.</given-names></name><article-title>Molecular Similarity
and Diversity in Chemoinformatics: From Theory to Applications</article-title>. <source>Mol. Divers.</source><year>2006</year>, <volume>10</volume> (<issue>1</issue>), <fpage>39</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1007/s11030-006-8697-1</pub-id>.<pub-id pub-id-type="pmid">16404528</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Zwierzyna</surname><given-names>M.</given-names></name>; <name><surname>Vogt</surname><given-names>M.</given-names></name>; <name><surname>Maggiora</surname><given-names>G. M.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name><article-title>Design and
Characterization
of Chemical Space Networks for Different Compound Data Sets</article-title>. <source>J. Comput. Aided Mol. Des.</source><year>2015</year>, <volume>29</volume> (<issue>2</issue>), <fpage>113</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-014-9821-4</pub-id>.<pub-id pub-id-type="pmid">25465052</pub-id></mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="book" id="cit45"><person-group person-group-type="allauthors"><name><surname>Chavez</surname><given-names>E.</given-names></name>; <name><surname>Dobrev</surname><given-names>S.</given-names></name>; <name><surname>Kranakis</surname><given-names>E.</given-names></name>; <name><surname>Opatrny</surname><given-names>J.</given-names></name>; <name><surname>Stacho</surname><given-names>L.</given-names></name>; <name><surname>Tejeda</surname><given-names>H.</given-names></name>; <name><surname>Urrutia</surname><given-names>J.</given-names></name></person-group><article-title>Half-Space Proximal:
A New Local Test for Extracting a Bounded Dilation Spanner of a Unit
Disk Graph</article-title>. In <source>Principles of Distributed Systems</source>; <person-group person-group-type="editor"><name><surname>Anderson</surname><given-names>J. H.</given-names></name>, <name><surname>Prencipe</surname><given-names>G.</given-names></name>, <name><surname>Wattenhofer</surname><given-names>R.</given-names></name></person-group>, Eds.; <series>Lecture
Notes in Computer Science</series>; <publisher-name>Springer</publisher-name>: <publisher-loc>Berlin</publisher-loc>, <year>2006</year>; pp <fpage>235</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1007/11795490_19</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Corral-Corral</surname><given-names>R.</given-names></name>; <name><surname>Chavez</surname><given-names>E.</given-names></name>; <name><surname>Del Rio</surname><given-names>G.</given-names></name><article-title>Machine Learnable
Fold Space Representation
Based on Residue Cluster Classes</article-title>. <source>Comput. Biol.
Chem.</source><year>2015</year>, <volume>59</volume>, <fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.compbiolchem.2015.07.010</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Smith</surname><given-names>T. F.</given-names></name>; <name><surname>Waterman</surname><given-names>M. S.</given-names></name><article-title>Identification of Common Molecular Subsequences</article-title>. <source>J. Mol. Biol.</source><year>1981</year>, <volume>147</volume> (<issue>1</issue>), <fpage>195</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/0022-2836(81)90087-5</pub-id>.<pub-id pub-id-type="pmid">7265238</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Ashtiani</surname><given-names>M.</given-names></name>; <name><surname>Mirzaie</surname><given-names>M.</given-names></name>; <name><surname>Jafari</surname><given-names>M.</given-names></name><article-title>CINNA: An
R/CRAN Package to Decipher
Central Informative Nodes in Network Analysis</article-title>. <source>Bioinformatics</source><year>2019</year>, <volume>35</volume> (<issue>8</issue>), <fpage>1436</fpage>–<lpage>1437</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bty819</pub-id>.<pub-id pub-id-type="pmid">30239607</pub-id></mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="undeclared" id="cit49"><person-group person-group-type="allauthors"><name><surname>Cherven</surname><given-names>K.</given-names></name></person-group><source>Network Graph Analysis
and Visualization with Gephi</source>; Birmingham, UK, <year>2013</year>.</mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="journal" id="cit50"><name><surname>Fruchterman</surname><given-names>T. M. J.</given-names></name>; <name><surname>Reingold</surname><given-names>E. M.</given-names></name><article-title>Graph Drawing by
Force-Directed Placement</article-title>. <source>Softw. Pract. Exp.</source><year>1991</year>, <volume>21</volume> (<issue>11</issue>), <fpage>1129</fpage>–<lpage>1164</lpage>. <pub-id pub-id-type="doi">10.1002/spe.4380211102</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Gilbert</surname><given-names>E. N.</given-names></name><article-title>Random
Graphs</article-title>. <source>Ann. Math. Stat.</source><year>1959</year>, <volume>30</volume> (<issue>4</issue>), <fpage>1141</fpage>–<lpage>1144</lpage>. <pub-id pub-id-type="doi">10.1214/aoms/1177706098</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>Csárdi</surname><given-names>G.</given-names></name>; <name><surname>Nepusz</surname><given-names>T.</given-names></name><article-title>The Igraph Software
Package for Complex Network Research</article-title>. <source>Int. J.
Complex Sys</source><year>2006</year>, <volume>1695</volume>, <fpage>1</fpage>–<lpage>9</lpage>.</mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Bastian</surname><given-names>M.</given-names></name>; <name><surname>Heymann</surname><given-names>S.</given-names></name>; <name><surname>Jacomy</surname><given-names>M.</given-names></name><article-title>Gephi: An
Open Source Software for
Exploring and Manipulating Networks</article-title>. <source>ICWSM</source><year>2009</year>, <volume>3</volume>, <fpage>361</fpage><pub-id pub-id-type="doi">10.1609/icwsm.v3i1.13937</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="computer-program" id="cit54"><person-group><collab>Inkscape</collab></person-group>. <source>Inkscape
Project</source>; <year>2021</year>.</mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="book" id="cit55"><person-group person-group-type="allauthors"><name><surname>Newman</surname><given-names>M.</given-names></name></person-group><source>Networks</source>; <publisher-name>Oxford University Press</publisher-name>, <year>2018</year>.</mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Blondel</surname><given-names>V. D.</given-names></name>; <name><surname>Guillaume</surname><given-names>J.-L.</given-names></name>; <name><surname>Lambiotte</surname><given-names>R.</given-names></name>; <name><surname>Lefebvre</surname><given-names>E.</given-names></name><article-title>Fast Unfolding of Communities
in Large Networks</article-title>. <source>J. Stat. Mech. Theory Exp.</source><year>2008</year>, <volume>2008</volume> (<issue>10</issue>), <fpage>P10008</fpage><pub-id pub-id-type="doi">10.1088/1742-5468/2008/10/P10008</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="journal" id="cit57"><name><surname>Barrat</surname><given-names>A.</given-names></name>; <name><surname>Barthélemy</surname><given-names>M.</given-names></name>; <name><surname>Pastor-Satorras</surname><given-names>R.</given-names></name>; <name><surname>Vespignani</surname><given-names>A.</given-names></name><article-title>The Architecture
of Complex Weighted Networks</article-title>. <source>Proc. Natl. Acad.
Sci. U. S. A.</source><year>2004</year>, <volume>101</volume> (<issue>11</issue>), <fpage>3747</fpage>–<lpage>3752</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0400087101</pub-id>.<pub-id pub-id-type="pmid">15007165</pub-id></mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="undeclared" id="cit58"><person-group person-group-type="allauthors"><name><surname>Wickham</surname><given-names>H.</given-names></name></person-group><source>Ggplot2: Elegant Graphics
for Data Analysis</source>; <series>Use R!</series>; <publisher-name>Springer-Verlag</publisher-name>: <publisher-loc>New York</publisher-loc>, <year>2009</year>. <pub-id pub-id-type="doi">10.1007/978-0-387-98141-3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Ashtiani</surname><given-names>M.</given-names></name>; <name><surname>Salehzadeh-Yazdi</surname><given-names>A.</given-names></name>; <name><surname>Razaghi-Moghadam</surname><given-names>Z.</given-names></name>; <name><surname>Hennig</surname><given-names>H.</given-names></name>; <name><surname>Wolkenhauer</surname><given-names>O.</given-names></name>; <name><surname>Mirzaie</surname><given-names>M.</given-names></name>; <name><surname>Jafari</surname><given-names>M.</given-names></name><article-title>A Systematic
Survey of Centrality
Measures for Protein-Protein Interaction Networks</article-title>. <source>BMC Syst. Biol.</source><year>2018</year>, <volume>12</volume> (<issue>1</issue>), <fpage>80</fpage><pub-id pub-id-type="doi">10.1186/s12918-018-0598-2</pub-id>.<pub-id pub-id-type="pmid">30064421</pub-id></mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="computer-program" id="cit60"><person-group person-group-type="allauthors"><name><surname>Link</surname><given-names>R.</given-names></name></person-group><source>Corrmorant:
Flexible Correlation Matrices Based on Ggplot2</source>; <year>2021</year>.</mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="journal" id="cit61"><name><surname>Lafita</surname><given-names>A.</given-names></name>; <name><surname>Bliven</surname><given-names>S.</given-names></name>; <name><surname>Prlić</surname><given-names>A.</given-names></name>; <name><surname>Guzenko</surname><given-names>D.</given-names></name>; <name><surname>Rose</surname><given-names>P. W.</given-names></name>; <name><surname>Bradley</surname><given-names>A.</given-names></name>; <name><surname>Pavan</surname><given-names>P.</given-names></name>; <name><surname>Myers-Turnbull</surname><given-names>D.</given-names></name>; <name><surname>Valasatava</surname><given-names>Y.</given-names></name>; <name><surname>Heuer</surname><given-names>M.</given-names></name>; <name><surname>Larson</surname><given-names>M.</given-names></name>; <name><surname>Burley</surname><given-names>S. K.</given-names></name>; <name><surname>Duarte</surname><given-names>J. M.</given-names></name><article-title>BioJava 5: A Community Driven Open-Source
Bioinformatics
Library</article-title>. <source>PLOS Comput. Biol.</source><year>2019</year>, <volume>15</volume> (<issue>2</issue>), <fpage>e1006791</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006791</pub-id>.<pub-id pub-id-type="pmid">30735498</pub-id></mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Hert</surname><given-names>J.</given-names></name>; <name><surname>Willett</surname><given-names>P.</given-names></name>; <name><surname>Wilton</surname><given-names>D. J.</given-names></name>; <name><surname>Acklin</surname><given-names>P.</given-names></name>; <name><surname>Azzaoui</surname><given-names>K.</given-names></name>; <name><surname>Jacoby</surname><given-names>E.</given-names></name>; <name><surname>Schuffenhauer</surname><given-names>A.</given-names></name><article-title>Comparison
of Fingerprint-Based Methods
for Virtual Screening Using Multiple Bioactive Reference Structures</article-title>. <source>J. Chem. Inf. Comput. Sci.</source><year>2004</year>, <volume>44</volume> (<issue>3</issue>), <fpage>1177</fpage>–<lpage>1185</lpage>. <pub-id pub-id-type="doi">10.1021/ci034231b</pub-id>.<pub-id pub-id-type="pmid">15154787</pub-id></mixed-citation>
    </ref>
    <ref id="ref63">
      <mixed-citation publication-type="journal" id="cit63"><name><surname>Rivera-Borroto</surname><given-names>O. M.</given-names></name>; <name><surname>García-de la Vega</surname><given-names>J. M.</given-names></name>; <name><surname>Marrero-Ponce</surname><given-names>Y.</given-names></name>; <name><surname>Grau</surname><given-names>R.</given-names></name><article-title>Relational Agreement Measures for
Similarity Searching of Cheminformatic
Data Sets</article-title>. <source>IEEE/ACM Trans. Comput. Biol. Bioinform.</source><year>2016</year>, <volume>13</volume> (<issue>1</issue>), <fpage>158</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1109/TCBB.2015.2424435</pub-id>.<pub-id pub-id-type="pmid">26886740</pub-id></mixed-citation>
    </ref>
    <ref id="ref64">
      <mixed-citation publication-type="journal" id="cit64"><name><surname>Hert</surname><given-names>J.</given-names></name>; <name><surname>Willett</surname><given-names>P.</given-names></name>; <name><surname>Wilton</surname><given-names>D. J.</given-names></name>; <name><surname>Acklin</surname><given-names>P.</given-names></name>; <name><surname>Azzaoui</surname><given-names>K.</given-names></name>; <name><surname>Jacoby</surname><given-names>E.</given-names></name>; <name><surname>Schuffenhauer</surname><given-names>A.</given-names></name><article-title>Comparison of Fingerprint-Based Methods
for Virtual Screening Using Multiple Bioactive Reference Structures</article-title>. <source>J. Chem. Inf. Comput. Sci.</source><year>2004</year>, <volume>44</volume> (<issue>3</issue>), <fpage>1177</fpage>–<lpage>1185</lpage>. <pub-id pub-id-type="doi">10.1021/ci034231b</pub-id>.<pub-id pub-id-type="pmid">15154787</pub-id></mixed-citation>
    </ref>
    <ref id="ref65">
      <mixed-citation publication-type="journal" id="cit65"><name><surname>Sokolova</surname><given-names>M.</given-names></name>; <name><surname>Lapalme</surname><given-names>G.</given-names></name><article-title>A Systematic Analysis
of Performance Measures for Classification
Tasks</article-title>. <source>Inf. Process. Manag.</source><year>2009</year>, <volume>45</volume> (<issue>4</issue>), <fpage>427</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1016/j.ipm.2009.03.002</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref66">
      <mixed-citation publication-type="journal" id="cit66"><name><surname>Baldi</surname><given-names>P.</given-names></name>; <name><surname>Brunak</surname><given-names>S.</given-names></name>; <name><surname>Chauvin</surname><given-names>Y.</given-names></name>; <name><surname>Andersen</surname><given-names>C. A.</given-names></name>; <name><surname>Nielsen</surname><given-names>H.</given-names></name><article-title>Assessing
the Accuracy of Prediction Algorithms for Classification: An Overview</article-title>. <source>Bioinforma. Oxf. Engl.</source><year>2000</year>, <volume>16</volume> (<issue>5</issue>), <fpage>412</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/16.5.412</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref67">
      <mixed-citation publication-type="book" id="cit67"><person-group person-group-type="allauthors"><name><surname>Iman</surname><given-names>R. L.</given-names></name>; <name><surname>Davenport</surname><given-names>J. M.</given-names></name></person-group><source>Approximations of
the Critical Region of the Friedman Statistic</source>; SAND-79-0883C;
CONF-790825-1; Sandia Labs., Albuquerque, NM (USA); <publisher-name>Texas Tech Univ.</publisher-name>: <publisher-loc>Lubbock, TX</publisher-loc>, <year>1979</year>.</mixed-citation>
    </ref>
    <ref id="ref68">
      <mixed-citation publication-type="journal" id="cit68"><name><surname>García</surname><given-names>S.</given-names></name>; <name><surname>Fernández</surname><given-names>A.</given-names></name>; <name><surname>Luengo</surname><given-names>J.</given-names></name>; <name><surname>Herrera</surname><given-names>F.</given-names></name><article-title>A Study of Statistical
Techniques and Performance Measures for Genetics-Based Machine Learning:
Accuracy and Interpretability</article-title>. <source>Soft Comput.
- Fusion Found. Methodol. Appl.</source><year>2009</year>, <volume>13</volume> (<issue>10</issue>), <fpage>959</fpage>–<lpage>977</lpage>. <pub-id pub-id-type="doi">10.1007/s00500-008-0392-y</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref69">
      <mixed-citation publication-type="journal" id="cit69"><name><surname>Demšar</surname><given-names>J.</given-names></name><article-title>Statistical
Comparisons of Classifiers over Multiple Data Sets</article-title>. <source>J. Machine Learn. Res.</source><year>2006</year>, <volume>30</volume>, <fpage>1</fpage>–<lpage>30</lpage>.</mixed-citation>
    </ref>
    <ref id="ref70">
      <mixed-citation publication-type="journal" id="cit70"><name><surname>Gupta</surname><given-names>S.</given-names></name>; <name><surname>Kapoor</surname><given-names>P.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><article-title>In Silico Approach for Predicting Toxicity of Peptides
and Proteins</article-title>. <source>PLoS One</source><year>2013</year>, <volume>8</volume> (<issue>9</issue>), <fpage>e73957</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0073957</pub-id>.<pub-id pub-id-type="pmid">24058508</pub-id></mixed-citation>
    </ref>
    <ref id="ref71">
      <mixed-citation publication-type="journal" id="cit71"><name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Tuknait</surname><given-names>A.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Mathur</surname><given-names>D.</given-names></name>; <name><surname>Anand</surname><given-names>P.</given-names></name>; <name><surname>Varshney</surname><given-names>G. C.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><article-title>A Web
Server and Mobile App for Computing Hemolytic Potency of Peptides</article-title>. <source>Sci. Rep.</source><year>2016</year>, <volume>6</volume> (<issue>1</issue>), <fpage>22843</fpage><pub-id pub-id-type="doi">10.1038/srep22843</pub-id>.<pub-id pub-id-type="pmid">26953092</pub-id></mixed-citation>
    </ref>
    <ref id="ref72">
      <mixed-citation publication-type="journal" id="cit72"><name><surname>Katoh</surname><given-names>K.</given-names></name>; <name><surname>Misawa</surname><given-names>K.</given-names></name>; <name><surname>Kuma</surname><given-names>K.</given-names></name>; <name><surname>Miyata</surname><given-names>T.</given-names></name><article-title>MAFFT: A Novel Method
for Rapid Multiple Sequence Alignment Based on Fast Fourier Transform</article-title>. <source>Nucleic Acids Res.</source><year>2002</year>, <volume>30</volume> (<issue>14</issue>), <fpage>3059</fpage>–<lpage>3066</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkf436</pub-id>.<pub-id pub-id-type="pmid">12136088</pub-id></mixed-citation>
    </ref>
    <ref id="ref73">
      <mixed-citation publication-type="journal" id="cit73"><name><surname>Edgar</surname><given-names>R. C.</given-names></name><article-title>MUSCLE:
Multiple Sequence Alignment with High Accuracy and High Throughput</article-title>. <source>Nucleic Acids Res.</source><year>2004</year>, <volume>32</volume> (<issue>5</issue>), <fpage>1792</fpage>–<lpage>1797</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkh340</pub-id>.<pub-id pub-id-type="pmid">15034147</pub-id></mixed-citation>
    </ref>
    <ref id="ref74">
      <mixed-citation publication-type="journal" id="cit74"><name><surname>Notredame</surname><given-names>C.</given-names></name>; <name><surname>Higgins</surname><given-names>D. G.</given-names></name>; <name><surname>Heringa</surname><given-names>J.</given-names></name><article-title>T-Coffee:
A Novel Method for Fast
and Accurate Multiple Sequence Alignment11Edited by J. Thornton</article-title>. <source>J. Mol. Biol.</source><year>2000</year>, <volume>302</volume> (<issue>1</issue>), <fpage>205</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.2000.4042</pub-id>.<pub-id pub-id-type="pmid">10964570</pub-id></mixed-citation>
    </ref>
    <ref id="ref75">
      <mixed-citation publication-type="journal" id="cit75"><name><surname>Waterhouse</surname><given-names>A. M.</given-names></name>; <name><surname>Procter</surname><given-names>J. B.</given-names></name>; <name><surname>Martin</surname><given-names>D. M. A.</given-names></name>; <name><surname>Clamp</surname><given-names>M.</given-names></name>; <name><surname>Barton</surname><given-names>G. J.</given-names></name><article-title>Jalview
Version 2—a Multiple Sequence Alignment Editor and Analysis
Workbench</article-title>. <source>Bioinformatics</source><year>2009</year>, <volume>25</volume> (<issue>9</issue>), <fpage>1189</fpage>–<lpage>1191</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp033</pub-id>.<pub-id pub-id-type="pmid">19151095</pub-id></mixed-citation>
    </ref>
    <ref id="ref76">
      <mixed-citation publication-type="journal" id="cit76"><name><surname>Rice</surname><given-names>P.</given-names></name>; <name><surname>Longden</surname><given-names>I.</given-names></name>; <name><surname>Bleasby</surname><given-names>A.</given-names></name><article-title>EMBOSS: The
European Molecular Biology
Open Software Suite</article-title>. <source>Trends Genet.</source><year>2000</year>, <volume>16</volume> (<issue>6</issue>), <fpage>276</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/S0168-9525(00)02024-2</pub-id>.<pub-id pub-id-type="pmid">10827456</pub-id></mixed-citation>
    </ref>
    <ref id="ref77">
      <mixed-citation publication-type="journal" id="cit77"><name><surname>Bailey</surname><given-names>T. L.</given-names></name><article-title>STREME:
Accurate and Versatile Sequence Motif Discovery</article-title>. <source>Bioinformatics</source><year>2021</year>, <volume>37</volume> (<issue>18</issue>), <fpage>2834</fpage>–<lpage>2840</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btab203</pub-id>.<pub-id pub-id-type="pmid">33760053</pub-id></mixed-citation>
    </ref>
    <ref id="ref78">
      <mixed-citation publication-type="journal" id="cit78"><name><surname>Bailey</surname><given-names>T. L.</given-names></name>; <name><surname>Boden</surname><given-names>M.</given-names></name>; <name><surname>Buske</surname><given-names>F. A.</given-names></name>; <name><surname>Frith</surname><given-names>M.</given-names></name>; <name><surname>Grant</surname><given-names>C. E.</given-names></name>; <name><surname>Clementi</surname><given-names>L.</given-names></name>; <name><surname>Ren</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>W. W.</given-names></name>; <name><surname>Noble</surname><given-names>W. S.</given-names></name><article-title>MEME Suite:
Tools for Motif Discovery and Searching</article-title>. <source>Nucleic
Acids Res.</source><year>2009</year>, <volume>37</volume> (<issue>suppl_2</issue>), <fpage>W202</fpage>–<lpage>W208</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkp335</pub-id>.<pub-id pub-id-type="pmid">19458158</pub-id></mixed-citation>
    </ref>
    <ref id="ref79">
      <mixed-citation publication-type="journal" id="cit79"><name><surname>Kanehisa</surname><given-names>M.</given-names></name><article-title>Linking Databases
and Organisms: GenomeNet Resources in Japan</article-title>. <source>Trends Biochem. Sci.</source><year>1997</year>, <volume>22</volume> (<issue>11</issue>), <fpage>442</fpage>–<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1016/S0968-0004(97)01130-4</pub-id>.<pub-id pub-id-type="pmid">9397687</pub-id></mixed-citation>
    </ref>
    <ref id="ref80">
      <mixed-citation publication-type="journal" id="cit80"><name><surname>Sigrist</surname><given-names>C. J. A.</given-names></name>; <name><surname>Cerutti</surname><given-names>L.</given-names></name>; <name><surname>Hulo</surname><given-names>N.</given-names></name>; <name><surname>Gattiker</surname><given-names>A.</given-names></name>; <name><surname>Falquet</surname><given-names>L.</given-names></name>; <name><surname>Pagni</surname><given-names>M.</given-names></name>; <name><surname>Bairoch</surname><given-names>A.</given-names></name>; <name><surname>Bucher</surname><given-names>P.</given-names></name><article-title>PROSITE: A Documented
Database Using Patterns and Profiles as Motif Descriptors</article-title>. <source>Brief. Bioinform.</source><year>2002</year>, <volume>3</volume> (<issue>3</issue>), <fpage>265</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1093/bib/3.3.265</pub-id>.<pub-id pub-id-type="pmid">12230035</pub-id></mixed-citation>
    </ref>
    <ref id="ref81">
      <mixed-citation publication-type="journal" id="cit81"><name><surname>Newman</surname><given-names>M. E. J.</given-names></name><article-title>Modularity
and Community Structure in Networks</article-title>. <source>Proc. Natl.
Acad. Sci. U. S. A.</source><year>2006</year>, <volume>103</volume> (<issue>23</issue>), <fpage>8577</fpage>–<lpage>8582</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0601602103</pub-id>.<pub-id pub-id-type="pmid">16723398</pub-id></mixed-citation>
    </ref>
    <ref id="ref82">
      <mixed-citation publication-type="journal" id="cit82"><name><surname>Stumpf</surname><given-names>M. P. H.</given-names></name>; <name><surname>Porter</surname><given-names>M. A.</given-names></name><article-title>Critical Truths
About Power Laws</article-title>. <source>Science</source><year>2012</year>, <volume>335</volume> (<issue>6069</issue>), <fpage>665</fpage>–<lpage>666</lpage>. <pub-id pub-id-type="doi">10.1126/science.1216142</pub-id>.<pub-id pub-id-type="pmid">22323807</pub-id></mixed-citation>
    </ref>
    <ref id="ref83">
      <mixed-citation publication-type="journal" id="cit83"><name><surname>Pirtskhalava</surname><given-names>M.</given-names></name>; <name><surname>Amstrong</surname><given-names>A. A.</given-names></name>; <name><surname>Grigolava</surname><given-names>M.</given-names></name>; <name><surname>Chubinidze</surname><given-names>M.</given-names></name>; <name><surname>Alimbarashvili</surname><given-names>E.</given-names></name>; <name><surname>Vishnepolsky</surname><given-names>B.</given-names></name>; <name><surname>Gabrielian</surname><given-names>A.</given-names></name>; <name><surname>Rosenthal</surname><given-names>A.</given-names></name>; <name><surname>Hurt</surname><given-names>D. E.</given-names></name>; <name><surname>Tartakovsky</surname><given-names>M.</given-names></name><article-title>DBAASP v3:
Database of Antimicrobial/Cytotoxic Activity and Structure of Peptides
as a Resource for Development of New Therapeutics</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume> (<issue>D1</issue>), <fpage>D288</fpage>–<lpage>D297</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa991</pub-id>.<pub-id pub-id-type="pmid">33151284</pub-id></mixed-citation>
    </ref>
    <ref id="ref84">
      <mixed-citation publication-type="journal" id="cit84"><name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Dhanda</surname><given-names>S. K.</given-names></name>; <name><surname>Bhalla</surname><given-names>S.</given-names></name>; <name><surname>Usmani</surname><given-names>S. S.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Tuknait</surname><given-names>A.</given-names></name>; <name><surname>Agrawal</surname><given-names>P.</given-names></name>; <name><surname>Mathur</surname><given-names>D.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><article-title>SATPdb:
A Database of Structurally Annotated Therapeutic
Peptides</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>, <volume>44</volume> (<issue>D1</issue>), <fpage>D1119</fpage>–<lpage>D1126</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1114</pub-id>.<pub-id pub-id-type="pmid">26527728</pub-id></mixed-citation>
    </ref>
    <ref id="ref85">
      <mixed-citation publication-type="journal" id="cit85"><name><surname>Wang</surname><given-names>G.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name><article-title>APD3: The
Antimicrobial Peptide Database as a Tool
for Research and Education</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>, <volume>44</volume> (<issue>D1</issue>), <fpage>D1087</fpage>–<lpage>D1093</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1278</pub-id>.<pub-id pub-id-type="pmid">26602694</pub-id></mixed-citation>
    </ref>
    <ref id="ref86">
      <mixed-citation publication-type="journal" id="cit86"><name><surname>Mukaka</surname><given-names>M. M.</given-names></name><article-title>A Guide
to Appropriate Use of Correlation Coefficient in Medical Research</article-title>. <source>Malawi Med. J.</source><year>2012</year>, <volume>24</volume> (<issue>3</issue>), <fpage>69</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.4314/mmj.v24i3</pub-id>.<pub-id pub-id-type="pmid">23638278</pub-id></mixed-citation>
    </ref>
    <ref id="ref87">
      <mixed-citation publication-type="journal" id="cit87"><name><surname>Schober</surname><given-names>P.</given-names></name>; <name><surname>Boer</surname><given-names>C.</given-names></name>; <name><surname>Schwarte</surname><given-names>L. A.</given-names></name><article-title>Correlation Coefficients: Appropriate
Use and Interpretation</article-title>. <source>Anesth. Analg.</source><year>2018</year>, <volume>126</volume> (<issue>5</issue>), <fpage>1763</fpage>–<lpage>1768</lpage>. <pub-id pub-id-type="doi">10.1213/ANE.0000000000002864</pub-id>.<pub-id pub-id-type="pmid">29481436</pub-id></mixed-citation>
    </ref>
    <ref id="ref88">
      <mixed-citation publication-type="journal" id="cit88"><name><surname>Zucchini</surname><given-names>W.</given-names></name><article-title>An Introduction
to Model Selection</article-title>. <source>J. Math. Psychol.</source><year>2000</year>, <volume>44</volume> (<issue>1</issue>), <fpage>41</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1006/jmps.1999.1276</pub-id>.<pub-id pub-id-type="pmid">10733857</pub-id></mixed-citation>
    </ref>
    <ref id="ref89">
      <mixed-citation publication-type="journal" id="cit89"><name><surname>Gupta</surname><given-names>S.</given-names></name>; <name><surname>Kapoor</surname><given-names>P.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><article-title>In Silico Approach for Predicting Toxicity of Peptides
and Proteins</article-title>. <source>PLoS One</source><year>2013</year>, <volume>8</volume> (<issue>9</issue>), <fpage>e73957</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0073957</pub-id>.<pub-id pub-id-type="pmid">24058508</pub-id></mixed-citation>
    </ref>
    <ref id="ref90">
      <mixed-citation publication-type="journal" id="cit90"><name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Tuknait</surname><given-names>A.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Mathur</surname><given-names>D.</given-names></name>; <name><surname>Anand</surname><given-names>P.</given-names></name>; <name><surname>Varshney</surname><given-names>G. C.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><article-title>A Web
Server and Mobile App for Computing Hemolytic Potency of Peptides</article-title>. <source>Sci. Rep.</source><year>2016</year>, <volume>6</volume> (<issue>1</issue>), <fpage>22843</fpage><pub-id pub-id-type="doi">10.1038/srep22843</pub-id>.<pub-id pub-id-type="pmid">26953092</pub-id></mixed-citation>
    </ref>
    <ref id="ref91">
      <mixed-citation publication-type="journal" id="cit91"><name><surname>Shi</surname><given-names>G.</given-names></name>; <name><surname>Kang</surname><given-names>X.</given-names></name>; <name><surname>Dong</surname><given-names>F.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Zhu</surname><given-names>N.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Xu</surname><given-names>H.</given-names></name>; <name><surname>Lao</surname><given-names>X.</given-names></name>; <name><surname>Zheng</surname><given-names>H.</given-names></name><article-title>DRAMP 3.0: An Enhanced
Comprehensive Data Repository of Antimicrobial Peptides</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>50</volume> (<issue>gkab651</issue>), <fpage>D488</fpage><pub-id pub-id-type="doi">10.1093/nar/gkab651</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref92">
      <mixed-citation publication-type="journal" id="cit92"><name><surname>Maclean</surname><given-names>M. J.</given-names></name>; <name><surname>Brinkworth</surname><given-names>C. S.</given-names></name>; <name><surname>Bilusich</surname><given-names>D.</given-names></name>; <name><surname>Bowie</surname><given-names>J. H.</given-names></name>; <name><surname>Doyle</surname><given-names>J. R.</given-names></name>; <name><surname>Llewellyn</surname><given-names>L. E.</given-names></name>; <name><surname>Tyler</surname><given-names>M. J.</given-names></name><article-title>New Caerin Antibiotic Peptides from
the Skin Secretion of the Dainty Green Tree Frog Litoria Gracilenta.
Identification Using Positive and Negative Ion Electrospray Mass Spectrometry</article-title>. <source>Toxicon</source><year>2006</year>, <volume>47</volume> (<issue>6</issue>), <fpage>664</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2006.01.019</pub-id>.<pub-id pub-id-type="pmid">16554081</pub-id></mixed-citation>
    </ref>
    <ref id="ref93">
      <mixed-citation publication-type="journal" id="cit93"><name><surname>VanCompernolle</surname><given-names>S.</given-names></name>; <name><surname>Smith</surname><given-names>P. B.</given-names></name>; <name><surname>Bowie</surname><given-names>J. H.</given-names></name>; <name><surname>Tyler</surname><given-names>M. J.</given-names></name>; <name><surname>Unutmaz</surname><given-names>D.</given-names></name>; <name><surname>Rollins-Smith</surname><given-names>L. A.</given-names></name><article-title>Inhibition of HIV Infection by Caerin
1 Antimicrobial
Peptides</article-title>. <source>Peptides</source><year>2015</year>, <volume>71</volume>, <fpage>296</fpage>–<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2015.05.004</pub-id>.<pub-id pub-id-type="pmid">26026377</pub-id></mixed-citation>
    </ref>
    <ref id="ref94">
      <mixed-citation publication-type="journal" id="cit94"><name><surname>Park</surname><given-names>I. Y.</given-names></name>; <name><surname>Cho</surname><given-names>J. H.</given-names></name>; <name><surname>Kim</surname><given-names>K. S.</given-names></name>; <name><surname>Kim</surname><given-names>Y.-B.</given-names></name>; <name><surname>Kim</surname><given-names>M. S.</given-names></name>; <name><surname>Kim</surname><given-names>S. C.</given-names></name><article-title>Helix Stability
Confers Salt Resistance upon Helical
Antimicrobial Peptides *</article-title>. <source>J. Biol. Chem.</source><year>2004</year>, <volume>279</volume> (<issue>14</issue>), <fpage>13896</fpage>–<lpage>13901</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M311418200</pub-id>.<pub-id pub-id-type="pmid">14718539</pub-id></mixed-citation>
    </ref>
    <ref id="ref95">
      <mixed-citation publication-type="journal" id="cit95"><name><surname>Haney</surname><given-names>E. F.</given-names></name>; <name><surname>Nazmi</surname><given-names>K.</given-names></name>; <name><surname>Lau</surname><given-names>F.</given-names></name>; <name><surname>Bolscher</surname><given-names>J. G. M.</given-names></name>; <name><surname>Vogel</surname><given-names>H. J.</given-names></name><article-title>Novel Lactoferrampin
Antimicrobial Peptides Derived from Human Lactoferrin</article-title>. <source>Biochimie</source><year>2009</year>, <volume>91</volume> (<issue>1</issue>), <fpage>141</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/j.biochi.2008.04.013</pub-id>.<pub-id pub-id-type="pmid">18534196</pub-id></mixed-citation>
    </ref>
    <ref id="ref96">
      <mixed-citation publication-type="journal" id="cit96"><name><surname>Mechkarska</surname><given-names>M.</given-names></name>; <name><surname>Coquet</surname><given-names>L.</given-names></name>; <name><surname>Leprince</surname><given-names>J.</given-names></name>; <name><surname>Auguste</surname><given-names>R. J.</given-names></name>; <name><surname>Jouenne</surname><given-names>T.</given-names></name>; <name><surname>Mangoni</surname><given-names>M. L.</given-names></name>; <name><surname>Conlon</surname><given-names>J. M.</given-names></name><article-title>Peptidomic Analysis
of the Host-Defense
Peptides in Skin Secretions of the Trinidadian Leaf Frog Phyllomedusa
Trinitatis (Phyllomedusidae)</article-title>. <source>Comp. Biochem.
Physiol. Part D Genomics Proteomics</source><year>2018</year>, <volume>28</volume>, <fpage>72</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbd.2018.06.006</pub-id>.<pub-id pub-id-type="pmid">29980138</pub-id></mixed-citation>
    </ref>
    <ref id="ref97">
      <mixed-citation publication-type="journal" id="cit97"><name><surname>Rost</surname><given-names>B.</given-names></name><article-title>Twilight Zone
of Protein Sequence Alignments</article-title>. <source>Protein Eng.
Des. Sel.</source><year>1999</year>, <volume>12</volume> (<issue>2</issue>), <fpage>85</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1093/protein/12.2.85</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref98">
      <mixed-citation publication-type="journal" id="cit98"><name><surname>Thompson</surname><given-names>J. D.</given-names></name>; <name><surname>Higgins</surname><given-names>D. G.</given-names></name>; <name><surname>Gibson</surname><given-names>T. J.</given-names></name><article-title>CLUSTAL W: Improving the Sensitivity
of Progressive Multiple Sequence Alignment through Sequence Weighting,
Position-Specific Gap Penalties and Weight Matrix Choice</article-title>. <source>Nucleic Acids Res.</source><year>1994</year>, <volume>22</volume> (<issue>22</issue>), <fpage>4673</fpage>–<lpage>4680</lpage>. <pub-id pub-id-type="doi">10.1093/nar/22.22.4673</pub-id>.<pub-id pub-id-type="pmid">7984417</pub-id></mixed-citation>
    </ref>
    <ref id="ref99">
      <mixed-citation publication-type="journal" id="cit99"><name><surname>Thomsen</surname><given-names>M. C. F.</given-names></name>; <name><surname>Nielsen</surname><given-names>M.</given-names></name><article-title>Seq2Logo: A Method
for Construction and Visualization
of Amino Acid Binding Motifs and Sequence Profiles Including Sequence
Weighting, Pseudo Counts and Two-Sided Representation of Amino Acid
Enrichment and Depletion</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>, <volume>40</volume> (<issue>W1</issue>), <fpage>W281</fpage>–<lpage>W287</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks469</pub-id>.<pub-id pub-id-type="pmid">22638583</pub-id></mixed-citation>
    </ref>
    <ref id="ref100">
      <mixed-citation publication-type="journal" id="cit100"><name><surname>Bailey</surname><given-names>T. L.</given-names></name><article-title>DREME:
Motif Discovery in Transcription Factor ChIP-Seq
Data</article-title>. <source>Bioinformatics</source><year>2011</year>, <volume>27</volume> (<issue>12</issue>), <fpage>1653</fpage>–<lpage>1659</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btr261</pub-id>.<pub-id pub-id-type="pmid">21543442</pub-id></mixed-citation>
    </ref>
    <ref id="ref101">
      <mixed-citation publication-type="journal" id="cit101"><name><surname>Heinz</surname><given-names>S.</given-names></name>; <name><surname>Benner</surname><given-names>C.</given-names></name>; <name><surname>Spann</surname><given-names>N.</given-names></name>; <name><surname>Bertolino</surname><given-names>E.</given-names></name>; <name><surname>Lin</surname><given-names>Y. C.</given-names></name>; <name><surname>Laslo</surname><given-names>P.</given-names></name>; <name><surname>Cheng</surname><given-names>J. X.</given-names></name>; <name><surname>Murre</surname><given-names>C.</given-names></name>; <name><surname>Singh</surname><given-names>H.</given-names></name>; <name><surname>Glass</surname><given-names>C. K.</given-names></name><article-title>Simple Combinations
of Lineage-Determining
Transcription Factors Prime Cis-Regulatory Elements Required for Macrophage
and B Cell Identities</article-title>. <source>Mol. Cell</source><year>2010</year>, <volume>38</volume> (<issue>4</issue>), <fpage>576</fpage>–<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id>.<pub-id pub-id-type="pmid">20513432</pub-id></mixed-citation>
    </ref>
    <ref id="ref102">
      <mixed-citation publication-type="journal" id="cit102"><name><surname>Gull</surname><given-names>S.</given-names></name>; <name><surname>Shamim</surname><given-names>N.</given-names></name>; <name><surname>Minhas</surname><given-names>F.</given-names></name><article-title>AMAP: Hierarchical
Multi-Label Prediction of Biologically Active and Antimicrobial Peptides</article-title>. <source>Comput. Biol. Med.</source><year>2019</year>, <volume>107</volume>, <fpage>172</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2019.02.018</pub-id>.<pub-id pub-id-type="pmid">30831306</pub-id></mixed-citation>
    </ref>
    <ref id="ref103">
      <mixed-citation publication-type="journal" id="cit103"><name><surname>Yan</surname><given-names>J.</given-names></name>; <name><surname>Bhadra</surname><given-names>P.</given-names></name>; <name><surname>Li</surname><given-names>A.</given-names></name>; <name><surname>Sethiya</surname><given-names>P.</given-names></name>; <name><surname>Qin</surname><given-names>L.</given-names></name>; <name><surname>Tai</surname><given-names>H. K.</given-names></name>; <name><surname>Wong</surname><given-names>K. H.</given-names></name>; <name><surname>Siu</surname><given-names>S. W. I.</given-names></name><article-title>Deep-AmPEP30:
Improve Short Antimicrobial Peptides Prediction with Deep Learning</article-title>. <source>Mol. Ther. - Nucleic Acids</source><year>2020</year>, <volume>20</volume>, <fpage>882</fpage>–<lpage>894</lpage>. <pub-id pub-id-type="doi">10.1016/j.omtn.2020.05.006</pub-id>.<pub-id pub-id-type="pmid">32464552</pub-id></mixed-citation>
    </ref>
    <ref id="ref104">
      <mixed-citation publication-type="journal" id="cit104"><name><surname>Win</surname><given-names>T. S.</given-names></name>; <name><surname>Malik</surname><given-names>A. A.</given-names></name>; <name><surname>Prachayasittikul</surname><given-names>V.</given-names></name>; <name><surname>S Wikberg</surname><given-names>J. E.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>HemoPred:
A Web Server for Predicting the Hemolytic Activity of Peptides</article-title>. <source>Future Med. Chem.</source><year>2017</year>, <volume>9</volume> (<issue>3</issue>), <fpage>275</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.4155/fmc-2016-0188</pub-id>.<pub-id pub-id-type="pmid">28211294</pub-id></mixed-citation>
    </ref>
    <ref id="ref105">
      <mixed-citation publication-type="journal" id="cit105"><name><surname>Timmons</surname><given-names>P. B.</given-names></name>; <name><surname>Hewage</surname><given-names>C. M.</given-names></name><article-title>HAPPENN Is a Novel
Tool for Hemolytic
Activity Prediction for Therapeutic Peptides Which Employs Neural
Networks</article-title>. <source>Sci. Rep.</source><year>2020</year>, <volume>10</volume> (<issue>1</issue>), <fpage>10869</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-67701-3</pub-id>.<pub-id pub-id-type="pmid">32616760</pub-id></mixed-citation>
    </ref>
    <ref id="ref106">
      <mixed-citation publication-type="journal" id="cit106"><name><surname>Santos-Júnior</surname><given-names>C. D.</given-names></name>; <name><surname>Pan</surname><given-names>S.</given-names></name>; <name><surname>Zhao</surname><given-names>X.-M.</given-names></name>; <name><surname>Coelho</surname><given-names>L. P.</given-names></name><article-title>Macrel: Antimicrobial Peptide Screening
in Genomes
and Metagenomes</article-title>. <source>PeerJ.</source><year>2020</year>, <volume>8</volume>, <fpage>e10555</fpage><pub-id pub-id-type="doi">10.7717/peerj.10555</pub-id>.<pub-id pub-id-type="pmid">33384902</pub-id></mixed-citation>
    </ref>
    <ref id="ref107">
      <mixed-citation publication-type="book" id="cit107"><person-group person-group-type="allauthors"><name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name></person-group><article-title>Computer-Aided Virtual Screening
and Designing of Cell-Penetrating Peptides</article-title>. In <source>Cell-Penetrating Peptides: Methods and Protocols</source>; <person-group person-group-type="editor"><name><surname>Langel</surname><given-names>Ü.</given-names></name></person-group>, Ed.; <publisher-name>Springer New York</publisher-name>: <publisher-loc>New York, NY</publisher-loc>, <year>2015</year>; pp <fpage>59</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-2806-4_4</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref108">
      <mixed-citation publication-type="journal" id="cit108"><name><surname>Tang</surname><given-names>H.</given-names></name>; <name><surname>Su</surname><given-names>Z.-D.</given-names></name>; <name><surname>Wei</surname><given-names>H.-H.</given-names></name>; <name><surname>Chen</surname><given-names>W.</given-names></name>; <name><surname>Lin</surname><given-names>H.</given-names></name><article-title>Prediction
of Cell-Penetrating Peptides with Feature Selection Techniques</article-title>. <source>Biochem. Biophys. Res. Commun.</source><year>2016</year>, <volume>477</volume> (<issue>1</issue>), <fpage>150</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.06.035</pub-id>.<pub-id pub-id-type="pmid">27291150</pub-id></mixed-citation>
    </ref>
    <ref id="ref109">
      <mixed-citation publication-type="journal" id="cit109"><name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Patra</surname><given-names>M. C.</given-names></name><article-title>MLCPP 2.0: An Updated
Cell-Penetrating
Peptides and Their Uptake Efficiency Predictor</article-title>. <source>Comput. Resour. Mol. Biol.</source><year>2022</year>, <volume>434</volume> (<issue>11</issue>), <fpage>167604</fpage><pub-id pub-id-type="doi">10.1016/j.jmb.2022.167604</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref110">
      <mixed-citation publication-type="journal" id="cit110"><name><surname>Mathur</surname><given-names>D.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Mehta</surname><given-names>A.</given-names></name>; <name><surname>Agrawal</surname><given-names>P.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><article-title>In Silico Approaches for Predicting the Half-Life of
Natural and Modified Peptides in Blood</article-title>. <source>PLoS
One</source><year>2018</year>, <volume>13</volume> (<issue>6</issue>), <fpage>e0196829</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0196829</pub-id>.<pub-id pub-id-type="pmid">29856745</pub-id></mixed-citation>
    </ref>
    <ref id="ref111">
      <mixed-citation publication-type="journal" id="cit111"><name><surname>Sharma</surname><given-names>A.</given-names></name>; <name><surname>Singla</surname><given-names>D.</given-names></name>; <name><surname>Rashid</surname><given-names>M.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><article-title>Designing
of Peptides with Desired Half-Life in Intestine-like Environment</article-title>. <source>BMC Bioinformatics</source><year>2014</year>, <volume>15</volume> (<issue>1</issue>), <fpage>282</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-15-282</pub-id>.<pub-id pub-id-type="pmid">25141912</pub-id></mixed-citation>
    </ref>
    <ref id="ref112">
      <mixed-citation publication-type="journal" id="cit112"><name><surname>Sharma</surname><given-names>N.</given-names></name>; <name><surname>Patiyal</surname><given-names>S.</given-names></name>; <name><surname>Dhall</surname><given-names>A.</given-names></name>; <name><surname>Pande</surname><given-names>A.</given-names></name>; <name><surname>Arora</surname><given-names>C.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><article-title>AlgPred 2.0: An Improved Method for
Predicting Allergenic Proteins and Mapping of IgE Epitopes</article-title>. <source>Brief. Bioinform.</source><year>2021</year>, <volume>22</volume> (<issue>4</issue>), <fpage>bbaa294</fpage><pub-id pub-id-type="doi">10.1093/bib/bbaa294</pub-id>.<pub-id pub-id-type="pmid">33201237</pub-id></mixed-citation>
    </ref>
    <ref id="ref113">
      <mixed-citation publication-type="journal" id="cit113"><name><surname>Munir</surname><given-names>F.</given-names></name>; <name><surname>Gul</surname><given-names>S.</given-names></name>; <name><surname>Asif</surname><given-names>A.</given-names></name>; <name><surname>Minhas</surname><given-names>F. -u. -A. A.</given-names></name><article-title>MILAMP: Multiple Instance Prediction of Amyloid Proteins</article-title>. <source>IEEE/ACM Trans. Comput. Biol. Bioinform.</source><year>2021</year>, <volume>18</volume> (<issue>3</issue>), <fpage>1142</fpage>–<lpage>1150</lpage>. <pub-id pub-id-type="doi">10.1109/TCBB.2019.2936846</pub-id>.<pub-id pub-id-type="pmid">31443048</pub-id></mixed-citation>
    </ref>
    <ref id="ref114">
      <mixed-citation publication-type="journal" id="cit114"><name><surname>Tian</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>N.</given-names></name>; <name><surname>Guo</surname><given-names>J.</given-names></name>; <name><surname>Fan</surname><given-names>Y.</given-names></name><article-title>Prediction
of Amyloid Fibril-Forming Segments Based on a Support Vector Machine</article-title>. <source>BMC Bioinformatics</source><year>2009</year>, <volume>10</volume> (<issue>Suppl 1</issue>), <fpage>S45</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-10-S1-S45</pub-id>.<pub-id pub-id-type="pmid">19208147</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
